AN OFFERING STATEMENT PURSUANT TO REGULATION A RELATING TO THESE SECURITIES HAS BEEN FILED WITH THE SECURITIES AND EXCHANGE COMMISSION. INFORMATION CONTAINED IN THIS PRELIMINARY OFFERING CIRCULAR IS SUBJECT TO COMPLETION OR AMENDMENT. THESE SECURITIES MAY NOT BE SOLD NOR MAY OFFERS TO BUY BE ACCEPTED BEFORE THE OFFERING STATEMENT FILED WITH THE COMMISSION IS QUALIFIED. THIS PRELIMINARY OFFERING CIRCULAR SHALL NOT CONSTITUTE AN OFFER TO SELL OR THE SOLICITATION OF AN OFFER TO BUY NOR MAY THERE BE ANY SALES OF THESE SECURITIES IN ANY STATE IN WHICH SUCH OFFER, SOLICITATION OR SALE WOULD BE UNLAWFUL BEFORE REGISTRATION OR QUALIFICATION UNDER THE LAWS OF SUCH STATE. THE COMPANY MAY ELECT TO SATISFY ITS OBLIGATION TO DELIVER A FINAL OFFERING CIRCULAR BY SENDING YOU A NOTICE WITHIN TWO BUSINESS DAYS AFTER THE COMPLETION OF THE COMPANY’S SALE TO YOU THAT CONTAINS THE URL WHERE THE FINAL OFFERING CIRCULAR OR THE OFFERING STATEMENT IN WHICH SUCH FINAL OFFERING CIRCULAR WAS FILED MAY BE OBTAINED.
PRELIMINARY OFFERING CIRCULAR DATED AUGUST 15, 2022
THE BULLET ID CORPORATION
1018 Finch Avenue West, Suite 404, Toronto, Ontario, M3J 3L5.
www.bulletidentification.com
UP TO 52,000,000 SHARES OF COMMON STOCK CONSISTING OF 40,000,000 SHARES TO BE SOLD BY THE COMPANY AND 12,000,000 SHARES TO BE SOLD BY SELLING SHAREHOLDERS (1)
MINIMUM INVESTMENT: $750
SEE “SECURITIES BEING OFFERED” AT PAGE 35
The Bullet ID Corporation., a Canadian corporation, is offering up to 52,000,000 shares of its Common Stock, including 12,000,000 shares to be sold by selling shareholders, no par value (the “Common Stock”). The shares of Common Stock are being offered on a “best efforts” basis, which means that there is no guarantee that any minimum amount will be sold in this Offering. If less than the maximum proceeds are available to us, our development and prospects could be adversely affected. All funds received as a result of this Offering will be immediately available to us for our general business purposes. Because there is no minimum dollar amount of Common Stock that must be sold in order for the offering to close, there is a risk that we may not receive sufficient proceeds from the offering to fully and effectively execute on our business plan as described in this Offering Circular. See “Securities Being Offered” at page 35 for additional details.
Price to Public | Underwriting Discount and commissions(2) | Proceeds to issuer(2)(3) | Proceeds to Selling Shareholders (2)(3) | |||||||||||||
Per Share | $ | 1.00 | $ | 0.04125 | $ | 0.95875 | $ | 0.95875 | ||||||||
Total Maximum | $ | 52,000,000.00 | $ | 2,010,000 | $ | 37,990,000 | $ | 11,505,000 |
(1) | The Company is offering up to 40,000,000 shares of Common Stock. The Selling Stockholders are offering up to 12,000,000 shares of Common Stock. | |
(2) | The Company has engaged Rialto Markets LLC (“Rialto”) to act as a placement agent for this offering and to perform certain administrative and technology-related functions as set forth in “Plan of Distribution.” The Company will pay a cash commission of 3% to Rialto on sales of the Common Stock. The Company may pay a cash commission of a 6% to Rialto on sales of up to $15,000,000 in Common Stock sold solely due to Rialto’s direct selling efforts up to an amount not exceeding $900,000. The Company will also pay a $6,500 advance fee for reasonable accountable out of pocket expenses actually anticipated to be incurred by Rialto, including fees due to FINRA. Any unused portion of this fee not actually incurred by Rialto will be returned to the Company. The maximum amount the Company may pay to Rialto is $2,016,500. This does not include processing fees paid directly in commissions to the Rialto Platform by investors. |
(3) | Does not include estimated offering expenses including, without limitation, legal, accounting, auditing, other professional, printing, advertising, travel, marketing, blue-sky compliance and other expenses of this Offering. We estimate the total expenses of this Offering, including commissions to Rialto, will be $2,119,500, not including other expenses or state filing fees. |
The Company has engaged Thread Bank (the “Escrow Agent”) to hold funds tendered by investors. We may hold a series of closings at which we receive the funds from the Escrow Agent and issue the shares of Common Stock to investors. This offering (the “Offering”) will terminate at the earlier of: (i) the date at which the maximum offering amount has been sold, (ii) the date at which the Offering is earlier terminated by the Company, in its sole discretion or (iii) the date which is one year from this Offering being qualified by the United States Securities and Exchange Commission (the “Commission”). The Offering is being conducted on a best-efforts basis. The Company may undertake one or more closings on a rolling basis. After each closing, funds tendered by investors will be available to the Company.
INVESTING IN THE SHARES OF COMMON STOCK OF BULLET ID CORPORATION IS SPECULATIVE AND INVOLVES SUBSTANTIAL RISKS. YOU SHOULD PURCHASE THESE SECURITIES ONLY IF YOU CAN AFFORD A COMPLETE LOSS OF YOUR INVESTMENT. SEE “RISK FACTORS” BEGINNING ON PAGE 3 TO READ ABOUT THE MORE SIGNIFICANT RISKS YOU SHOULD CONSIDER BEFORE BUYING THE SHARES OF COMMON STOCK OF THE COMPANY.
THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION DOES NOT PASS UPON THE MERITS OR GIVE ITS APPROVAL OF ANY SECURITIES OFFERED OR THE TERMS OF THE OFFERING, NOR DOES IT PASS UPON THE ACCURACY OR COMPLETENESS OF ANY OFFERING CIRCULAR OR OTHER SOLICITATION MATERIALS. THESE SECURITIES ARE OFFERED PURSUANT TO AN EXEMPTION FROM REGISTRATION WITH THE COMMISSION; HOWEVER, THE COMMISSION HAS NOT MADE AN INDEPENDENT DETERMINATION THAT THE SECURITIES OFFERED ARE EXEMPT FROM REGISTRATION
GENERALLY, NO SALE MAY BE MADE TO YOU IN THIS OFFERING IF THE AGGREGATE PURCHASE PRICE YOU PAY IS MORE THAN 10% OF THE GREATER OF YOUR ANNUAL INCOME OR NET WORTH. DIFFERENT RULES APPLY TO ACCREDITED INVESTORS AND NON-NATURAL PERSONS. BEFORE MAKING ANY REPRESENTATION THAT YOUR INVESTMENT DOES NOT EXCEED APPLICABLE THRESHOLDS, WE ENCOURAGE YOU TO REVIEW RULE 251(d)(2)(i)(C) OF REGULATION A. FOR GENERAL INFORMATION ON INVESTING, WE ENCOURAGE YOU TO REFER TO www.investor.gov.
Sales of these securities will commence on approximately ___________, 2022.
The Company is following the “Offering Circular” format of disclosure under Regulation A.
In the event that we become a reporting company under the Securities Exchange Act of 1934, we intend to take advantage of the provisions that relate to “Emerging Growth Companies” under the JOBS Act of 2012. See “Implications of Being an Emerging Growth Company.”
TABLE OF CONTENTS
i
In this Offering Circular, the terms “Bullet”, “Bullet ID” “our”, “we”, “us”, and the “Company” refer to The Bullet ID Corporation. All references to $ amounts are stated in Canadian Dollars, unless otherwise noted.
THIS OFFERING CIRCULAR MAY CONTAIN FORWARD-LOOKING STATEMENTS AND INFORMATION RELATING TO, AMONG OTHER THINGS, THE COMPANY, ITS BUSINESS PLAN AND STRATEGY, AND ITS INDUSTRY. THESE FORWARD-LOOKING STATEMENTS ARE BASED ON THE BELIEFS OF, ASSUMPTIONS MADE BY, AND INFORMATION CURRENTLY AVAILABLE TO THE COMPANY’S MANAGEMENT. WHEN USED IN THE OFFERING MATERIALS, THE WORDS “ESTIMATE,” “PROJECT,” “BELIEVE,” “ANTICIPATE,” “INTEND,” “EXPECT” AND SIMILAR EXPRESSIONS ARE INTENDED TO IDENTIFY FORWARD-LOOKING STATEMENTS, WHICH CONSTITUTE FORWARD LOOKING STATEMENTS. THESE STATEMENTS REFLECT MANAGEMENT’S CURRENT VIEWS WITH RESPECT TO FUTURE EVENTS AND ARE SUBJECT TO RISKS AND UNCERTAINTIES THAT COULD CAUSE THE COMPANY’S ACTUAL RESULTS TO DIFFER MATERIALLY FROM THOSE CONTAINED IN THE FORWARD-LOOKING STATEMENTS. INVESTORS ARE CAUTIONED NOT TO PLACE UNDUE RELIANCE ON THESE FORWARD-LOOKING STATEMENTS, WHICH SPEAK ONLY AS OF THE DATE ON WHICH THEY ARE MADE. THE COMPANY DOES NOT UNDERTAKE ANY OBLIGATION TO REVISE OR UPDATE THESE FORWARD-LOOKING STATEMENTS TO REFLECT EVENTS OR CIRCUMSTANCES AFTER SUCH DATE OR TO REFLECT THE OCCURRENCE OF UNANTICIPATED EVENTS.
Implications of Being an Emerging Growth Company
As an issuer with less than $1.07 billion in total annual gross revenues during our last fiscal year, we will qualify as an “emerging growth company” under the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”) and this status will be significant if and when we become subject to the ongoing reporting requirements of the Exchange Act upon filing a Form 8-A. An emerging growth company may take advantage of certain reduced reporting requirements and is relieved of certain other significant requirements that are otherwise generally applicable to public companies. In particular, as an emerging growth company we:
● | will not be required to obtain an auditor attestation on our internal controls over financial reporting pursuant to the Sarbanes-Oxley Act of 2002; | |
● | will not be required to provide a detailed narrative disclosure discussing our compensation principles, objectives and elements and analysing how those elements fit with our principles and objectives (commonly referred to as “compensation discussion and analysis”); | |
● | will not be required to obtain a non-binding advisory vote from our members on executive compensation or golden parachute arrangements (commonly referred to as the “say-on-pay,” “say-on-frequency” and “say-on-golden-parachute” votes); | |
● | will be exempt from certain executive compensation disclosure provisions requiring a pay-for-performance graph and CEO pay ratio disclosure; | |
● | may present only two years of audited financial statements and only two years of related Management’s Discussion and Analysis of Financial Condition and Results of Operations, or MD&A; and | |
● | will be eligible to claim longer phase-in periods for the adoption of new or revised financial accounting standards. |
We intend to take advantage of all of these reduced reporting requirements and exemptions, including the longer phase-in periods for the adoption of new or revised financial accounting standards, and hereby elect to do so. Our election to use the phase-in periods may make it difficult to compare our financial statements to those of non-emerging growth companies and other emerging growth companies that have opted out of the phase-in periods under Section 107 of the JOBS Act.
Under the JOBS Act, we may take advantage of the above-described reduced reporting requirements and exemptions for up to five years after our initial sale of common equity pursuant to a registration statement declared effective under the Securities Act of 1933, as amended, or such earlier time that we no longer meet the definition of an emerging growth company. Note that this Offering, while a public offering, is not a sale of common equity pursuant to a registration statement, since the Offering is conducted pursuant to an exemption from the registration requirements. In this regard, the JOBS Act provides that we would cease to be an “emerging growth company” if we have more than $1.07 billion in annual revenues, have more than $700 million in market value of our limited liability company membership interests held by non-affiliates, or issue more than $1 billion in principal amount of non-convertible debt over a three-year period.
Certain of these reduced reporting requirements and exemptions are also available to us due to the fact that we may also qualify, once listed, as a “smaller reporting company” under the Commission’s rules. For instance, smaller reporting companies are not required to obtain an auditor attestation on their assessment of internal control over financial reporting; are not required to provide a compensation discussion and analysis; are not required to provide a pay-for-performance graph or CEO pay ratio disclosure; and may present only two years of audited financial statements and related MD&A disclosure.
ii
Overview
The Bullet ID Corporation (the “Company”) has created an authenticated ammunition tracking system. The Company was incorporated under the Business Corporation Act of Ontario on December 23, 2016.
The Company owns machines and proprietary software that work together to laser-etch a unique bar code onto the brass cartridge case of a bullet. The Company intends to sell its machines and proprietary software to ammunition manufacturers, law enforcement and the military. The Company believes that this system of laser-etching allows for the traceability of a round of bullets from the point of manufacturing to the point of distribution to the end user. As of December 31, 2021, the Company has not generated any revenue.
The Offering
Securities offered | 52,000,000 shares of Common Stock, consisting of 40,000000 shares to be sold by the Company and 12,000,000 shares of Common Stock to be sold by selling shareholders | |
Minimum Investment | $750 | |
Common Stock outstanding before the Offering (as of August 15, 2022 (1)(2) | 71,338,511 | |
Common Stock outstanding after the Offering assuming a fully subscribed offering (1)(2) | 111,338,511 |
(1) | Does not include 10,325,928 shares issuable upon exercise of outstanding warrants issued as of August 15, 2022. |
(2) | Does not include 6,404,250 shares issuable upon conversion of convertible debt issued as of August 15, 2022. |
Selected Risks Associated with Our Business
Our business expects to be subject to a number of risks and uncertainties, including those highlighted in the section titled “Risk Factors” immediately following this summary. These risks include, but are not limited to, the following:
● | The Company has a limited operating history upon which you can evaluate its performance and has not yet generated profits. Accordingly, the Company’s prospects must be considered in light of the risks that any new Company encounters. | |
● | The Company anticipates sustaining continued operating losses. | |
● | The Company’s business projections are only projections. | |
● | If the Company cannot raise sufficient funds, it will not succeed. | |
● | Future fundraising may affect the rights of investors. | |
● | We are targeting a new and unproven segment within the ammunition market. | |
● | Any valuation at this stage is difficult to assess. | |
● | The Company’s Financial Statements include a Going Concern Opinion. | |
● | Our product and services may never be purchased. | |
● | Our products could fail to achieve the sales projections we expected. | |
● | You are trusting that management will make the best decision for the Company. |
1
● | Management discretion as to use of proceeds. | |
● | The loss of one or more of our key personnel or our failure to attract and retain other highly qualified personnel in the future could harm our business. | |
● | The Company relies on third parties to provide services essential to the success of its business | |
● | The Company’s ability to sell its product or service is dependent on outside government regulation which can be subject to change at any time. | |
● | The Company may not be able to protect its intellectual property. | |
● | We have pending patent approval’s that might be vulnerable. | |
● | The Company’s success will depend on its ability to secure additional patent protection for its core technologies and be able to enforce those patents. | |
● | The Company’s trademarks, copyrights and other intellectual property could be unenforceable or ineffective. by entering into sublicenses. This would cut off a significant potential revenue stream for the Company. | |
● | Our information technology and websites may be susceptible to cybersecurity breaches, outages and other risks. | |
● | Failure to adequately maintain the security of our electronic and other confidential information could materially adversely affect our business. | |
● | We are subject to risks related foreign currency exchange rates and we are exposed to fluctuations in currency exchange rates that could negatively impact our financial results and cash flows. We operate on a global basis. | |
● | There is no current market for any shares of the Company’s stock. | |
● | Investors will hold minority interests in the Company. | |
● | Some of the Company’s other investors have rights to receive information that you may not receive. | |
● | The offering price has been arbitrarily set by the Company. | |
● | The Company is controlled by its Founder and other shareholders. | |
● | The Subscription Agreement has a forum selection provision that requires disputes be resolved in state or federal courts in the State of Delaware, regardless of convenience or cost to you, the investor. | |
● | Investors in this offering may not be entitled to a jury trial with respect to claims arising under the Subscription Agreement, which could result in less favorable outcomes to the plaintiff(s) in any action under the Subscription Agreement. | |
● | The Company’s results of operations may be negatively impacted by the coronavirus outbreak. |
2
The SEC requires the Company to identify risks that are specific to its business and its financial condition. The company is still subject to all the same risks that all companies in its business, and all companies in the economy, are exposed to. These include risks relating to economic downturns, political and economic events and technological developments (such as cyber-attacks and the ability to prevent such attacks). Additionally, early-stage companies are inherently more risky than more developed companies, and the risk of business failure and complete loss of your investment capital is present. You should consider general risks as well as specific risks when deciding whether to invest.
Risks Related to the Company
The Company has a limited operating history upon which you can evaluate its performance and has not yet generated profits. Accordingly, the Company’s prospects must be considered in light of the risks that any new Company encounters. Bullet ID was incorporated under the Business Corporation Act of Ontario on December 23, 2016. The Company has not yet generated sustained profits. The likelihood of its creation of a viable business must be considered in light of the problems, expenses, difficulties, complications, and delays frequently encountered in connection with the growth of a business, operation in a new industry, and the continued development of its technology and products. Bullet ID has incurred a net loss and has not yet generated revenue. The Company anticipates that its operating expenses will increase for the near future, and there is no assurance that it will be profitable in the near future. You should consider the business, operations and prospects in light of the risks, expenses and challenges faced as an emerging growth company.
The Company anticipates sustaining continued operating losses. It is anticipated that the Company will continue to sustain operating losses. Bullet ID’s ability to become profitable depends on success in licensing and selling of products. There can be no assurance that this will occur. Unanticipated problems and expenses are often encountered in offering new products, which may impact whether the Company is successful. Furthermore, the Company may encounter substantial delays and unexpected expenses related to development, technological changes, marketing, regulatory requirements and changes to such requirements or other unforeseen difficulties. There can be no assurance that the Company will ever become profitable. If the Company sustains losses over an extended period of time, it may be unable to continue in business.
The Company’s business projections are only projections. There can be no assurance that the Company will meet its projections. There can be no assurance that the Company will be able to find sufficient demand for its product, that people think it’s a better option than a competing product, or that the Company will able to provide the service at a level that allows it to make a profit and still attract business.
If the Company cannot raise sufficient funds, it will not succeed. Bullet ID and the Company’s selling stockholders are offering Common Stock in the amount of 52,000,000 shares and up to $52,000,000 in this offering on a best-efforts basis and may not raise the complete amount. Even if the maximum amount is raised, the Company is likely to need additional funds in the future in order to grow, and if it cannot raise those funds for whatever reason, including reasons relating to the Company itself or to the broader economy, it may not survive. If the Company manages to raise a substantially lesser amount than the Maximum Raise, it will have to find other sources of funding for some of the plans outlined in “Use of Proceeds to Issuer”
Future fundraising may affect the rights of investors. In order to expand, the Company is likely to raise funds again in the future, either by offerings of securities or through borrowing from banks or other sources. The terms of future capital-raising, such as loan agreements, may include covenants that give creditors greater rights over the financial resources of the Company.
We are targeting a new and unproven segment within the ammunition market. Targeting a new and unproven segment, such as bullet tracking, introduces unknowns, such as customer adoption. We will only succeed (and you will only make money) if there is sufficient demand for this service, people think it is a better option than the competition and the Company has priced its services at a level that allows the Company to make a profit and still attract business. Further, competitors may succeed in developing and marketing competing equivalent products, or superior products than those developed by the Company. There can be no assurance that competitors will render the Company’s technology or products obsolete or that the products developed by the Company will be preferred to any existing or newly developed technologies. It should further be assumed that competition will intensify as new entrants to the bullet tracking market emerge.
3
Any valuation at this stage is difficult to assess. The valuation for this offering was established by the Company. Unlike listed companies that are valued publicly through market-driven stock prices, the valuation of private companies, especially early-stage companies, is difficult to assess and you may risk overpaying for your investment.
The Company’s Financial Statements include a Going Concern Opinion. The Company’s financial statements were prepared on a “going concern” basis. Certain matters, as described in the accompanying financial statements, indicate there may be substantial doubt about the Company’s ability to continue as a going concern. The Company is in the start-up stage and as such no revenue has been generated from its operations. At December 31, 2021, the Company’s current liabilities exceeded its current assets by $979,654 and as of that date, there was an accumulated deficit of $5,843,729. The Company’s ability to continue as a going concern is dependent upon completion of the development of its bullet identification process, successful marketing launch of its products and obtaining adequate financing from third parties and related parties to finance its ongoing operations. There is no assurance that the Company will be successful at these initiatives. These material uncertainties may cast significant doubt about the Company’s ability to continue as a going concern. These financial statements do not reflect any adjustments to the carrying values of assets and liabilities that would be necessary if the Company were unable to achieve profitable operations or obtain adequate financing.
Our product and services may never be purchased. It is possible that ammunition manufacturers, law enforcement and military will never purchase our machines and proprietary software with which to laser-etch a unique bar code on the brass cartridge of bullets. If our products fail to achieve significant sales and acceptance in the marketplace, this could materially and adversely impact the value of your investment.
Our products could fail to achieve the sales projections we expected. Our growth projections are based on an assumption that with an increased advertising and marketing budget our products will be able to gain traction in the marketplace at a faster rate than our products have done previously. It is possible that our new products will fail to gain market acceptance for any number of reasons. If the new products fail to achieve significant sales and acceptance in the marketplace, this could materially and adversely impact the value of your investment.
You are trusting that management will make the best decision for the Company. You are trusting in management discretion. You are buying securities as a minority holder, and therefore must trust the management of the Company to make good business decisions that grow your investment.
Management discretion as to use of proceeds. The Company’s success will be substantially dependent upon the discretion and judgment of its management team with respect to the application and allocation of the proceeds of this offering. The use of proceeds described in “Use of Proceeds to Issuer” is an estimate based on the Company’s current business plan. The Company, however, may find it necessary or advisable to re-allocate portions of the net proceeds reserved for one category to another, and it will have broad discretion in doing so.
The loss of one or more of our key personnel or our failure to attract and retain other highly qualified personnel in the future could harm our business. To be successful, the Company requires capable people to run its day to day operations. As the Company grows, it will need to attract and hire additional employees in sales, marketing, design, development, operations, finance, legal, human resources and other areas. Depending on the economic environment and the Company’s performance, we may not be able to locate or attract qualified individuals for such positions when we need them. We may also make hiring mistakes, which can be costly in terms of resources spent in recruiting, hiring and investing in the incorrect individual and in the time delay in locating the right employee fit. If we are unable to attract, hire and retain the right talent or make too many hiring mistakes, it is likely our business will suffer from not having the right employees in the right positions at the right time. This would likely adversely impact the value of your investment.
The Company relies on third parties to provide services essential to the success of its business. The Company relies on third parties to provide a variety of essential business functions for it, including manufacturing, shipping, accounting, legal work, public relations, advertising, retailing, and distribution. It is possible that some of these third parties will fail to perform their services or will perform them in an unacceptable manner. It is possible that the Company will experience delays, defects, errors, or other problems with their work that will materially impact its operations and it may have little or no recourse to recover damages for these losses. A disruption in these key or other suppliers’ operations could materially and adversely affect the Company’s business. As a result, your investment could be adversely impacted by the Company’s reliance on third parties and their performance.
4
The Company’s success in selling its product is dependent on outside government regulation which can be subject to change at any time. The Company’s success in selling its product is dependent on the outside government regulation such as mandating the use of serialization of ammunition and other relevant government laws and regulations. The laws and regulations concerning the selling of products related to ammunition may be subject to change and if they do then the selling of product may no longer be economically feasible for the Company. At such point the Company may no longer want to sell product and therefore your investment in the Company may be affected.
We have pending patent approvals that might be vulnerable. One of the Company’s most valuable assets is its intellectual property, including a patent applicable filed in April, 2017. Other Company intellectual property may include trademarks, copyrights, Internet domain names, and trade secrets. Due to the value, competitors may misappropriate or violate the rights owned by the Company. The Company intends to continue to protect its intellectual property portfolio from such violations. It is important to note that unforeseeable costs associated with such practices may increase the expenses of the Company.
The Company’s success will depend on its ability to secure additional patent protection for its core technologies and be able to enforce those patents. Some patent applications that are pending may not result in issued patents. If any patent application results in an issued patent, that patent may later be invalidated or held unenforceable as patent law changes. Further, the outsourcing of the manufacture of the Company’s product may result in the unauthorized exposure of the intellectual property of the Company.
The Company’s patents, trademarks, copyrights and other intellectual property could be unenforceable or ineffective. Intellectual property is a complex field of law in which few things are certain. It is possible that competitors will be able to design around the Company’s intellectual property, find prior art to invalidate it, or render the patents unenforceable through some other mechanism. If competitors are able to bypass the Company’s intellectual property protection, it is likely that the Company’s value will be materially and adversely impacted. This could also impair the Company’s ability to compete in the marketplace. Moreover, if the intellectual property is deemed unenforceable, the Company will almost certainly lose any potential revenue it might be able to raise by entering into sublicenses. This would cut off a significant potential revenue stream for the Company.
Our information technology and websites may be susceptible to cybersecurity breaches, outages and other risks. We rely on information technology (outsourced and in-house) that support our business processes, including product development, marketing, sales, order processing, production, distribution, finance and intracompany communications throughout the world. We have e-commerce and other Internet websites in the United States and many other countries. These systems may be susceptible to outages due to fire, floods, power loss, telecommunications failures, break-ins and other events. Despite the implementation of network security measures, our systems may be vulnerable to constantly evolving cybersecurity threats such as malware, break-ins and similar disruptions from unauthorized tampering. The occurrence of these or other events could disrupt or damage our information technology and adversely affect our business. Insurance policies that may provide coverage with regard to such events may not cover any or all of the resulting financial losses.
We are subject to risks related foreign currency exchange rates and we are exposed to fluctuations in currency exchange rates that could negatively impact our financial results and cash flows. We operate on a global basis. The future cash flows or fair value of the Company’s financial instruments that are denominated in a currency that is not the Company’s functional currency will fluctuate due to the change in foreign exchange rate. The functional currency of the Company is the Canadian dollar. The Company is exposed to the currency exchange rate risk on its cash and accounts payable and accrued liabilities held in US dollar. As at the period ended December 31 2021, the Company had $141 of cash and $171,670 of accounts payable and accrued liabilities held in US dollars. The Company does not use derivative financial instruments to mitigate its exposure to currency risk. Management, however, mitigates currency risk by regular monitoring and transacting in stable currencies. A 10% change in the value of the US dollar will result in approximately $17,200 increase/decrease in the Company’s net loss. These exposures may change over time as business practices evolve, and they could have a material adverse impact on our financial results and cash flows.
5
Risks Related to Securities in this Offering
There is no current market for any shares of the Company’s stock. You should be prepared to hold this investment for several years or longer. More importantly, there is no established market for these securities and there may never be one. As a result, if you decide to sell these securities in the future, you may not be able to find a buyer. Investors should assume that they may not be able to liquidate their investment for some time, or be able to pledge their shares as collateral.
Investors will hold minority interests in the Company. The Company has already issued 71,338,511 shares of its Common Stock. Investors will hold minority interests in the Company and will not be able to direct its operations.
Some of the Company’s other investors have rights to receive information that you may not receive. While no shares have been issued, holders of Class A Preferred Shares would be entitled to receive notice and to attend all shareholder meetings. Thus, holders of Class A Preferred Shares may have access to information about the Company that you do not have.
The offering price has been arbitrarily set by the Company. Bullet ID has set the price of its Common Stock at $1.00 per share. Valuations for companies at this stage are purely speculative. The company’s valuation has not been validated by any independent third party and may fall precipitously. It is a question of whether you, the investor, are willing to pay this price for a percentage ownership of a start-up company. You should not invest if you disagree with this valuation.
The Company is controlled by its Founder and other shareholders. The Company’s Founder, Bruce Lewis currently holds a significant portion of the Company’s common stock, which gives him control over voting for the Company’s board of directors and for certain shareholder actions. At the conclusion of this offering, he will continue to hold a significant portion of the Company’s voting rights. Therefore, investors in this offering will not have the ability to impact elections of directors or matters presented to a vote of shareholders. See “Securities Being Offered.”
Risks related to forum selection and jury waivers
The Subscription Agreement has a forum selection provision that requires disputes be resolved in state or federal courts in the State of Delaware, regardless of convenience or cost to you, the investor. As part of this investment, each investor will be required to agree to the terms of the subscription agreement included as Exhibit 4.1 to the Offering Statement of which this Offering Circular is part (the “Subscription Agreement”). In the agreement, investors agree to resolve disputes arising under the subscription agreement in state or federal courts located in the State of Delaware, for the purpose of any suit, action or other proceeding arising out of or based upon the agreement. Section 22 of the Securities Act creates concurrent jurisdiction for federal and state courts over all suits brought to enforce any duty or liability created by the Securities Act or the rules and regulations thereunder. The Company believes that the exclusive forum provision applies to claims arising under the Securities Act, but there is uncertainty as to whether a court would enforce such a provision in this context. Section 27 of the Exchange Act creates exclusive federal jurisdiction over all suits brought to enforce any duty or liability created by the Exchange Act or the rules and regulations thereunder. As a result, the exclusive forum provision will not apply to suits brought to enforce any duty or liability created by the Exchange Act or any other claim for which the federal courts have exclusive jurisdiction. You will not be deemed to have waived the Company’s compliance with the federal securities laws and the rules and regulations thereunder. This forum selection provision may limit your ability to obtain a favorable judicial forum for disputes with us. Although we believe the provision benefits us by providing increased consistency in the application of Delaware law in the types of lawsuits to which it applies and in limiting our litigation costs, to the extent it is enforceable, the forum selection provision may limit investors’ ability to bring claims in judicial forums that they find favorable to such disputes, may increase investors’ costs of bringing suit and may discourage lawsuits with respect to such claims. Alternatively, if a court were to find the provision inapplicable to, or unenforceable in an action, the Company may incur additional costs associated with resolving such matters in other jurisdictions, which could adversely affect its business, financial condition or results of operations.
Investors in this offering may not be entitled to a jury trial with respect to claims arising under the Subscription Agreement, which could result in less favorable outcomes to the plaintiff(s) in any action under the Subscription Agreement. Investors in this offering will be bound by the Subscription Agreement, which includes a provision under which investors waive the right to a jury trial of any claim they may have against the Company arising out of or relating to the Agreement, including any claims made under the federal securities laws. By signing the Agreement, the investor warrants that the investor has reviewed this waiver with his or her legal counsel, and knowingly and voluntarily waives the investor’s jury trial rights following consultation with the investor’s legal counsel.
6
If the Company opposed a jury trial demand based on the waiver, a court would determine whether the waiver was enforceable based on the facts and circumstances of that case in accordance with the applicable state and federal law. To the Company’s knowledge, the enforceability of a contractual pre-dispute jury trial waiver in connection with claims arising under the federal securities laws has not been finally adjudicated by a federal court. However, the Company believes that a contractual pre-dispute jury trial waiver provision is generally enforceable, including under the laws of the State of Delaware, which governs the agreement, by a federal or state court in the State of Delaware. In determining whether to enforce a contractual pre-dispute jury trial waiver provision, courts will generally consider whether the visibility of the jury trial waiver provision within an agreement is sufficiently prominent such that a party knowingly, intelligently, and voluntarily waived the right to a jury trial. The Company believes that this is the case with respect to the Subscription Agreement. You should consult legal counsel regarding the jury waiver provision before entering into the Subscription Agreement.
If you bring a claim against the Company in connection with matters arising under the Subscription Agreement, including claims under the federal securities laws, you may not be entitled to a jury trial with respect to those claims, which may have the effect of limiting and discouraging lawsuits against the Company. If a lawsuit is brought against the Company under the agreement, it may be heard only by a judge or justice of the applicable trial court, which would be conducted according to different civil procedures and may result in different outcomes than a trial by jury would have had, including results that could be less favorable to the plaintiff(s) in such an action.
Nevertheless, if the jury trial waiver provision is not permitted by applicable law, an action could proceed under the terms of the Agreement with a jury trial. No condition, stipulation or provision of the Subscription Agreement serves as a waiver by any holder of the Company’s securities or by the Company of compliance with any substantive provision of the federal securities laws and the rules and regulations promulgated under those laws.
In addition, when the shares are transferred, the transferee is required to agree to all the same conditions, obligations, and restrictions applicable to the shares or to the transferor with regard to ownership of the shares, that were in effect immediately prior to the transfer of the shares, including but not limited to the Subscription Agreement.
Risks Related to Covid-19
The Company’s results of operations may be negatively impacted by the coronavirus outbreak. In December 2019, a novel strain of coronavirus, or COVID-19, was reported to have surfaced in Wuhan, China. COVID-19 has spread to many countries, including the United States, and was declared to be a pandemic by the World Health Organization. Efforts to contain the spread of COVID-19 have intensified, and the U.S., Europe, and Asia have implemented severe travel restrictions and social distancing. The impacts of the outbreak are unknown and rapidly evolving. A widespread health crisis has adversely affected and could continue to affect the global economy, resulting in an economic downturn that could negatively impact the value of the common shares and investor demand for the common shares generally.
The continued spread of COVID-19 has also led to severe disruption and volatility in the global capital markets, which could increase the Company’s cost of capital and adversely affect its ability to access the capital markets in the future. It is possible that the continued spread of COVID-19 could cause a further economic slowdown or recession or cause other unpredictable events, each of which could adversely affect Bullet ID’s business, results of operations, or financial condition.
The extent to which COVID-19 affects the Company’s financial results will depend on future developments, which are highly uncertain and cannot be predicted, including new information which may emerge concerning the severity of the COVID-19 outbreak and the actions to contain the outbreak or treat its impact, among others. Moreover, the COVID-19 outbreak has had and may continue to have indeterminable adverse effects on general commercial activity and the world economy, and the Company’s business and results of operations could be adversely affected to the extent that COVID-19 or any other pandemic harms the global economy generally.
Actual or threatened epidemics, pandemics, outbreaks, or other public health crises may adversely affect Bullet ID’s business. Bullet ID’s business could be materially and adversely affected by the risks, or the public perception of the risks, related to an epidemic, pandemic, outbreak, or other public health crisis, such as the recent outbreak of novel coronavirus, or -19. The risk, or public perception of the risk, of a pandemic or media coverage of infectious diseases could adversely affect the value of the Common Stock and the financial condition of our investors or prospective investors, resulting in reduced demand for the Common Stock generally. “Shelter-in-place” or other such orders by governmental entities could also disrupt the Company’s operations, if employees, who cannot perform their responsibilities from home, are not able to report to work.
7
Dilution means a reduction in value, control, or earnings of the shares the investor owns.
Immediate dilution
An early-stage company typically sells its shares (or grants options over its shares) to its founders and early employees at a very low cash cost, because they are, in effect, putting their “sweat equity” into the Company. When the Company seeks cash investments from outside investors, like you, the new investors typically pay a much larger sum for their shares than the founders or earlier investors, which means that the cash value of your stake is diluted because all the shares are worth the same amount, and you paid more than earlier investors for your shares.
The following table compares the price that new investors are paying for their shares with the effective cash price paid by existing shareholders assuming that the shares are sold at $1.00 USD per share. The schedule presents shares and pricing as issued and reflects all transactions since Inception.
The following table presents the approximate effective cash price paid for all shares and potential shares issuable by the Company as of August 12, 2022, and excludes sales by selling securityholders in this offering.
Date Issued | Issued Shares(2) | Potential Shares(1) | Total Issued and Potential Shares(2) |
Effective Cash Price at Issuance or Potential Conversion(3) |
|||||||||||||
Common Stock | Up to June 23, 2022 | 71,170,611 | -- | 71,170,611 | $0.04 USD | ||||||||||||
Total Common Share Equivalents | Up to June 23, 2022 | -- | 9,009,250 | 9,009,250 | (1) | $0.08 USD | |||||||||||
Warrants | Up to June 23, 2022 | -- | 10,325,928 | 10,325,928 | $0.29 USD | ||||||||||||
Investors in this offering, assuming $40,000,000 USD raised | 40,000,000 | -- | 40,000,000 | $1 USD/share | |||||||||||||
Total after inclusion of this offering | 111,170,611 | 19,335,178 | 130,505,789 | $0.36 USD/share |
(1) | Includes: |
● | Convertible debt issued prior to June 23, 2022. Units can be converted into 6,404,250 shares of Common Stock. | |
● | Vested options: Can be exercised for issuance of 2,605,000 common shares. |
(2) | Does not include: |
● | 100,000 units issued on June 23, 2022, at a price of $0.25 per unit for a total of $25,000. Each unit comprised of one common share and one half of one common share purchase warrant, with each warrant entitling the holder thereof to acquire one common share at an exercise price of $0.40 per share for a period of two years. |
● | On July 28, 2022 a conversion of warrants into 67,900 shares of Common Stock occurred. The shares of Common Stock were issued at $0.06 USD and the Company received $4,074. |
(3) | Weighted average pricing presented. |
The following table illustrates the dilution that new investors will experience upon investment in the Company relative to existing holders of the Company’s securities. Because this calculation is based on the net tangible assets of the Company, the Company is calculating based on its net tangible book value of ($1,085,148 USD) as of December 31, 2021. The offering costs assumed in the following table includes up to: $2,100,000 USD in fees to Rialto, accounting fees, Blue Sky fees, and Edgarization and other costs and incurred for this offering.
8
The table presents four scenarios for the convenience of the reader: a fully subscribed $40,000,000 raise from this offering, a $30,000,000 raise from this offering, a $20,000,000 raise from this offering, and a $10,000,000 raise from this offering, in each case excluding shares being offered by the selling shareholders.
Percentage of funding | 100% | 75% | 50% | 25% | ||||
Offering price | $1 USD/share | $1USD/share | $1USD/share | $1USD/share | ||||
Total Gross Proceeds | $40,000,000 USD | $30,000,000 USD | $20,000,000 USD | $10,000,000 USD | ||||
Total Shares outstanding Prior to the Offering as of December 31, 2021 | 65,779,995 shares | 65,779,995 shares | 65,779,995 shares | 65,779,995 shares | ||||
Net Tangible Book value as of December 31, 2021 | ($1,085,148USD) | ($1,085,148USD) | ($1,085,148USD) | ($1,085,148USD) | ||||
Net Tangible Book value per share Prior to the Offering | ($0.0165 USD/share) | ($0.0165 USD/share) | ($0.0165 USD/share) | ($0.0165 USD/share) | ||||
Proforma outstanding Shares after Offering | 105,779,995 shares | 105,779,995 shares | 105,779,995 shares | 105,779,995 shares | ||||
Offering Expense | $2,100,000 USD | $1,575,000 USD | $1,050,000 USD | $525,000 USD | ||||
Proceed from the Offering (net of expenses) | $37,900,000 USD | $28,425,000 USD | $18,950,000 USD | $9,475,000 USD | ||||
Proforma Net Tangible book value after Offering | $36,814,852 USD | $27,339,852 USD | $17,864,852 USD | $8,389,852 USD | ||||
Increase in book value | $37,900,000 USD | $28,425,000 USD | $18,950,000 USD | $9,475,000 USD | ||||
Proforma Net tangible book value per share after Offering | $0.35 USD/share | $0.26 USD/share | $0.17 USD/share | $0.08/share | ||||
Increase in book value per share | $0.37 USD/share | $0.28 USD/share | $0.19 USD/share | $0.10/share | ||||
Offering price | $1 USD/share | $1USD/share | $1USD/share | $1USD/share | ||||
Dilution per share to new investors | $0.63 USD/share | $0.72 USD/share | $0.81 USD/share | $0.90 USD/share | ||||
Percent dilution | 63% | 72% | 81% | 90% |
* | The conversion value is based on the exchange rate of $1.2678 CAD to $1 USD as of December 31, 2021. |
Future dilution
Another important way of looking at dilution is the dilution that happens due to future actions by the Company. The investor’s stake in a company could be diluted due to the Company issuing additional shares. In other words, when the Company issues more shares, the percentage of the Company that you own will go down, even though the value of the Company may go up. You will own a smaller piece of a larger company. This increase in number of shares outstanding could result from a stock offering (such as an initial public offering, another crowdfunding round, a venture capital round, or an angel investment), employees exercising stock options, or by conversion of certain instruments (e.g. convertible bonds, preferred shares or warrants) into common stock.
If the Company decides to issue more shares, an investor could experience value dilution, with each share being worth less than before, and control dilution, with the total percentage an investor owns being less than before. There may also be earnings dilution, with a reduction in the amount earned per share (though this typically occurs only if the Company offers dividends, and most early-stage companies are unlikely to offer dividends, preferring to invest any earnings into the Company).
9
The type of dilution that hurts early-stage investors most occurs when the Company sells more shares in a “down round,” meaning at a lower valuation than in earlier offerings. An example of how this might occur is as follows (numbers are for illustrative purposes only):
● | In June 2020 Jane invests $20,000 for shares that represent 2% of a company valued at $1 million. |
● | In December 2020 the company is doing very well and sells $5 million in shares to venture capitalists on a valuation (before the new investment) of $10 million. Jane now owns only 1.3% of the company but her stake is worth $200,000. |
● | In June 2021 the company has run into serious problems, and in order to stay afloat it raises $1 million at a valuation of only $2 million (the “down round”). Jane now owns only 0.89% of the company and her stake is worth only $26,660. |
This type of dilution might also happen upon conversion of convertible notes into shares. Typically, the terms of convertible notes issued by early-stage companies provide that in the event of another round of financing, the holders of the convertible notes get to convert their notes into equity at a “discount” to the price paid by the new investors, i.e., they get more shares than the new investors would for the same price. Additionally, convertible notes may have a “price cap” on the conversion price, which effectively acts as a share price ceiling. Either way, the holders of the convertible notes get more shares for their money than new investors. In the event that the financing is a “down round” the holders of the convertible notes will dilute existing equity holders, and even more than the new investors do, because they get more shares for their money. Investors should pay careful attention to the amount of convertible notes that the Company has issued (and may issue in the future), and the terms of those notes.
If you are making an investment expecting to own a certain percentage of the Company or expecting each share to hold a certain amount of value, it’s important to realize how the value of those shares can decrease by actions taken by the Company. Dilution can cause drastic changes to the value of each share, ownership percentage, voting control, and earnings per share.
10
The Company and selling shareholders are offering up to 52,000,000 shares of Common Stock in this Offering at $1.00 per share, with a minimum investment of $750. There is no minimum amount we are required to raise from the shares of Common Stock being offered hereby. There is no guarantee that we will sell any of the shares of Common Stock being offered in this Offering. Additionally, there is no guarantee that this Offering will successfully raise enough funds to implement our Company’s business plan or pay for the expenses of this Offering, which we estimate to be approximately $450,000, excluding commissions and state filing fees, for a fully subscribed offering.
The approximate date of the commencement of the sales of the shares of Common Stock will be within two calendar days from the date on which the Offering is qualified by the SEC and on a continuous basis thereafter until the maximum number of shares of Common Stock offered hereby are sold or the Offering is earlier terminated. All offering expenses will be borne by us and will be paid out of the proceeds of this Offering. The company may undertake one or more closings on an ongoing basis. After each closing, funds tendered by investors will be available to the Company.
This Offering will terminate at the earlier of (i) the date at which the maximum offering amount has been sold; (ii) the date the Offering is earlier terminated by the Company, in its sole discretion or (iii) the date which is one year from qualification by the SEC. The Company may undertake one or more closings on a rolling basis. After each closing, funds tendered by investors will be available to the Company. No sales of shares of Common Stock will be made prior to the qualification of the Offering statement by the SEC.
The Company may undertake one or more closings on a rolling basis. At each closing 70% of the shares sold to new investors will be newly issued shares sold by us and 30% will be shares sold by the selling shareholders on a pro rata basis (rounding to eliminate fractional shares) until all of the shares offered by the selling shareholders have been sold. After each closing, funds tendered by investors will be available to the Company and the selling shareholders.
Rialto Markets LLC (“Rialto”) has agreed to act as placement agent to assist in connection with this offering. The placement agent is not purchasing or selling any securities offered by this offering circular, nor is it required to arrange the purchase or sale of any specific number or dollar amount of securities but have agreed to use their best efforts to arrange for the sale of all of the securities offered hereby. In addition, the placement agent may engage other brokers to sell the securities on their behalf. Rialto will receive compensation for sales of the shares offered and sold through its platform (“Rialto Platform”). Persons who desire information about the offering may find it at invest.bulletid.net.
The Company will also publicly market the offering using general solicitation through methods that include emails to potential investors, the internet, social media, and any other means of widespread communication.
This Offering Circular will be furnished to prospective investors via download 24 hours per day, 7 days per week on the Company’s website at invest.bulletid.net.
The following table shows the total discounts and commissions payable to Rialto in connection with this offering by the Company:
Per Share | Total | |||||||
Public Offering Price | $ | 1.00 | $ | 52,000,000 | ||||
Placement Agent Commissions | $ | 0.04125 | $ | 2,016,500 |
In the event that Rialto’s targeted selling efforts lead to sales of up to $15,000,000 in shares of Common Stock, Rialto will be entitled to 6.0% of the gross proceeds from the sale of such shares of Common Stock not to exceed $900,000. For any sales thereafter, Rialto is entitled to 3.0% of the gross proceeds from the sale of such shares of Common Stock. The maximum amount Rialto may receive in commissions is $2,016,500, which includes a one-time payment of $6,500 for certain expenses described below.
Other Terms
Rialto has also agreed to perform the following services in exchange for the compensation discussed above:
● | act as lead broker for the offering, coordinating efforts of parties involved and providing regulatory guidance, | |
● | provide offering platform technology, the use of a “microsite” for RYSE to reach potential investors, provide investors with information and details on the offering, and to invest in the offering using an escrow agent and the registered transfer agent, | |
● | reviewing marketing materials, |
● | performing AML/KYC checks on all investors, and | |
● | providing other financial advisory services normal and customary for Regulation A offerings and coordinate with the Company’s registered transfer agent, escrow agent and legal representatives. |
11
In addition to the commission described above, the Company will also pay $6,500 to Rialto for out-of-pocket accountable expenses paid prior to commencing. This fee will be used for the purpose of coordinating filings with regulators and conducting a compliance review of the Company’s offering. Any portion of this amount not expended and accounted for will be returned to the Company. In addition, the Company will pay Rialto a $5,000 blue sky filing service fee and will reimburse Rialto for any state notice filing fees, estimated to be approximately $13,000. Assuming the full amount of the offering is raised and that Rialto’s targeted selling efforts lead to sales of $52,000,000, we estimate that the total fees and expenses of the offering payable by the Company to Rialto will be approximately $2,034,500.
Procedures for Subscribing
After the qualification of this Offering Statement by the SEC, if you decide to subscribe for any shares of Common Stock in this Offering, you should complete the following steps:
1. | Go to invest.bulletid.net and click on the “Invest Now” button |
2. | Complete the online investment form. |
3. | Deliver funds directly by check, wire, debit card, or electronic funds transfer via ACH to the specified account or deliver evidence of cancellation of debt. |
4. | Once funds or documentation are received an automated AML check will be performed to verify the identity and status of the investor |
5. | Once AML is verified, investor will electronically receive, review, execute and deliver to us a Subscription Agreement |
A form of our Subscription Agreement is filed as Exhibit 4.1 to the Offering Statement.
The shares of Common Stock acquired under the Subscription Agreement will be issued to you by our transfer agent in book entry form upon acceptance of your Subscription Agreement and confirmation of funds received by the Company.
Selling Shareholders
Certain shareholders of the Company intend to sell up to 12,000,000 shares of Common Stock in this offering. Selling shareholders will participate in this Offering at the same time as the Company, selling no more than thirty percent (30%) of the shares issued to investors at each closing. That means at each closing, 30 shares will be sold by the selling shareholders for each 70 shares sold by the Company, until all 12,000,000 shares have been sold by the selling shareholders.
Selling shareholders will participate on a pro rata basis, which means that at each closing in which selling shareholders are participating, a shareholder will be able to sell its pro rata portion of the shares that the shareholder is offering (as set forth in the table below) of the number of securities being issued to investors.
After qualification of the Offering Statement, each of the selling shareholders will enter into an irrevocable power of attorney (“POA”) with the Company and the CEO, as attorney-in-fact, in which they direct the Company and the attorney-in-fact to take the actions necessary in connection with the offering and sale of their shares. A form of the POA is filed as an exhibit to the Offering Statement of which this Offering Circular forms a part.
Name of Selling Shareholder | Shares Owned Prior to the Offering (3) | Shares offered by Selling Shareholders (1) | Shares Owned after the Offering (1) | Stockholder's Pro Rata Portion (2) | ||||||||||||
1563822 Ontario Inc | 216,000 | 57,739 | 158,261 | 0.48 | % | |||||||||||
Albert Oppenheimer | 40,000 | 5,774 | 34,226 | 0.05 | % | |||||||||||
Alexandru Oancea | 50,000 | 4,812 | 45,188 | 0.04 | % | |||||||||||
Ami&Tamara Lohr | 433,332 | 60,144 | 373,188 | 0.50 | % | |||||||||||
Ana Silva | 50,000 | 7,217 | 42,783 | 0.06 | % | |||||||||||
Anthony Ralph-Edwards | 150,000 | 21,652 | 128,348 | 0.18 | % | |||||||||||
Anthony Wright | 420,000 | 60,626 | 359,374 | 0.51 | % | |||||||||||
Base Camp Holding Inc | 363,000 | 120,289 | 242,711 | 1.00 | % | |||||||||||
Bearcliff Trading Corp., | 1,595,808 | 767,832 | 827,976 | 6.40 | % | |||||||||||
The Saunders Family Trust | 500,000 | 240,578 | 259,422 | 2.00 | % | |||||||||||
Bob Pence | 2,381,660 | 144,347 | 2,237,313 | 1.20 | % | |||||||||||
Bruce Lewis | 19,990,066 | 360,867 | 19,629,199 | 3.01 | % | |||||||||||
James Cecchetto | 200,000 | 48,116 | 151,884 | 0.40 | % | |||||||||||
Centrys Inc | 5,250,000 | 962,312 | 4,287,688 | 8.02 | % | |||||||||||
Clint Sharples | 250,000 | 36,087 | 213,913 | 0.30 | % | |||||||||||
Deborah Smith | 250,000 | 24,058 | 225,942 | 0.20 | % | |||||||||||
Daniel Dwyer | 250,000 | 36,087 | 213,913 | 0.30 | % | |||||||||||
Daniella Samuel | 50,000 | 7,217 | 42,783 | 0.06 | % | |||||||||||
David Alge | 66,666 | 32,077 | 34,589 | 0.27 | % | |||||||||||
David Eaton | 416,666 | 200,481 | 216,185 | 1.67 | % | |||||||||||
David Piccolo | 50,000 | 9,623 | 40,377 | 0.08 | % | |||||||||||
Djazayeri&Jijina | 99,000 | 14,435 | 84,565 | 0.12 | % | |||||||||||
Eddie Blasiak | 100,000 | 14,435 | 85,565 | 0.12 | % | |||||||||||
Emil Mihaescu | 60,000 | 4,812 | 55,188 | 0.04 | % | |||||||||||
Emin Zeynalov | 310,000 | 44,747 | 265,253 | 0.37 | % | |||||||||||
Emma Verity | 100,000 | 12,029 | 87,971 | 0.10 | % | |||||||||||
Fraser Toms | 100,000 | 43,304 | 56,696 | 0.36 | % | |||||||||||
Gerald Hickey | 40,000 | 19,246 | 20,754 | 0.16 | % | |||||||||||
International Defence Force Inc | 500,000 | 240,578 | 259,422 | 2.00 | % | |||||||||||
Gonzalo Couce | 376,150 | 180,987 | 195,163 | 1.51 | % | |||||||||||
Greg Sullivan | 2,100,000 | 1,010,427 | 1,089,573 | 8.42 | % | |||||||||||
Hailey Verity | 64,000 | 7,121 | 56,879 | 0.06 | % | |||||||||||
Hindy Friedman | 66,667 | 9,623 | 57,044 | 0.08 | % |
12
Howard Crangle | 100,000 | 12,029 | 87,971 | 0.10 | % | |||||||||||
Hy Bergel | 394,800 | 59,702 | 335,098 | 0.50 | % | |||||||||||
Jackie&Leo Darmitz | 40,000 | 7,217 | 32,783 | 0.06 | % | |||||||||||
James Williams | 500,000 | 240,097 | 259,903 | 2.00 | % | |||||||||||
Jamet Hendershot | 150,000 | 24,058 | 125,942 | 0.20 | % | |||||||||||
Jonathan Verity | 80,000 | 9,623 | 70,377 | 0.08 | % | |||||||||||
Josephine Kandiah | 50,000 | 14,435 | 35,565 | 0.12 | % | |||||||||||
Kareem Younis | 611,114 | 29,405 | 581,709 | 0.25 | % | |||||||||||
Karen Lauriston | 583,333 | 93,558 | 489,775 | 0.78 | % | |||||||||||
Keith Verity | 40,000 | 5,293 | 34,707 | 0.04 | % | |||||||||||
Kilgorie Investment Inc | 3,065,000 | 384,925 | 2,680,075 | 3.21 | % | |||||||||||
Kim Miller | 750,000 | 96,231 | 653,769 | 0.80 | % | |||||||||||
Mark Spillman | 30,000 | 2,887 | 27,113 | 0.02 | % | |||||||||||
Messiano-Crookston Law P.C | 100,000 | 48,116 | 51,884 | 0.40 | % | |||||||||||
Midama Investments LTD | 3,000,000 | 1,443,467 | 1,556,533 | 12.03 | % | |||||||||||
Global Financial Network LTD | 1,000,000 | 160,385 | 839,615 | 1.34 | % | |||||||||||
Midas Letter Corp. Global Financials | 1,000,000 | 160,385 | 839,615 | 1.34 | % | |||||||||||
Natianal Bank Financials Inc (ITF Foster) | 67,900 | 32,670 | 35,230 | 0.27 | % | |||||||||||
Orhan Kara | 300,000 | 43,304 | 256,696 | 0.36 | % | |||||||||||
Peter&Tami Beck | 300,000 | 144,347 | 155,653 | 1.20 | % | |||||||||||
Philip Hitchie | 100,000 | 36,087 | 63,913 | 0.30 | % | |||||||||||
R. Senechal | 1,635,629 | 481,156 | 1,154,473 | 4.01 | % | |||||||||||
Ravi Raman | 850,000 | 122,695 | 727,305 | 1.02 | % | |||||||||||
Richard Sutin | 5,000,000 | 2,405,779 | 2,594,221 | 20.05 | % | |||||||||||
Robert Hirschberg | 1,666,666 | 230,955 | 1,435,711 | 1.92 | % | |||||||||||
Rosalind Lee Hildebrandt | 100,000 | 14,435 | 85,565 | 0.12 | % | |||||||||||
Scott Secord | 595,808 | 86,003 | 509,805 | 0.72 | % | |||||||||||
Sean Charland | 83,333 | 11,708 | 71,625 | 0.10 | % | |||||||||||
Sean McNulty | 100,000 | 24,058 | 75,942 | 0.20 | % | |||||||||||
Sethu Raman | 3,166,666 | 481,156 | 2,685,510 | 4.01 | % | |||||||||||
Sima&Shlomo Teva | 66,667 | 4,812 | 61,855 | 0.04 | % | |||||||||||
Sorin Tanasescu | 800,000 | 115,477 | 684,523 | 0.96 | % | |||||||||||
Stephen Dunn | 150,000 | 21,652 | 128,348 | 0.18 | % | |||||||||||
Tatiana Trofimova | 715,580 | 55,612 | 659,968 | 0.46 | % | |||||||||||
Vicky Berman | 20,000 | 9,623 | 10,377 | 0.08 | % | |||||||||||
Marsha Bidloff | 20,000 | 9,623 | 10,377 | 0.08 | % | |||||||||||
Voiko Gartner | 200,000 | 28,869 | 171,131 | 0.24 | % | |||||||||||
William Gale | 100,000 | 14,435 | 85,565 | 0.12 | % | |||||||||||
Yana Pchelkin | 158,333 | 24,058 | 134,275 | 0.20 | % | |||||||||||
TOTAL | 64,579,844 | 12,000,000 | 52,579,844 | 100 | % |
(1) | Assumes maximum number of shares are sold in this offering. |
(2) | “Pro Rata Portion” represents that portion that a shareholder may sell in the offering expressed as a percentage where the numerator is the amount offered by the shareholder divided by the total number of shares offered by all selling shareholders. |
(3) | May include shares issuable upon exercise of warrants. |
13
The total number of shares owned by the selling shareholders prior to this offering represents 16.9% of the Company’s capital stock, on a fully diluted basis, assuming all warrants and options are exercised.
Selling Stockholder Bruce Lewis is the Founder and CEO of the Company. Tatiana Trofimova is the CAO of the Company. Sethu Raman is a director of the Company.
Perks
The Company will provide certain investors in this offering the following perquisites (“Perks”). At stepped investment levels, the Company plans to offer certain Perks listed below at various levels of investment.
Investment Amount | Perks | Estimated Value | ||||||
$ | 750 | Signed book by MGEN (RET'D) David Fraser | $ | 20.00 | ||||
$ | 5,000 | Signed book by MGEN (RET'D) David Fraser | $ | 25.00 | ||||
Custom etched bullet | ||||||||
$ | 10,000 | Signed book by MGEN (RET'D) David Fraser | $ | 40.00 | ||||
Custom etched bullet | ||||||||
Bullet ID Jacket | ||||||||
$ | 25,000 | Signed book by MGEN (RET'D) David Fraser | $ | 90.00 | ||||
Custom etched bullet | ||||||||
Bullet ID Jacket | ||||||||
4-foot bullet | ||||||||
$ | 100,000 | Signed book by MGEN (RET'D) David Fraser | $ | 1,600 | ||||
Custom etched bullet | ||||||||
Bullet ID Jacket | ||||||||
4-foot bullet | ||||||||
Travel and accommodations to participate in a private Bullet ID warehouse tour and dinner with various executives |
We are of the opinion that these Perks do not have any cash value and do not alter the sales price or cost basis of the securities in this offering. Instead, the Perks are a “thank you” to investors that help us achieve our mission. However, it is recommended that investors consult with a tax professional to fully understand any tax implications of receiving any Perks before investing.
TAX CONSEQUENCES FOR RECIPIENT (INCLUDING FEDERAL, STATE, LOCAL AND FOREIGN INCOME TAX CONSEQUENCES) WITH RESPECT TO THE INVESTMENT BENEFIT PACKAGES ARE THE SOLE RESPONSIBILITY OF THE INVESTOR. INVESTORS MUST CONSULT WITH THEIR OWN PERSONAL ACCOUNTANT(S) AND/OR TAX ADVISOR(S) REGARDING THESE MATTERS.
Investors’ Tender of Funds
After the SEC has qualified the Offering Statement, the Company will accept tenders of funds to purchase our Common Stock. The company may close on investments on a “rolling” basis (so not all investors will receive their securities on the same date). Investors may subscribe by tendering funds via ACH, debit card, or wire. Investors should note that processing of checks by financial institutions has been impacted by restrictions on businesses due to the coronavirus pandemic. Delays in the processing and closing of subscriptions paid by check may occur. Upon closing, funds tendered by investors will be made available to the Company for its use.
The Company maintains the right to accept or reject subscriptions in whole or in part, for any reason or for no reason, including, but not limited to: in the event that an investor fails to provide all necessary information, even after further requests; in the event an investor fails to provide requested follow up information to complete background checks or fails background checks; or in the event the Offering is oversubscribed in excess of the maximum offering amount.
14
Escrow Agent
Company has entered into an Escrow Services Agreement with Thread Bank (the “Escrow Agent”). Investor funds will be held in an account by the Escrow Agent pending a closing or the termination of the Offering. While funds are held the escrow account and prior to a closing of the sale of our Common Stock in bona fide transactions that are fully paid and cleared, (i) the escrow account and escrowed funds will be held for the benefit of the investors, (ii) the Company will not be entitled to any funds received into the escrow account, and (iii) no amounts deposited into the escrow account shall become the property of the Company, or be subject to any debts, liens or encumbrances of any kind of the Company. No interest shall be paid on balances in the escrow account.
The Escrow Agent has not investigated the desirability or advisability of investment in the shares nor approved, endorsed or passed upon the merits of purchasing the securities.
Provisions of Note in Our Subscription Agreement
Jury Trial Waiver
The subscription agreement provides that subscribers waive the right to a jury trial of any claim they may have against us arising out of or relating to any of those agreements, including any claim under federal securities laws. By signing the subscription agreement an investor will be agreeing to be bound by the terms and the investor will warrant that the investor has reviewed this waiver with the investor’s legal counsel, and knowingly and voluntarily waives his or her jury trial rights following consultation with the investor’s legal counsel. If we opposed a jury trial demand based on the waiver, a court would determine whether the waiver was enforceable given the facts and circumstances of that case in accordance with applicable case law. In addition, by agreeing to the provision in the subscription agreement, subscribers will not be deemed to have waived the Company’s compliance with the federal securities laws and the rules and regulations promulgated thereunder.
Forum Selection Provisions
The subscription agreement includes a forum selection provision that require any claims against the Company based on these agreements to be brought in a state or federal court of competent jurisdiction in the State of Delaware, for the purpose of any suit, action or other proceeding arising out of or based upon the agreements. Although we believe these provisions benefit us by providing increased consistency in the application of Delaware law in the types of lawsuits to which they apply and in limiting our litigation costs, to the extent they are enforceable, these forum selection provisions may limit investors’ ability to bring claims in judicial forums that they find favorable to such disputes and may discourage lawsuits with respect to such claims. The Company has adopted these provisions to limit the time and expense incurred by its management to challenge any such claims. As a company with a small management team, this provision allows its officers to not lose a significant amount of time travelling to any particular forum so they may continue to focus on operations of the Company. Section 22 of the Securities Act creates concurrent jurisdiction for federal and state courts over all suits brought to enforce any duty or liability created by the Securities Act or the rules and regulations thereunder. We believe that the exclusive forum provisions apply to claims arising under the Securities Act, but there is uncertainty as to whether a court would enforce such provision in this context. Investors will not be deemed to have waived the Company’s compliance with the federal securities laws and the rules and regulations thereunder
15
The company intends to raise offering proceeds to engage in the following activities: (i) software development, (ii) product development for second generation hardware, (iii) marketing, (iv) sales team development, and (v) working capital.
Please see the table below for a summary of the Company’s estimated intended uses of net proceeds from this Offering:
Offering Proceeds to the Company | $40,000,000 (100%) ($USD) |
$30,000,000 (75%) ($USD) |
$20,000,000 ($USD) |
$10,000,000 (25%) ($USD) |
||||||||||||
Gross Proceeds from this offering | $ | 40,000,000 | $ | 30,000,000 | $ | 20,000,000 | $ | 10,000,000 | ||||||||
Offering expenses (1) | $ | 2,100,000 | $ | 1,575,000 | $ | 1,050,000 | $ | 525,000 | ||||||||
Total Proceeds Available for Use | $ | 37,900,000 | $ | 28,425,000 | $ | 18,950,000 | $ | 9,475,000 | ||||||||
Software Development | $ | 3,000,000 | $ | 3,000,000 | $ | 1,500,000 | $ | 500,000 | ||||||||
Product Development for Next Generation Hardware | $ | 1,000,000 | $ | 1,000,000 | $ | 500,000 | $ | 500,000 | ||||||||
Marketing | $ | 5,000,000 | $ | 5,000,000 | $ | 2,500,000 | $ | 1,500,000 | ||||||||
Machine inventory | $ | 20,000,000 | $ | 11,000,000 | $ | 10,000,000 | $ | 4,525,000 | ||||||||
Sales Team Development | $ | 5,000,000 | $ | 5,000,000 | $ | 2,500,000 | $ | 1,500,000 | ||||||||
Working Capital | $ | 3,900,000 | $ | 3,425,000 | $ | 1,950,000 | $ | 950,000 |
(1) | Includes: (i) commission payable by the Company to Rialto, (ii) administrative fees payable to Rialto for out-of-pocket expenses and FINRA fees, (iii) legal fees, (iv) accounting fees, (v) EDGARization expenses, and (vi) blue sky fees. |
The Company reserves the right to change the above use of proceeds if management believes it is in the best interests of the Company.
16
Overview
The Bullet ID Corporation was incorporated under the Business Corporation Act of Ontario on December 23, 2016. Since its founding, the Company’s mission has been to solve a crucial challenge facing the world’s ammunition management systems: transparency, accountability, and control.
In furtherance of its mission the Company has developed an authenticated ammunition tracking system. This system uses machines and proprietary software that work together to laser-etch a unique bar code onto the brass cartridge case of a bullet. The Company intends to sell its machines and proprietary software to ammunition manufacturers, law enforcement and the military. The Company believes that this system of laser-etching allows for the traceability of a round of bullets from the point of manufacturing to the point of distribution to the end user.
To date, the Company has limited operating history, and has been primarily in research and software development of its serialized bullets.
Bullet ID believes that the need for an authenticated ammunition tracking system is large. Currently, the Company believes there are 4 factors that need to be addressed with regards to ammunition traceability: (i) limited logistics and inventory information for ammunition, (ii) limited global ammunition traceability, (iii) traceability is imperative to national security, and (iv) there is a large opportunity cost, particularly with regards to crime scenes when cartridges are not tracked with serial numbers.
Limited logistics and inventory information for ammunition: There is currently almost zero logistics and inventory information available for ammunition. This is reflected in the high amount of scrapped ammunition every year, in excess of $100 million in the Unites States. We believe that this problem is avoidable with quality quantitative performance data, such us the utilization of our ammunition tracking system for command field intelligence.
Limited global ammunition traceability: Currently, there is no forensic database to track illicit ammunition use. We believe the utilization of our ammunition tracking system would solve for this and create a system similar to the current global fingerprint database.
National security: National Security anonymity requirements render the global illicit ammunition tracing initiatives ineffective. We believe this should change. For example, the United States provides ammunition to foreign countries pursuant to applicable aid bills. However, during the transportation and distribution of the ammunition theft of ammunition occurs. Currently, this cannot be traced. An authenticated ammunition tracking system would help mitigate this risk.
Opportunity cost: Money, knowledge, & significant opportunity costs are left behind with every cartridge issued and NOT identified/tracked. Specifically, the cost of research and forensic investigations would be significantly reduced if the ownership of cartridges could be traced closer to the end user. Currently, there is no study or information available as to the opportunity costs that are lost.
Background –Traditional Methods for Tracking Ammunition
Bullet ID is engaged in providing solutions for ammunition tracking, and in particular creating systems and methods for tracking ammunition and identifying indicia and inventory tracking systems.
After a firearm has been used, the casing of the ammunition may be ejected from the firearm. During operation of the firearm, certain distinguishing marks may be left on the casing, which may be analyzed to ascertain information about the firearm, such as the type of firearm used to fire the ammunition. This information may contribute to identifying the person who operated the firearm. Accordingly, ballistic evidence from casing may be used by law enforcement and the judicial system to make decisions on arrests and convictions.
Typically, to identify whether a suspect firearm fired ammunition corresponding to a casing found at a crime scene, the suspect firearm is used to fire several test ammunitions sharing the same brand as the ammunition corresponding to the casing found at the crime scene. Then, markings on these test ammunition re compared with the markings on the casing found at the crime scene to determine if the suspect firearm fired the ammunition corresponding to the casing found at the crime scene.
Unfortunately, the process is subject to issues of variability, affecting its repeatability reliability and accuracy. Moreover, as firearms are mass produced, the typical ballistics analysis may not reliably link a particular casing or particular ammunition to a particular firearm at the exclusion of other firearms. We believe that it would be desirable to more reliably track the origin of the casings and ammunition.
17
Bullet ID Technology
The Bullet ID system is an effective and automated inventory management system, allowing accountability at the level of the individual round. The Bullet ID system is fully automated, with intuitive software integration into the machine. This unique combination of high-speed laser engraving, coupled with Bullet ID’s robust software, allows for real-time monitoring of production, tracking of distribution, and real-time inventory levels.
![]() |
![]() |
The breakthrough in Bullet ID’s technology is the unique code that is micro-laser engraved on factory-produced ammunition. The laser engraved etching is on the outside of the bullet case, and each code matches to a single box of cartridges that is distinctive from all other ammunition produced.
Each Bullet ID code is trackable, allowing instantaneous control over inventory volume, location, and history. The data is encrypted and require authenticated access, delivered through a regular smartphone app accessible to anyone.
The Bullet ID technology provides a method for law enforcement, military and distribution personnel to manage ammunition inventories, and track valuable information regarding a bullet’s supply chain. We believe this technology is the first and only one in the world that allows inventory management and control at the level of the individual round.
The design of the laser engraving, in addition to the robustness of the system, allows for the successful scanning of the code even if 60% of the marking remains intact. Bullet ID’s visionary technology is designed with the future in mind and can accommodate an unlimited number of unique codes. With approximately 10 billion rounds of ammunition sold annually in the United States, and 20-30 billion rounds sold worldwide, Bullet ID is capable of keeping pace with the current volumes for decades to come.
18
How Bullet ID Intends to Change Traditional Methods for Tracking Ammunition
As designed, the Bullet ID system is instantly accessible to authorized law enforcement, miliary and government personnel, and features intelligent traceability, customizable detail, and rich data analytics. Bullet ID intends to license the serialization and packaging equipment as well as the supply chain infrastructure software—Infrastructure as a Service (“IaaS”). This model allows each country/client to preserve the confidentiality around the volume of manufactured/used ammunition while allowing the exchange of information/transfer of custody between supply chains/countries. It incorporates verifiable credentials technology allowing easy integration into latest generation of digital identity infrastructure.
We believe that if we can acquire a sufficient customer base, the Bullet ID solution will:
● | Improve safety by guaranteeing the quality of the ammunition used by military personnel and also acts as a deterrent for misuse of ammunition. |
● | Reduce outdated inventory & misdirected ammunition. If the agencies know where the ammunition has been, with this information, the agencies will know how much inventory is available and if it will perform properly. |
● | Achieve more effective global ammunition traceability |
● | Meet national security needs such as discretionary anonymity and nation-segregated data storage. This maintains confidentiality of volumes and distribution of ammunition within a particular jurisdiction. |
● | Secure real-time forensic data with the ability to trace cases. |
Inventory: The Ammunition Packaging Machine
As of December 31, 2021, the Company owns one ammunition packaging machine.
During the year ended December 31, 2021, a new and improved laser technology became available that management expects to use instead of the technology encompassed in the existing inventory. As of December 31, 2021, the Company has updated its ammunition packaging machine with the new technology available.
Software
Prior to 2021 the Company contracted the development of custom enterprise blockchain/database software. As of July 2021, the Company’s solution was re-built on top of newer technology sourced from technology partners, in order to ensure production-readiness and ongoing development and support. This allows the integration of existing database/blockchain infrastructure as well as inter-operability with upcoming digital identity infrastructure.
Customers
The Company believes that its primary customers include: ammunition manufacturers, law enforcement and the military. The Company intends to sell the ammunition packaging machines and supply chain software with a dedicated sales team and global partners. Currently, the Company is in discussion with representatives of law enforcement, various countries. We believe these discussions reflect the value our solution but may not result in revenues or contracts.
Unique Benefits for Ammunition Manufacturers
Ammunition manufacturers receive unique benefits when utilizing the Bullet ID system. Specifically, the Bullet ID system assigns a unique barcode to each box of new ammunition. The majority of ammunition manufacturers already use barcoding for inventory control and management. This makes integrating the Bullet ID system into the manufacturing process easier. The system simply includes inputting the Bullet ID code into a manufacturer’s current barcoding system. This allows for:
19
● | Inventory management: Full control and accountability over inventory and supply chain. | |
● | Barcoded rounds: Laser-marked and will integrate seamlessly into the manufacturing process. | |
● | Distributing Tracking: Allows manufacturers to track inventory from production to the final consumer. | |
● | Laser etching machine is provided: Manufacturers will be provided with laser etching capability for 60K/hr – 120k/hr, laser etching machines and ammunition material handlers to produce Bullet ID coded ammunition and packaging. |
The laser etching process does not affect the performance, integrity or accuracy of the round.
Manufacturing and Suppliers
The Company will not be manufacturing inhouse. The funds raised from this Offering will be used to acquire and keep in its inventory equipment (hardware) for serializing bullets. The equipment the Company intends to keep on hand include:
● | 20 machines | |
● | Extra parts for machines | |
● | Tray-Erector Units | |
● | 1 and 2 laser heads Serializing and Packaging Units | |
● | Case Packaging Units | |
Various suppliers of the Company include:
● | Modex: Supplier of BCDB (patented hybrid blockchain database infrastructure). | |
● | Verio Technologies: Supplier of the digital identity / verifiable credentials infrastructure and in-app wallet component. | |
● | Indicio: Provider of a global network to enable verifiable credentials and support a large SSI (self-sovereign identity) ecosystem. | |
● | Cognex: Provider of mobile app SDK to enable scanning of barcodes from unconventional surfaces such as bullet shell cases and also industrial scanning equipment (cameras, sensors and mobile scanners). | |
● | Actemium: Provider of global automation / industrial design services. | |
● | Keyence - Supplier of industrial laser etching equipment. | |
The Company is in the process of signing exclusive agreements with the suppliers listed above. As of the date of this Offering Circular, the Company has not finalized the terms of those agreements.
20
Our Products
Serialization and Packaging
Bullet ID’s specialized laser technology etches a unique barcode onto each brass cartridge of the bullet as well as its packaging. The identifying code is then scanned onto a secure and trackable blockchain database. Our technology is designed with the future in mind and can accommodate an unlimited number of unique codes.
21
Supply Chain Logistics
Globally, the standardization of serialized bullets has received strong advocacy from law enforcement bodies, military branches and international governments. Our team not only listened but designed and developed technology that enables the logistics of ammunition to be tracked and traced instantly and in real-time.
The below image is an example of our inventory management system, which represents how clients can track and determine the status of their ammunition inventory.
The data included in our inventory management system can also be delivered via API to systems currently used by customers allowing for increased customization based on use and needs of that specific customer.
22
Mobile Scanning App
Access to the app’s encrypted database is secure for authenticated users only and offers essential information such as product and order information or details (Type of bullet, caliber, ammunition parameters, velocity, date and place of manufacturing, name of customer) and also pool tracking information including geolocations for all the ammunition, within seconds of scanning a bullet’s unique code. An individual round’s journey from production to distribution enables the ability to manage ammunition stockpiles and shortages. We believe this may save taxpayers, military and law enforcement, billions of dollars annually.
23
Potential Revenue Sources
SELLS/LICENSES/RECEIVES A ROYALTY | NAME OF PRODUCT | DESCRIPTION OF THE PRODUCT | APPROXIMATE PRICE | |||
Sell or Royalty | ASP-100SC (one laser head) and ASP-200SC (two laser heads) serialization and packaging machine | Ammunition Serialized Cartridge Etching Technology | $600,000 USD Purchase option or 1¢ per round licensing, minimum 5-year term/volume commitment | |||
Royalty | Supply Chain Logistics Software | Software to assign, register, securely store and track the bullet and packaging codes throughout the distribution chain. | Licensed at 1¢ per round minimum 5-year term/volume commitment | |||
Licensed | Mobile app | User app that provides access to tracking and inventory information from a regular smartphone | Included with the supply chain logistics software. May be licensed separately depending on deployment. |
Industry Overview
The global ammunition market is expected to grow from USD 20 to 25 Billion by 2025. We believe this growth is due in part to:
● | Increasing number of police modernization programs. | |
● | An increased expenditure on defense products. | |
● | Rising crime rate. |
However, with growth comes challenges. We believe the global ammunition market will encounter the following: (i) growing number of illicit ammunition manufacturers and (ii) strict regulations on the supply and trade of ammunition.
Further, illicitly manufactured ammunition is a major threat to the security of countries around the world. According to the UN Office of Disarmament Affairs, more than 80% of ammunition trade seems to remain outside of reliable export data. Expert groups monitoring United Nations arms embargoes noted years ago that the lack of basic accountability systems was a factor in the diversion of ammunition. National security anonymity requirements render the global illicit ammunition tracing initiatives ineffective.
We intend to provide a solution to the many challenges within the ammunition market.
Competition
The Company believes there are competitors in this market providing limited solutions to the challenges the Company intends to solve.
For instance, The Education Fund to Stop Gun Violence (“EFSGV”) has focused on Microstamping. EFSGV states that Microstamping is a ballistics identification technology that allows law enforcement officers to quickly link cartridge cases found at crime scenes to the firearm from which they were discharged. It starts with a firearm that has microscopic identification codes engraved into the gun’s firing pin. When the gun is fired, these codes are stamped onto each cartridge case. These codes correspond with the firearm’s serial number, allowing law enforcement to match spent cartridge casings to a specific firearm in a manner similar to how law enforcement can use a license plate to quickly identify the make, model, VIN, and registered owner of a car. However, we believe this only addresses one aspect of the challenge of ammunition traceability.
24
Intellectual Property
The Company is seeking to protect its developed intellectual property through patent protection. The following table summarizes the status of our patent protection:
Mark/Country | International Class | Serial NO. Filing Date | Registration No. Registration Date | Status | ||||
65/541,504 United States | August 4, 2017 | Patent pending | ||||||
European Patent Application 18841435.3 in the name of The Bullet ID Corporation |
Employees
The Company currently has 2 full-time employees based in Canada.
Government Regulation
As of August 15, 2022 there are no specific regulations governing the ammunition tracking.
Litigation
On March 29, 2019, a claim was commenced against the Company by a previous consultant for breach of contract. It is expected this proceeding will be resolved via settlement negotiation.
The Company’s Property
The Company leases office space at 1018 Finch Avenue West, Toronto Ontario.
We believe that our existing facilities are suitable and adequate to meet our current business requirements.
25
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
The following discussion includes information from the audited financial statements for the year ended December 31, 2021, compared to the year ended December 31, 2020. All references to $ amounts are stated in Canadian Dollars, unless otherwise noted.
The following discussion contains forward-looking statements that reflect our plans, estimates, and beliefs. Our actual results could differ materially from those discussed in the forward-looking statements.
Overview
The Bullet ID Corporation has created an authenticated ammunition tracking system. The Company owns machines and proprietary software that work together to laser-etch a unique bar code onto the brass cartridge case of a bullet. The Company intends to sell its machines and proprietary software to ammunition manufacturers, law enforcement and the military. The Company aims to be the leader in ammunition tracking. To date, the Company has not generated any revenues.
Results of Operations
Year ended December 31, 2021, Compared to Year ended December 31, 2020
Revenues
The Company’s revenues for the year ended December 31, 2021, were $0 compared to $0 for the year ended December 31, 2020. During these periods the Company was primarily focused on research and development.
Operating Expenses
The Company’s operating expenses for the year ended December 31, 2021, were $957,987 compared to $1,973,371 for the year ended December 31, 2020. The 51% decrease was primarily due to the impairment of an intangible asset. Specifically, the intangible asset represents ammunition tracking software acquired from a third party. During 2021 a new software technology became available that management expects to use instead of the technology encompassed in the existing intangible assets. Thus, the Company determined that the existing software was impaired.
Operating expense consist of: (i) professional fees, (ii) salaries and benefits, (iii) research and development, (iv) inventory write downs, (v) impairment of intangible assets, (vi) advertising and (vii) travel to name a few. For the year ended December 31, 2021, the Company’s professional fees amounted to $339,688 compared to $149,014 for the year ended December 31, 2020. The increase was due to legal fees and technical consulting fees. In addition, for the year ended December 31, 2021, the Company spent $74,652 on advertising and promotion. Comparatively, for the year ended December 31, 2020, the Company spent $4,564 on advertising and promotion. The increase of approximately $70,000 was due to spending on video content and branding.
Net Income
As a result of the foregoing, the Company realized a net loss of $1,002,049 for the year ended December 31, 2021, compared to net loss of $1,884,160 for the year ended December 31, 2020.
Liquidity and Capital Resources
As of the date of this Offering Circular, the Company has not generated any revenues from operations. As of December 31, 2021, the Company had cash of $265,134 compared to $16,045 for the year ended December 31, 2020. The increase can be attributed to cash proceeds from financing activities including the issuance of new common shares and units. During the next twelve months, the Company intends to fund its operations with the proceeds in this Offering.
Historically, the Company has been funded through investor financing and support of the Company founders. The Company has incurred and accumulated deficit of $5,843,729 as of December 31, 2021, and anticipated additional deficits for the foreseeable future. We believe this offering under Regulation A will provide sufficient financing for the Company to undertake its planned operations until the Company is able to begin generating revenues.
26
Recent offerings of Securities and Outstanding Debt
Subsequent events (January 1, 2022, to August 12, 2022)
From February 16, 2022, to June 23, 2022, the Company issued 1,600,000 common shares for a total of $180,000. 800,000 of the 1,600,000 common shares were issued for $0.125 per share and the second 800,000 were issued for $0.10 per share. The Company relied on Section 4(a)(2) of the Securities Act of 1933 (the “Securities Act”). The Company used the proceeds from that offering for general operations.
From February 16, 2022, to August 12, 2022, the Company issued 1,954,000 units at a price of $0.25 per unit for a total of $488,500. Each unit comprised of one common share and one half of one common share purchase warrant, with each warrant entitling the holder thereof to acquire one common share at an exercise price of $0.40 per share for a period of two years. The Company relied on Section 4(a)(2) of the Securities Act. The Company used the proceeds from that offering for general operations.
From January 10, 2022, to June 23, 2022, the Company settled $186,250 of debt through the issuance of the following:
● | 221,000 common shares were issued for $0.25 per share for a total of $55,250 of the $186,250 debt owed. |
● | 524,000 units, at a price of $0.25 per unit for a total of $131,000 of the $186,250 debt owed. Each unit comprised of one common share and one common share purchase warrant, with each warrant entitling the holder thereof to acquire one common share at an exercise price of $0.40 per share for a period of two years. |
○ | 144,000 units were issued to the CTO of the Company. |
The Company relied on Section 4(a)(2) of the Securities Act. The company used the proceeds from that offering for the settlement of a debt obligation.
On June 2, 2022, $200,000 in convertible debentures issued during the year ended December 31, 2021, were converted into 1,191,616 units. Each unit comprised of one common share and one common share purchase warrant, with each warrant entitling the holder thereof to acquire one common share at an exercise price of $0.40 per share for a period of two years.
On July 28, 2022 a conversion of warrants occurred, resulting in the issuance of 67,900 shares of Common Stock. The shares of Common Stock were issued at $0.06 USD and the Company received $4,074. The Company relied on Section 4(a)(2) of the Securities Act. The Company used the proceeds from that offering for general operations.
Year ended December 31, 2021:
From January 1, 2021, to December 31, 2021, the Company issued $200,000 in convertible debentures. The Company relied on Section 4(a)(2) of the Securities Act. The Company used the proceeds from that offering for general operations. As noted above, the convertible debentures were converted on June 2, 2022, into 1,191,616 units. Each unit comprised of one common share and one common share purchase warrant, with each warrant entitling the holder thereof to acquire one common share at an exercise price of $0.40 per share for a period of two years.
On February 25, 2021, the Company issued 200,000 common shares at $0.10 per share to Vincent Couce as settlement of a loan payable in the amount of $20,000. The loan was made by Gonzalo Couce to the Company. Gonzalo Couce instructed the Company to pay the settlement amount of 200,000 common shares to Vincent Couce.
On May 10, 2021, the Company received $200,000 in connection with 800,000 units at $0.25 per unit issued to subscribers subsequent to the year- end, to Sethu Raman, a Director of the Company. Each unit consists of one common share and one common share purchase warrant, with each warrant exercisable into one common share for a period of 24 months at an exercise price of $0.40. The Company relied on Section 4(a)(2) of the Securities Act. The Company used the proceeds from that offering for general operations.
From May 27, 2021, to November 12, 2021, the Company issued 2,455,990 units in a private placement, of which 2,218,020 units were issued for cash at $0.25 per unit and 237,970 were issued for services valued at $0.25 per unit. 72,000 out of 2,455,990 units were issued to the CTO of the Company. 71,190 out of 2,455,990 units were issued to a director of the Company. Each unit consists of one common share and one common share purchase warrant, except for 71,190 units of the 2,455,990 units issued consisted of one common share and one half of a common share purchase warrant, with each warrant exercisable into one common share for a period of 24 months at an exercise price of $0.40. The proceeds from issuance of units were allocated between common shares and warrants. $366,973 was allocated to warrants and $247,025 was allocated to share capital. The Company relied on Section 4(a)(2) of the Securities Act. The Company used the proceeds from that offering for general operations.
Year ended December 31, 2020:
From January 22, 2020, to March 5, 2020, the Company raised $230,000 by issuing 2,300,000 common shares in a private placement at $0.10 per share. 1,000,000 out of 2,300,000 common shares were issued to Sethu Raman, a Director of the Company. The Company relied on Section 4(a)(2) of the Securities Act. The Company used the proceeds from that offering for general operations.
On January 22, 2020, and February 26, 2020, 1,379,439 common shares were issued for proceeds received of $128,620 from the year ended December 31, 2018, from Richard Senechal, a Director of the Company and $1,500 from the year ended December 31, 2019. The Company relied on Section 4(a)(2) of the Securities Act. The Company used the proceeds from that offering for general operations.
On September 4, 2020, to settle $229,031 in accrued salaries and $40,035 in amounts due to Bruce Lewis, Director and Chief Executive Officer of the Company, 2,690,066 common shares were issued at $0.10 per share.
On October 7, 2020, to settle $110,000 in accrued salaries owed to Greg Sullivan, previous Chief Executive Officer of the Company, 1,100,000 common shares were issued at $0.10 per share.
27
On October 7, 2020, to settle $188,166 in accounts payable owed to Robert Pence, a consultant, 1,881,660 common shares were issued at $0.10 per share.
On October 7, 2020, to settle $21,114 in accounts payable owed to Abdul-Kareem Younis, an employee of the Company, 211,114 common shares were issued at $0.10 per share.
On October 7, 2020, to settle $21,580 in accounts payable owed to Tatiana Trofimova, an employee of the Company, 215,580 common shares were issued at $0.10 per share.
On October 7, 2020, to settle $37,615 in accounts payable owed to Gonzalo Couce, a consultant, 376,150 common shares were issued at $0.10 per share.
On February 25, 2020, $10,000 was received during the year in connection with 100,000 common shares to be issued to subscribers. The Company relied on Section 4(a)(2) of the Securities Act. The Company used the proceeds from that offering for general operations.
Indebtedness
On October 7, 2020, the Company and Greg Sullivan, a previous officer of the Company, entered into a loan agreement in the amount of $1,982. The loan is non-interest bearing, unsecured and due on demand.
On December 16, 2020, the Company and Richard Senechal, an officer of the Company, entered into a loan agreement in the amount of $3,000. The loan is non-interest bearing, unsecured and due on demand.
During 2020, $80,000 in consulting services were performed for the Company.
As of December 31, 2021, the Company had a lease liability for a premises lease (carrying value of $62,818) with interest at a rate of 10% per annum, maturing in December 2023. The lease liability is payable in monthly instalments of $3,400. As of December 31, 2021, the Company has a balance of $73,681.
During the year ended December 31, 2019, the Company issued Convertible Unsecured Subordinated Debentures in three tranches of $150,000 originally maturing on December 1, 2019, $50,000 and $100,000 maturing on August 1, 2020, with an aggregate principal of $300,000 bearing interest at 10% per annum. During the year ended December 31, 2021, the debenture holders did not exercise their option to convert or demand for repayment and have agreed to extend the maturity date until December 31, 2025.
During the year ended December 31, 2020, the Company issued, to the Chief Executive Officer of the Company, additional Convertible Unsecured Subordinated Debentures in two separate tranches of $16,950 and $110,000 maturing on July 27, 2025, and October 29, 2025 respectively. These convertible debentures bear interest at a rate of 8% per annum. The debenture holders have an option to convert each debenture into one unit for the purpose of conversion at a conversion price of $0.10 per unit. Each unit entitles the holder to one common share and one half of a warrant to acquire a common share of the Company at $0.15. The share purchase warrant expires from July 27, 2025, to October 29, 2025.
During the year ended December 31, 2021, the Company issued two additional unsecured convertible debentures of $100,000 each both maturing on May 19, 2022. These convertible debentures bear interest at a rate of 8% per annum. The debenture holders have an option to convert each debenture into one unit for the purpose of conversion at a conversion price equal to a 20% discount to their subscription price subject to a maximum of $0.25 per unit. Each unit entitles the holder to one common share and one half of a warrant to acquire a common share of the Company at $0.40. These convertible debentures were converted into 1,191,616 units. Each unit comprised of one common share and one common share purchase warrant, with each warrant entitling the holder thereof to acquire one common share at an exercise price of $0.40 per share for a period of two years
The Company has applied for, and received, governmental assistance related to the COVID-19 pandemic. The Canada Emergency Business Account (CEBA) bears interest at 0% per annum, with no principal repayments required until January 1, 2024. The Company was advanced $60,000 during the year ended December 31, 2020. If 67% of the loan $40,000 is repaid by December 31, 2023, the remaining balance of the loan $20,000 will be forgiven. Balances thereafter bear interest at the rate of 5% per annum, payable monthly. The present value of the loan of $46,817 was discounted using a rate of 5% and has been classified under non-current liabilities as there is no reasonable assurance that the Company will meet the repayment conditions. During the year ended December 31, 2020, the discount on the government loan payable has been accounted for under other income as government assistance amounting to $13,183. Interest expense on government loan payable amounted to $2,467 for the year ended December 31, 2021. The balance is due in full on December 31, 2025.
Going Concern
The financial statements have been prepared on a going concern basis, which assumes that the Company will be able to realize its assets and discharge its liabilities in the normal course of business for the foreseeable future. In assessing whether the going concern assumption is appropriate, management takes into account all available information about the future, which is at least, but not limited to, twelve months from the end of the reporting period. The Company is in the start-up stage and as such no revenue has been generated from its operations. At December 31, 2021, the Company’s current liabilities exceeded its current assets by $979,654 and as of that date, there was an accumulated deficit of $5,843,729 The Company’s ability to continue as a going concern is dependent upon completion of the development of its bullet identification process, successful marketing launch of its products and obtaining adequate financing from third parties and related parties to finance its ongoing operations. There is no assurance that the Company will be successful at these initiatives. These material uncertainties may cast significant doubt about the Company’s ability to continue as a going concern. These financial statements do not reflect any adjustments to the carrying values of assets and liabilities that would be necessary if the Company were unable to achieve profitable operations or obtain adequate financing.
28
Plan of Operations
Bullet ID intends to lead the market in ammunition supply chain solutions and technology. As part of its plan of operations, the Company intends to execute the following milestones over the course of the next 12 months:
● | Software Development | |||
○ | Advance the level of functionality and integration of our supply chain solution, including the mobile app | |||
● | Product Development | |||
○ | Improve throughput and incorporate new technologies in the packaging process (Such as RFID for packaging, more resilient marking for ammunition rounds). | |||
● | Hire | |||
○ | Develop Sales Teams | |||
○ | Develop Marketing Teams | |||
● | Marketing roll out | |||
○ | Develop market awareness of the Bullet ID products via marketing strategies such as website and digital marketing, press releases, social media and tradeshows, including communication and joint marketing with technology partners and their channels |
Trend Information
We believe that Bullet ID is poised to be the leader in the ammunition tracking market.
The most prominent factors that drive the ammunition tracking market growth are the following:
● | To achieving more effective global ammunition traceability and meet national security needs. |
● | The desire to improve safety. |
● | Real time reverse tracking of unauthorized scanning/software use |
● | Secure real-time forensic data and quantitative performance analytics |
● | Verifiable Identity credentials platform |
The global small caliber ammunition market size was USD 8,140.0 million in 2019 and is projected to reach USD 8,808.9 million by 2027, exhibiting a CAGR of 1.72% during the forecast period.
On balance, we believe that Bullet ID is poised to be a leader in the ammunition tracking market.
29
DIRECTORS, EXECUTIVE OFFICERS AND SIGNIFICANT EMPLOYEES
As of December 31, 2021, the Company’s executive officers and directors are as follows:
Name | Position | Age | Term
of Office (Date of Appointment) |
Approximate
hours per week | ||||
Executive Officers | ||||||||
Bruce Lewis | CEO, President Founder | 82 | December 2016 | 50 | ||||
Cristian Talle | CTO | 48 | November 2018 | 50 | ||||
Tatiana Trofimova | CAO | 55 | December 2016 | 50 | ||||
Directors | ||||||||
Sethu Raman | Director | 82 | December 2020 | |||||
Peter Breuer | Chairman, Corporate Secretary, Director | 70 | July 2017 | |||||
Michael Capombassis | Director | 55 | May 2021 | |||||
Bruce Lewis | Director | 82 | December 2016 | |||||
Richard Senechal | Director | 67 | July 2020 |
Bruce Lewis, Chief Executive Officer, President, Founder
Mr. Lewis is the Founder of Bullet ID; a serial entrepreneur including introduction of UPC codes in Canada. In 1979, having been in the food service business for many years, Mr. Lewis realized that there was an opportunity to create bar codes as a new, reliable and immediate way of identifying products. In 1980, he became part of the team that implemented the Universal Bar Code (UPC) that is today seen in supermarkets around the world. In conjunction with the first bar code printer, Bruce introduced his first customer, Loblaw, a national Canadian grocery chain, to the code identification system in the meat department, vegetable department and bakery departments of its supermarkets.
In 1993, Bruce was granted the rights to a new code called PDF-417, a 3D Dimensional bar code with a 13-digit alpha numerical combination which has more than 10 trillion combinations. By adding another digit, over 25 trillion combinations can be created, with unlimited, inexpensive storage in the cloud. Subsequently, Mr. Lewis formed a company known as The Tracker Corporation of America for which he was the Chief Executive Officer. Through a proprietary system created by Mr. Lewis, Tracker Corporation’s bar code readers and bar-coded identification labels identified the owners of lost or stolen property. The Tracker service was global in reach through the installation of computers within police departments. The most successful recoveries were bicycles, suitcases, etc. Bruce is a member of the International Association of Chiefs of Police (IACP).
Cristian Talle, Chief Technical Officer
Cristian brings extensive experience in designing, implementing and integrating enterprise software for various industries including Healthcare, VoIP, Insurance and Real Estate. He worked for over 20 years as an independent software consultant for large companies such as Agfa Healthcare, Allstream, Shred-It, MIPS and Munich-Re.
A creative thinker, Cristian participated as co-founder and technical lead in several technology startups. As of 2017 Cristian dedicated his time to study and apply blockchain technology. Cristian was co-founder in 2017 of Real-Block Inc., a blockchain based platform for identity and process management for Real Estate regulators which was acquired in 2018, also co-founder and Chief Innovation Officer at Centrys Inc. from 2018 to 2019 where he led the research and implementation of Spiro - a permissioned enterprise blockchain stack and performed extensive research in the field of Decentralized Identity Management and related technologies.
30
Tatiana Trofimova, Chief Administrative Officer
Tatiana is a multifaceted professional with two decades of progressive responsibility in operations and administration management. Transitioning to the private sector from senior Ministry of Labour posts, Tatiana has provided admin and operations leadership in Bruce Lewis’ ventures since 2003. Since becoming the first employee at Bullet ID, Tatiana has dedicated herself to nurturing organizational excellence and stakeholder cohesion, both within the firm and with key partners.
Peter Breuer, Chairman of the Board, Corporate Secretary, Director
Peter has over 40 years of experience in the Financial Services Insurance sector, 20 of those years in executive leadership roles focusing on Business Development and Sales. Pete has unique experience in this sector as he has held leadership positions in the Agency channel, (Allstate) (2007 – 2013), the Direct channel (Belairdirect) (1993-2002) and the Broker Channel (Cowan Insurance Brokers) (2002-2006). In addition, Pete was an officer in two large insurance brokers in Ontario, where he successfully introduced new programs, increasing revenues.
Sethu Raman, Director
Dr. K.Sethu Raman is a serial mine finder and a successful entrepreneur with more than 46 years of international experience in all phases of exploration, mine development, acquisitions and operations as well as experience in financial and legal areas. Currently focussed on investing in startup companies like Bullet ID.
As President and CEO of Holmer Gold Mines Ltd (1985-2004) and Director and Advisor to Lake Shore Gold Corp (2004-2016), Dr. Raman has been the driving force behind the discovery and development of the Timmins West Gold mine which was sold to Tahoe Resources Inc for $945 M. Dr. Raman previously spent 13 years in executive positions with Campbell Chibougamau Mines/Campbell Resources and the Royex Gold Mining Group of companies which were sold to Home Stake Mining (now Barrick Gold) and Patino Mining Corp.
Mike Capombassis, Director
Mike has been the President of Bristol Gate Capital Partners since 2014. He brings two decades of experience with him including 15 in New York with RBC and Bank of America Merrill Lynch. Prior roles include Head & Managing Director of Global Equity Sales at Merrill Lynch Canada and U.S. Desk Head/Canadian Equity Sales at Merrill Lynch in New York. Mike brings a core belief and passion for dividend growth investing from his experience in the institutional equities business globally with both RBC and Merrill Lynch.
Richard Senechal, Director
Richard was interim President & CEO of Bullet ID Corporation from 2020-2021; and a principal in Bredonmore Capital Solutions Inc. (2017-Present); and Corp Secretary, TT7 Inc. (2018-Present). Prior roles include DUCA Financial Credit Union CEO/President (2012-2016); Director, Corp Officer (1982-2012) and director of Mortgage Company of Canada Inc., a private equity mortgage corp. In addition to executive leadership, governance and risk management in regulated financial markets, Richard also brings the over 25 years’ experience in serial entrepreneur and operator.
31
COMPENSATION OF DIRECTORS AND EXECUTIVE OFFICERS
For the fiscal year ended December 31, 2021, we compensated our three highest-paid directors and executive officers as follows:
Name | Capacities
in which compensation was received |
Cash compensation ($) |
Other compensation ($) |
Total compensation ($) | ||||
Bruce Lewis | Chief Executive Officer | $14,000 Consulting fees | N/A | $14,000 | ||||
Cristian Talle | Chief Technical Officer | $60,000 consulting fees | $18,000 for 72,000 units with each unit consisting of one common share and one common share purchase warrant | $72,000 | ||||
Tatiana Trofimova | Chief Administrative Officer | $47,256 – Employment income | N/A | $47,256 |
For the fiscal year ended December 31, 2021, we paid our directors as a group $0. There are 5 directors in this group.
Share based compensation
Options: The Company has adopted a stock option plan pursuant to which options may be granted to directors, officers, employees, and consultants of the Company to a maximum of 20% of the issued and outstanding. These options vest 33% per year over three years. The number of exercisable options is 2,605,000 (1,736,666 - December 31, 2020). The remaining contractual life of the outstanding options as at December 31, 2021 was 1.48 years (December 31, 2020 - 2.48 years).
Warrants: During the year ended December 31, 2021, the Company issued 2,420,395 units in a private placement of $0.25 per unit. Each unit consisted of one common share and one common share purchase warrant, with each warrant exercisable into one common share for a period of 24 months at an exercise price of $0.40, except for 71,190 of the units consisted of one common share and one half of a common share purchase warrant. The fair value of these warrants were calculated using the Black-Scholes pricing model with the assumptions of a share price of $0.25, risk-free interest rate ranging from 0.33% to 1%, 0% expected dividend yield, 2 years expected life and 100% volatility.
The remaining contractual life for the outstanding warrants as at December 31, 2021 is 1.55 years (0.37 years in 2020).
32
SECURITY OWNERSHIP OF MANAGEMENT AND CERTAIN SECURITYHOLDERS
The following table sets out, as of December 31, 2021, the voting securities of the Company that are owned by executive officers and directors, and other persons holding more than 10% of any class of the Company’s voting securities or having the right to acquire those securities. The table assumes that all options and warrants have vested. The Company’s voting securities include all shares of its limited liability company interests, designated as “Common Shares”.
Beneficial owner | Title of class | Name
and address of beneficial owner |
Amount
and nature of beneficial ownership |
Amount
and nature of beneficial ownership acquirable |
Percent of class | ||||||
Bruce Lewis | Common shares | 19,225,066 Common Shares - voting | N/A | 29.2% |
The column “Percent of Class” includes a calculation of the amount the person owns now, plus the amount that person is entitled to acquire. That amount is then shown as a percentage of the outstanding amount of securities in that class if no other people exercised their rights to acquire those securities. The result is a calculation of the maximum amount that person could ever own based on their current and acquirable ownership, which is why the amounts in this column will not add up to 100%.
33
INTEREST OF MANAGEMENT AND OTHERS IN CERTAIN TRANSACTIONS
Year ended December 31, 2021
From September 2021 to December 2021, $14,000 in consulting fees was paid to a company owned by Bruce Lewis, a Director of the Company.
Amounts due to Bruce Lewis, a director amounted to $43,537 as at December 31, 2021.
Year ended December 31, 2020
Amounts due from Bruce Lewis, a director of the Company, amounted to $20,525 as at December 31, 2020.
On September 4, 2020, to settle $229,031 in accrued salaries and $40,035 in amounts due to Bruce Lewis, Director and Chief Executive Officer of the Company, 2,690,066 common shares were issued at $0.10 per share.
To settle $110,000 in accrued salaries owed to Greg Sullivan, previous Chief Executive Officer of the Company, 1,100,000 common shares were issued at $0.10 per share.
From July 2020 to December 2020, the Company issued $126,950 in convertible debentures to Richard Senechal, a Director of the Company.
On January 22, 2020, 1,000,000 common shares at $0.10 per share were issued to Sethu Raman, a Director of the Company in a private placement.
On January 22, 2020, and February 26, 2020, 1,379,439 common shares were issued for proceeds received of $128,620 from the year ended December 31, 2018 from Richard Senechal, a Director of the Company and $1,500 from the year ended December 31, 2019.
During the 2020 year, the Company paid salaries and benefits to its Bruce Lewis and Greg Sullivan, Chief Executive Officer and co-Chief Executive Officer in the amount of $39,210 each, included in salaries and benefits. $128,883 was included in accounts payable and accrued liabilities representing the amounts owed to management.
34
General
The Company and selling shareholders are offering up to 52,000,000 shares of Common Stock in this Offering at a price of $1.00 per share. The Company is authorized to issue an unlimited amount of Common Stock, no par value. As of August 15, 2022, 71,338,511 share of Common Stock have been issued. The terms of the Company’s Common Stock are outlined below.
In addition, the Company is authorized to issue an unlimited number of Class A Preferred Shares and an unlimited number of Class B Preferred Shares. As of August 15, 2022, 0 Class A Preferred Shares are issued and outstanding and 0 shares of Class B Preferred Shares are issued and outstanding.
Terms of the Company’s Authorized Classes of Capital Stock
Common Stock
Each holder of our Common Stock is entitled to one vote for each share owned of record on all matters voted upon by shareholders. In the event of a dividend distribution declared by the Company, each holder of Common Stock is entitled to receive their applicable dividend distribution. In the event of a liquidation, dissolution or winding-up of the Company, the holders of Common Stock are entitled to share equally and ratably in the assets of the Company, if any, remaining after the payment of all debts and liabilities of the Company. The Common Stock has no preemptive rights, no cumulative voting rights and no redemption, sinking fund or conversion provisions.
Class A Preferred Shares
Each holder of our Class A Preferred Shares is entitled to one vote for each share owned of record on all matters voted upon by shareholders,
Each year, holders are entitled to receive non-cumulative dividends in such amount as may be determined by the directors, not exceeding 12% per annum of the redemption price for such shares, payable on such terms as declared by the directors of the Company in their sole discretion.
In the event of a liquidation, dissolution or winding-up of the Company, the holders of Class A Preferred Stock are entitled to share equally and ratably in the assets of the Company, if any, remaining after the payment of all debts and liabilities of the Company. The Common Stock has no preemptive rights, no cumulative voting rights and no redemption, sinking fund or conversion provisions.
Each holder of one or more Class A Preferred Stock may demand that the Company redeem all or any of the said shares registered to them.
The holders of Class A Preferred Stock shall be entitled to receive notice of and to attend and vote at all meetings of the shareholders of the Company.
Class B Preferred Shares
Each holder of our Class B Preferred Shares is entitled to one vote for each share owned of record on all matters voted upon by shareholders,
Each year, holders are entitled to receive non-cumulative dividends in such amount as may be determined by the directors, not exceeding 13% per annum of the redemption price for such shares, payable on such terms as declared by the directors of the Company in their sole discretion.
In the event of a liquidation, dissolution or winding-up of the Company, the holders of Class B Preferred Stock are entitled to share equally and ratably in the assets of the Company, if any, remaining after the payment of all debts and liabilities of the Company. The Common Stock has no preemptive rights, no cumulative voting rights and no redemption, sinking fund or conversion provisions.
Each holder of one or more Class B Preferred Stock may demand that the Company redeem all or any of the said shares registered to them.
35
ONGOING REPORTING AND SUPPLEMENTS TO THIS OFFERING CIRCULAR
The Company will be required to make annual and semi-annual filings with the SEC. The Company will make annual filings on Form 1-K, which will be due by the end of April each year and will include audited financial statements for the previous fiscal year. The Company will make semi-annual filings on Form 1-SA, which will be due by September 28 each year, which will include unaudited financial statements for the six months to June 30. The Company will also file a Form 1-U to announce important events such as the loss of a senior officer, a change in auditors or certain types of capital-raising. The Company will be required to keep making these reports unless we file a Form 1-Z to exit the reporting system, which it will only be able to do if it has less than 300 shareholders of record and have filed at least one Form 1-K.
Relaxed Ongoing Reporting Requirements
If the Company becomes a public reporting company in the future, the Company will be required to publicly report on an ongoing basis as an “emerging growth company” (as defined in the Jumpstart Our Business Startups Act of 2012, which the Company refers to as the JOBS Act) under the reporting rules set forth under the Exchange Act. For so long as the Company remains an “emerging growth company”, the Company may take advantage of certain exemptions from various reporting requirements that are applicable to other Exchange Act reporting companies that are not “emerging growth companies”, including but not limited to:
● | not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act; |
● | taking advantage of extensions of time to comply with certain new or revised financial accounting standards; |
● | being permitted to comply with reduced disclosure obligations regarding executive compensation in the Company’s periodic reports and proxy statements; and |
● | being exempt from the requirement to hold a non-binding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. |
If the Company becomes a public reporting company in the future, the Company expects to take advantage of these reporting exemptions until it is no longer an emerging growth company. The Company would remain an “emerging growth company” for up to five years, although if the market value of the Company’s Common Stock that is held by non-affiliates exceeds $700 million as of any June 30 before that time, the Company would cease to be an “emerging growth company” as of the following December 31.
If the Company does not become a public reporting company under the Exchange Act for any reason, it will be required to publicly report on an ongoing basis under the reporting rules set forth in Regulation A for Tier 2 issuers. The ongoing reporting requirements under Regulation A are more relaxed than for “emerging growth companies” under the Exchange Act. The differences include, but are not limited to, being required to file only annual and semiannual reports, rather than annual and quarterly reports. Annual reports are due within 120 calendar days after the end of the issuer’s fiscal year, and semiannual reports are due within 90 calendar days after the end of the first six months of the issuer’s fiscal year.
In either case, the Company will be subject to ongoing public reporting requirements that are less rigorous than Exchange Act rules for companies that are not “emerging growth companies”, and the Company’s shareholders could receive less information than they might expect to receive from more mature public companies.
The Company may supplement the information in this Offering Circular by filing a Supplement with the SEC. The Company hereby incorporate by reference into this Offering Circular all such Supplements, and the information on any Form 1-K, 1-SA or 1-U filed after the date of this Offering Circular.
All these filings will be available on the SEC’s EDGAR filing system. You should read all the available information before investing.
36
FINANCIAL STATEMENTS
DECEMBER 31, 2021 AND 2020
(Stated In Canadian Dollars)
THE BULLET ID CORPORATION
FINANCIAL STATEMENTS
DECEMBER 31, 2021 AND 2020
(Stated In Canadian Dollars)
TABLE OF CONTENTS
F-1
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Board of Directors and Shareholders of The Bullet ID Corporation
Opinion on the Financial Statements
We have audited the accompanying statements of financial position of The Bullet ID Corporation (the “Company”) as of December 31, 2021 and 2020, the related statements of operations and comprehensive loss, changes in shareholders’ deficit, and cash flows for each of the two years in the period ended December 31, 2021, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2021 and 2020, and the results of its operations and its cash flows for each of the two years in the period ended December 31, 2021, in conformity with the International Financial Reporting Standards.
Material Uncertainty Related to Going Concern
The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 2 to the financial statements, the Company has no revenue, incurred operating losses and negative cash flows from operations. The Company also had a net working capital deficiency and an accumulated deficit as at December 31, 2021 that raise substantial doubt about its ability to continue as a going concern. Management’s plans in regard to these matters are also described in Note 2. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.
Basis for Opinion
These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.
Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.
/s/ SRCO Professional Corporation | |
We have served as the Company’s auditor since 2021 | CHARTERED PROFESSIONAL ACCOUNTANTS |
Richmond Hill, Ontario, Canada | Authorized to practice public accounting by the |
June 23, 2022 | Chartered Professional Accountants of Ontario |
F-2
THE BULLET ID CORPORATION |
Statements of Financial Position |
As at December 31, 2021 and 2020 |
(Stated In Canadian Dollars) |
2021 | 2020 | |||||||
ASSETS | ||||||||
CURRENT | ||||||||
Cash | $ | 265,134 | $ | 16,045 | ||||
Investment tax credits receivable (note 5) | - | 113,511 | ||||||
Inventory (note 6) | - | 59,491 | ||||||
Prepaid expenses | 1,785 | 1,834 | ||||||
Government assistance receivable (note 18) | - | 7,774 | ||||||
Advances to director (note 10) | - | 20,525 | ||||||
Total Current Assets | 266,919 | 219,180 | ||||||
NON-CURRENT | ||||||||
Furniture and equipment (note 7) | 3,892 | 3,319 | ||||||
Rent deposit | 1,050 | 1,050 | ||||||
Right-of-use asset (note 8) | 62,818 | 40,656 | ||||||
Total | $ | 334,679 | $ | 264,205 |
Going concern (note 2)
Contingent liability (note 23)
Subsequent events (note 24)
The accompanying notes are an integral part of these financial statements.
F-3
THE BULLET ID CORPORATION |
Statements of Financial Position |
As at December 31, 2021 and 2020 |
(Stated In Canadian Dollars) |
2021 | 2020 | |||||||
LIABILITIES AND SHAREHOLDERS’ DEFICIT | ||||||||
CURRENT | ||||||||
Accounts payable and accrued liabilities | $ | 970,278 | $ | 1,016,604 | ||||
Loans payable to related parties (note 10) | 5,045 | 4,982 | ||||||
Current portion of lease liabilities (note 13) | 35,008 | 38,037 | ||||||
Advances from director (note 10) | 43,537 | - | ||||||
Convertible debentures (note 14) | 192,705 | - | ||||||
Loan payable (note 15) | - | 20,000 | ||||||
Total Current Liabilities | 1,246,573 | 1,079,623 | ||||||
NON-CURRENT | ||||||||
Lease liabilities (note 13) | 38,673 | 6,716 | ||||||
Government loan payable (note 17) | 51,823 | 49,356 | ||||||
Deferred income taxes (note 12) | 28,693 | 40,941 | ||||||
Deposit | 18,701 | - | ||||||
Convertible debentures (note 14) | 325,967 | 385,967 | ||||||
Total Liabilities | 1,710,430 | 1,562,603 | ||||||
SHAREHOLDERS’ DEFICIT | ||||||||
Share capital (note 11) | 3,269,099 | 3,002,074 | ||||||
Common shares subscribed | 210,000 | 10,000 | ||||||
Stock option reserve | 142,282 | 134,703 | ||||||
Warrants and other reserves | 846,597 | 396,505 | ||||||
Accumulated deficit | (5,843,729 | ) | (4,841,680 | ) | ||||
Total Shareholders’ Deficit | (1,375,751 | ) | (1,298,398 | ) | ||||
Total Liabilities and Shareholders’ Deficit | $ | 334,679 | $ | 264,205 |
The accompanying notes are an integral part of these financial statements.
F-4
THE BULLET ID CORPORATION |
Statements of Operations and Comprehensive Loss |
For the years ended December 31, 2021 and 2020 |
(Stated In Canadian Dollars) |
2021 | 2020 | |||||||
REVENUE | $ | - | $ | - | ||||
EXPENSES | ||||||||
Professional fees | 339,688 | 149,014 | ||||||
Salaries and related benefits | 135,729 | 298,172 | ||||||
Research and development | 74,952 | - | ||||||
Inventory write-downs (note 6) | 186,125 | 291,811 | ||||||
Impairment of intangible asset (note 9) | - | 959,723 | ||||||
Advertising and promotion | 74,652 | 4,564 | ||||||
Office and general | 56,139 | 30,680 | ||||||
Automobile and travel | 27,012 | 38,007 | ||||||
Consulting fees | 16,860 | 127,798 | ||||||
Occupancy costs | 13,425 | 4,400 | ||||||
Share-based compensation (note 16) | 7,579 | 27,617 | ||||||
Foreign exchange (gain) loss | (7,175 | ) | 5,411 | |||||
Depreciation of furniture and equipment (note 7) | 1,592 | 1,326 | ||||||
Amortization of right-of-use asset (note 8) | 31,409 | 34,848 | ||||||
957,987 | 1,973,371 | |||||||
LOSS BEFORE UNDERNOTED ITEMS | (957,987 | ) | (1,973,371 | ) | ||||
OTHER EXPENSES (INCOME) | ||||||||
Investment tax credits | - | (113,511 | ) | |||||
Government assistance (note 18) | (20,720 | ) | (20,957 | ) | ||||
Other income (note 20) | - | (13,600 | ) | |||||
Gain on extinguishment of convertible debentures (note 14) | (15,879 | ) | - | |||||
Finance costs (note 19) | 92,909 | 49,223 | ||||||
56,310 | (98,845 | ) | ||||||
LOSS BEFORE INCOME TAXES | (1,014,297 | ) | (1,874,526 | ) | ||||
INCOME TAXES (RECOVERY) EXPENSES (note 12) | ||||||||
Income taxes - deferred | (12,248 | ) | 9,634 | |||||
NET LOSS AND COMPREHENSIVE LOSS | $ | (1,002,049 | ) | $ | (1,884,160 | ) | ||
BASIC AND DILUTED LOSS PER SHARE | (0.02 | ) | (0.03 | ) | ||||
AVERAGE WEIGHTED NUMBER OF COMMON SHARES | 64,205,545 | 58,224,835 |
The accompanying notes are an integral part of these financial statements.
F-5
THE BULLET ID CORPORATION |
Statements of Changes in Shareholders’ Deficit |
For the years ended December 31, 2021 and 2020 |
(Stated In Canadian Dollars) |
Number of shares | Share capital | Common shares subscribed | Stock option reserve | Warrants and other reserves | Accumulated deficit | Total shareholders’ deficit | ||||||||||||||||||||||
Balance, December 31, 2019 | 52,969,996 | $ | 1,998,412 | $ | 130,120 | $ | 107,086 | $ | 365,312 | $ | (2,957,520 | ) | $ | (356,590 | ) | |||||||||||||
Net loss and comprehensive loss | - | - | - | - | - | (1,884,160 | ) | (1,884,160 | ) | |||||||||||||||||||
Issuance of units under private placement (note 11) | 1,379,439 | 130,120 | (130,120 | ) | - | - | - | - | ||||||||||||||||||||
Settlement of payables (note 11) | 6,474,570 | 647,542 | - | - | - | - | 647,542 | |||||||||||||||||||||
Issuance of common shares (note 11) | 2,300,000 | 230,000 | - | - | - | - | 230,000 | |||||||||||||||||||||
Share issue cost | - | (4,000 | ) | - | - | - | - | (4,000 | ) | |||||||||||||||||||
Shares to be issued (note 11) | - | - | 10,000 | - | - | - | 10,000 | |||||||||||||||||||||
Issuance of convertible debentures (note 14) | - | - | - | - | 31,193 | - | 31,193 | |||||||||||||||||||||
Share-based compensations for options issued (note 16) | - | - | - | 27,617 | - | - | 27,617 | |||||||||||||||||||||
Balance, December 31, 2020 | 63,124,005 | $ | 3,002,074 | $ | 10,000 | $ | 134,703 | $ | 396,505 | $ | (4,841,680 | ) | $ | (1,298,398 | ) |
The accompanying notes are an integral part of these financial statements.
F-6
THE BULLET ID CORPORATION |
Statements of Changes in Shareholders’ Deficit (cont’d) |
For the years ended December 31, 2021 and 2020 |
(Stated In Canadian Dollars) |
Number of shares | Share capital | Common shares subscribed | Stock option reserve | Warrants and other reserves | Accumulated deficit |
Total shareholders’ deficit | ||||||||||||||||||||||
Balance, December 31, 2020 | 63,124,005 | $ | 3,002,074 | $ | 10,000 | $ | 134,703 | $ | 396,505 | $ | (4,841,680 | ) | $ | (1,298,398 | ) | |||||||||||||
Net loss and comprehensive loss | - | - | - | - | - | (1,002,049 | ) | (1,002,049 | ) | |||||||||||||||||||
Issuance of common shares to settle loan payable (note 11) | 200,000 | 20,000 | - | - | - | - | 20,000 | |||||||||||||||||||||
Issuance of units under private placement (note 11) | 2,455,990 | 247,025 | - | - | 366,973 | - | 613,998 | |||||||||||||||||||||
Shares to be issued (note 11) | - | - | 200,000 | - | - | - | 200,000 | |||||||||||||||||||||
Issuance of new convertible debentures (note 14) | - | - | - | - | 18,582 | - | 18,582 | |||||||||||||||||||||
Share-based compensations for options issued (note 16) | - | - | - | 7,579 | - | - | 7,579 | |||||||||||||||||||||
Extinguishment of convertible debentures (note 14) | - | - | - | - | 64,537 | - | 64,537 | |||||||||||||||||||||
Balance, December 31, 2021 | 65,779,995 | $ | 3,269,099 | $ | 210,000 | $ | 142,282 | $ | 846,597 | $ | (5,843,729 | ) | $ | (1,375,751 | ) |
The accompanying notes are an integral part of these financial statements.
F-7
THE BULLET ID CORPORATION |
Statements of Cash Flows |
For the years ended December 31, 2021 and 2020 |
(Stated In Canadian Dollars) |
2021 | 2020 | |||||||
OPERATING ACTIVITIES | ||||||||
Net loss and comprehensive loss | $ | (1,002,049 | ) | $ | (1,884,160 | ) | ||
Adjustments for non-cash items: | ||||||||
Depreciation of furniture and equipment | 1,592 | 1,326 | ||||||
Amortization of right-of-use asset | 31,409 | 34,848 | ||||||
Share-based compensation | 67,077 | 27,617 | ||||||
Deferred income taxes | (12,248 | ) | 9,634 | |||||
Impairment of intangible asset | - | 959,723 | ||||||
Accretion expense | 31,703 | 8,230 | ||||||
Interest on lease liability | 8,723 | 6,369 | ||||||
Discount on government loan | - | (13,183 | ) | |||||
Interest on government loan | 2,467 | 2,539 | ||||||
Gain on extinguishment of convertible debenture | (15,879 | ) | - | |||||
Inventory write-downs | 186,125 | 291,811 | ||||||
(701,080 | ) | (555,246 | ) | |||||
Change in non-cash working capital items: | ||||||||
Decrease (increase) in investment tax credits receivable | 113,511 | (37,811 | ) | |||||
Increase in inventory | (126,634 | ) | (276,531 | ) | ||||
Decrease in prepaid expenses | 49 | 116,825 | ||||||
Decrease (increase) in government assistance receivable | 7,774 | (7,774 | ) | |||||
Increase in deposit | 18,701 | - | ||||||
(Decrease) increase in accounts payable and accrued liabilities | (46,326 | ) | 448,845 | |||||
Decrease in rent deposit | - | 3,400 | ||||||
(734,005 | ) | (308,292 | ) | |||||
INVESTING ACTIVITIES | ||||||||
Purchase of equipment | (2,165 | ) | - | |||||
Decrease (increase) in advances to director | 20,525 | (20,525 | ) | |||||
18,360 | (20,525 | ) | ||||||
FINANCING ACTIVITIES | ||||||||
Proceeds from (repayment of) loans payable to related parties | 63 | (66,615 | ) | |||||
Advances from director | 43,537 | - | ||||||
Proceeds from loan payable | - | 20,000 | ||||||
Repayment of lease liabilities | (33,366 | ) | (40,800 | ) | ||||
Increase in government loan payable | - | 60,000 | ||||||
Proceeds from debentures | 200,000 | 126,950 | ||||||
Issuance of share capital | 554,500 | 230,000 | ||||||
Common shares subscribed | 200,000 | 10,000 | ||||||
Share issuance costs | - | (4,000 | ) | |||||
964,734 | 335,535 | |||||||
NET INCREASE IN CASH, DURING THE YEARS | 249,089 | 6,718 | ||||||
CASH, BEGINNING OF YEARS | 16,045 | 9,327 | ||||||
CASH, END OF YEARS | $ | 265,134 | $ | 16,045 | ||||
NON-CASH INFORMATION: | ||||||||
Settlement of payables through issuance of shares | $ | - | $ | 647,542 | ||||
Extinguishment of convertible debentures | 80,416 | - | ||||||
Addition of right-of-use assets due to modification of lease | 53,571 | - | ||||||
Interest paid | - | - | ||||||
Income taxes paid | - | - | ||||||
Shares issued to repay loan payable | 20,000 | - |
The accompanying notes are an integral part of these financial statements.
F-8
THE BULLET ID CORPORATION |
Notes to Financial Statements |
December 31, 2021 and 2020 |
(Stated In Canadian Dollars) |
1. | NATURE OF OPERATIONS |
The Bullet ID Corporation (the “Company”) was incorporated under the Business Corporations Act of Ontario on December 23, 2016. The Company’s registered office and the principal place of business is located at 1018 Finch Avenue West, Suite 404, Toronto, Ontario, M3J 3L5, Canada.
The Company is in the business of authenticated ammunition tracking system and plans to sell its machines and proprietary software to ammunition manufacturers, law enforcement and military. The system utilizes a process to laser-etch a unique bar code on each brass cartridge case of a bullet. This provides the ultimate inventory tool for law enforcements, allowing the traceability of a round from the point of manufacturing to the point of delivery. The financial statements were approved by the Board of Directors and authorized for issue on June 23, 2022.
The outbreak of COVID-19 has resulted in governments enacting emergency measures including various public health and safety protocols, government restrictions and financial assistance. While vaccine supplies have become available, it is expected to take some time before herd immunity is reached. At the date of approval of these financial statements, it is still not possible to reliably estimate the effect of these developments as well as the impact on the financial results and condition of the Company in future periods. Management is monitoring these developments on the Company’s operations and is taking all steps to ensure that employees are following all public health and safety protocols.
2. | GOING CONCERN |
The financial statements have been prepared on a going concern basis, which assumes that the Company will be able to realize its assets and discharge its liabilities in the normal course of business for the foreseeable future. In assessing whether the going concern assumption is appropriate, management takes into account all available information about the future, which is at least, but not limited to, twelve months from the end of the reporting period. The Company is in the start-up stage and as such no revenue has been generated from its operations. The Company has incurred significant operating losses and negative cash flows from operations during the current and previous years. At December 31, 2021, the Company’s current liabilities exceeded its current assets by $979,654 (2020 - $860,443) and as of that date, there was an accumulated deficit of $5,843,729 (2020 - $4,841,680). The Company’s ability to continue as a going concern is dependent upon completion of the development of its bullet identification process, successful marketing launch of its products and obtaining adequate financing from third parties and related parties to finance its ongoing operations. There is no assurance that the Company will be successful at these initiatives. These material uncertainties may cast significant doubt about the Company’s ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of these uncertainties.
3. | STATEMENT OF COMPLIANCE |
The financial statements have been prepared in accordance with International Financial Reporting Standards (“IFRS”) issued by the International Accounting Standards Board (“IASB”), and interpretations of the International Financial Reporting Interpretations Committee.
F-9
THE BULLET ID CORPORATION |
Notes to Financial Statements |
December 31, 2021 and 2020 |
(Stated In Canadian Dollars) |
4. | SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES |
(a) | Basis Of Presentation | |
The financial statements have been prepared on a historical cost basis except for items disclosed herein at fair value. In addition, the financial statements have been prepared using the accrual basis of accounting, except for cash flow information. | ||
(b) | Functional and Presentation Currency | |
The Company’s functional and presentation currency is in Canadian dollars. | ||
(c) | Inventory | |
Inventory includes ammunition packaging machine. Inventory is valued at lower of cost and net realizable value. Cost is determined using the first in first out method. Cost includes purchase price plus other costs in bringing the inventory to its present location and condition. Net realizable value is the estimated selling price in the ordinary course of business, less selling expenses.
The Company periodically reviews the inventory to determine if product modifications, technology changes, and other factors hinder their ability to recover the inventories’ net realizable value. The Company’s assessment is based upon estimated future product demand and various other judgments and estimates. Inventory obsolescence reserves are recorded when such assessments reveal that portions or components of the Company’s inventory will not be realized in the ordinary course of business. | ||
(d) | Furniture and Equipment |
Furniture and equipment are stated at historic cost less any accumulated depreciation and impairment. Historic cost includes all costs directly attributable to the acquisition or construction of the assets. Depreciation on furniture and equipment is calculated using the declining balance method to amortize the initial cost to its residual value over the estimated useful life, as follows:
Furniture | 20% declining balance | |
Computer equipment | 30% declining balance |
Useful lives, residual values and amortization methods are reviewed at the end of each reporting period, taking into consideration the nature of the assets, their intended use and technological changes. The carrying value of equipment is assessed annually for impairment for indicators that their carrying amounts may not be recoverable. An asset is impaired if its recoverable amount is lower than its carrying amount.
If there is an indication that an asset is impaired, the asset’s recoverable amount is determined as the higher of the asset’s fair value less cost of disposal and its value in use. An impairment loss is recognized immediately in comprehensive loss. If, in a subsequent period, the amount of the impairment loss decreases and the decrease can be related objectively to an event occurring after the impairment was recognized, the reversal of the previously recognized impairment losses is recognized in the statements of operations and comprehensive loss, limited to the carrying amount that would have been determined had no impairment losses been recognized in previous years.
F-10
THE BULLET ID CORPORATION |
Notes to Financial Statements |
December 31, 2021 and 2020 |
(Stated In Canadian Dollars) |
4. | SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (cont’d) |
(e) | Intangible Assets |
An intangible asset is recognized when it is probable that the expected future economic benefits are expected to flow to the entity, the cost of the asset can be measured reliably and is identifiable.
Indefinite life intangible assets acquired separately are measured on initial recognition at cost. Following initial recognition, indefinite life intangible assets are carried at cost less any accumulated impairment losses.
An intangible asset is regarded as having an indefinite useful life when, based on all relevant factors, there is no foreseeable limit to the period over which the asset is expected to generate net cash flows for the entity. Amortization is not provided for these externally acquired intangible assets, but they are tested for impairment annually at the same time every year and whenever there is an indication that the asset may be impaired. The assessment of indefinite life is reviewed annually to determine whether the indefinite life continues to be supportable. An impairment loss is recognized when the asset’s carrying amount exceeds its recoverable amount.
(f) | Government Assistance |
The Company received the Canada Emergency Business Account (CEBA) loan as a means of financial assistance during the COVID-19 pandemic. The loan is partially forgivable. A forgivable loan from the government is treated as a government grant when there is reasonable assurance that the entity will meet the terms for forgiveness of the loan. Government grants relating to income are recognized as other income in the statement of operations and comprehensive loss when there is reasonable assurance that the Company will comply with the conditions attached to the grants and the grants will be received. When there is no reasonable assurance of compliance but the grants have been received, they are presented as a liability.
Government assistance relating to eligible expenses incurred that meets certain eligibility criteria, is accounted for as other income in the same period as the related expense is incurred when there is reasonable assurance of compliance or continued compliance with the conditions applicable to the assistance.
F-11
THE BULLET ID CORPORATION |
Notes to Financial Statements |
December 31, 2021 and 2020 |
(Stated In Canadian Dollars) |
4. | SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (cont’d) |
(g) | Critical Accounting Judgements and Estimates |
The preparation of financial statements requires management to make judgments and estimates that affect the reported amount of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reported year. Actual outcomes could differ from these estimates.
The financial statements include estimates which, by their nature, are uncertain and are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the period in which the estimates are revised and may affect both the period of revision and future periods. Information about critical accounting judgements in applying accounting policies that have the most significant risk of causing material adjustments to the carrying amount of assets and liabilities and recognized in the financial statements are discussed below:
i) Inventory
Management is required to assess whether a write-down of inventory is required in situations where the selling price of inventory is less than its cost.
ii) Useful lives of Furniture and Equipment, Intangible Assets and Right-of-use assets
The Company reviews the estimated useful lives of furniture and equipment, intangible assets and right-of-use assets at the end of each year. Management has determined no change in the useful lives.
iii) Lease liabilities
For the measurement of lease liabilities, management considers all factors such as residual value guarantee, incentive to exercise extension options, or not exercise termination options available in leasing arrangements. Extension options, or periods subject to termination options, are only included in the lease term if management determines it is reasonably certain to be extended or not terminated. The assessment is reviewed if a significant event or a significant change in circumstances occurs which affect this assessment and that is within the control of the lessee.
iv) Fair value measurement of convertible instruments, stock options and warrants
Estimating fair value for convertible instruments, stock options and warrants requires determining the most appropriate valuation model, which is dependent on the terms and conditions of the instrument and the arrangement. This estimate also requires the determination of the most appropriate inputs to the valuation model including discount rate, the duration of instrument, volatility and dividend yield.
v)
Impairment testing of non-financial assets
The Company reviews and tests the carrying value of non-financial assets annually and
when events or changes in circumstances suggest that the carrying amount may not be recoverable. When such indicators exist, management
determine the recoverable amount by performing value in use and fair value calculations. These calculations require the use of estimates
and assumptions. When it is not possible to determine the recoverable amount for an individual asset, management assesses the recoverable
amount for the cash generating unit to which the asset belongs. The value in use calculation is based on a discounted cash flow (“DCF”)
model. The recoverable amount is sensitive to the discount rate used for the DCF model as well as the other assumptions relating to growth
rate and change in technology. These estimates are most relevant to the non-financial assets and intangibles with indefinite useful lives
recognized by the Company.
F-12
THE BULLET ID CORPORATION |
Notes to Financial Statements |
December 31, 2021 and 2020 |
(Stated In Canadian Dollars) |
4. | SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (cont’d) |
(h) | Share-Based Compensation |
Equity-settled share-based payment transactions with parties other than employees are measured at the fair value of services received, except where the fair value cannot be estimated reliably, in which case they are measured at the fair value of the equity instruments granted, measured at the date counterparty renders the service. Equity-settled share-based payment transactions with employees are measured at the fair value of equity instruments granted at grant date.
(i) | Leases |
Under IFRS 16, an entity recognizes a right of use asset and a lease liability at the lease commencement date. The right of use asset is initially measured at cost, which comprises the initial amount of the lease liability adjusted for any lease payments made at or before the commencement date, plus any initial direct costs incurred and an estimate of costs to dismantle and remove the underlying asset or to restore the underlying asset or the site on which it is located, less any lease incentives received.
The right-of-use asset is subsequently depreciated using the straight-line method from the commencement date to the earlier of the end of the useful life of the right-of-use asset or the end of the lease term. Amortization is provided over to the end of the lease term at the undernoted rates and methods:
Right-of-use asset – Premises lease | Straight-line, lower of three years or period of lease |
In addition, the right-of-use asset is periodically reduced by impairment losses, if any.
The lease liability is initially measured at the present value of the lease payments that are not paid at the commencement date, discounted using the interest rate implicit in the lease, or if that rate cannot be readily determined, the Company’s incremental borrowing rate.
The lease liability is measured at amortized cost using the effective interest method. It is re measured when there is a change in future lease payments arising from a change in an index or a rate, if there is a change in the Company’s estimate of the amount to be payable under a residual value guarantee, or if the Company changes its assessment of whether it will exercise a purchase, extension, or termination option. The Company did not make any such adjustments during the periods presented. When the lease liability is remeasured in this way, a corresponding adjustment is made to the carrying amount of the right of use asset, or is recorded in profit or loss if the carrying amount of the right of use asset has been reduced to zero.
F-13
THE BULLET ID CORPORATION |
Notes to Financial Statements |
December 31, 2021 and 2020 |
(Stated In Canadian Dollars) |
4. | SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (cont’d) |
(j) | Loss Per Share |
Basic loss per share is computed using the weighted average number of common shares outstanding during the period. The treasury stock method is used for the calculation of diluted loss per share, whereby all “in the money” stock options and share purchase warrants are assumed to have been exercised at the beginning of the period and the proceeds from their exercise are assumed to have been used to purchase common shares at the average market price during the period. When a loss is incurred during the period, basic and diluted loss per share are the same as the exercise of stock options and share purchase warrants is considered to be anti-dilutive.
(k) | Fair Value Measurements | |
Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value measurement is based on the presumption that the transaction to sell the asset or transfer the liability takes place either:
a) In the principal market for the asset or liability; and
b) In the absence of a principal market, in the most advantageous market for the asset or liability
The principal or the most advantageous market must be accessible by the Company. The fair value of an asset or a liability is measured using the assumptions that market participants would use when pricing the asset or liability, assuming that market participants act in their economic best interest.
A fair value measurement of a non-financial asset takes into account a market participant’s ability to generate economic benefits by using the asset in its highest and best use or by selling it to another market participant that would use the asset in its highest and best use.
The Company uses valuation techniques that are appropriate in the circumstances and for which sufficient data are available to measure fair value, maximizing the use of relevant observable inputs and minimizing the use of unobservable inputs.
All assets and liabilities for which fair value is measured or disclosed in the financial statements are categorized within the fair value hierarchy, described as follows, based on the lowest level input that is significant to the fair value measurement as a whole:
Level 1 — Quoted (unadjusted) market prices in active markets for identical assets or liabilities
Level 2 — Valuation techniques for which the lowest level input that is significant to the fair value measurement is directly or indirectly observable
Level 3 — Valuation techniques for which the lowest level input that is significant to the fair value measurement is unobservable |
F-14
THE BULLET ID CORPORATION |
Notes to Financial Statements |
December 31, 2021 and 2020 |
(Stated In Canadian Dollars) |
4. | SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (cont’d) |
(l) | Research and Development Costs | ||
Research costs are expensed as incurred. Development expenditures on an individual project are recognized as an intangible asset when the Company can demonstrate: | |||
- | The technical feasibility of completing the intangible asset so that the asset will be available for use or sale | ||
- | Its intention to complete and its ability and intention to use or sell the asset | ||
- | How the asset will generate future economic benefits | ||
- | The availability of resources to complete the asset | ||
- | The ability to measure reliably the expenditure during development | ||
Following initial recognition of the development expenditure as an asset, the asset is carried at cost less any accumulated amortization and accumulated impairment losses. Amortization of the asset begins when development is complete and the asset is available for use. It is amortized over the period of expected future benefit. Amortization is recorded in cost of sales. During the period of development, the asset is tested for impairment annually.
Investment tax credits (“ITCs”) are recorded when qualifying expenditures are incurred and there is reasonable assurance that they will be realized. ITCs related to the acquisition of assets are deducted from the related assets with any amortization calculated on the net amount or deferred and amortized to income on the same basis as the related assets. ITCs related to current expenses are included in the determination of net income for the period. |
(m) | Income Taxes | |
Income tax expense comprises current and deferred taxes. The Company recognizes income taxes currently payable or recoverable at tax rates that have been enacted or substantially enacted by the end of the year and deferred taxes on temporary differences between the carrying amounts of assets and liabilities and their tax bases and unused losses. Deferred tax assets and liabilities are measured using enacted or substantially enacted tax rates expected to apply to taxable income in the years in which such temporary differences are expected to be recovered or settled. Deferred tax assets are recognized to the extent that it is probable that there will be sufficient future taxable income against which to utilize the benefits of the deductible temporary differences or unused losses.
Unrecognized deferred tax assets are reassessed at each statement of financial position statement date and recognized to the extent that it has become probable that future taxable profits will be available against which they can be used. |
F-15
THE BULLET ID CORPORATION |
Notes to Financial Statements |
December 31, 2021 and 2020 |
(Stated In Canadian Dollars) |
4. | SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (cont’d) |
(n) | Share Capital |
Consideration received on the sale of a share and share purchase warrant classified as equity is allocated, within equity, to their respective equity accounts on a reasonable basis. The Company has adopted the residual method for allocation. Under the residual method, one component being the common shares is measured first and the residual amount is allocated to the remaining component being warrants.
| ||
(o) | Financial Instruments | |
Financial assets comprise cash, advances to director and rent deposit. Financial liabilities comprise of accounts payable and accrued liabilities, loan payable, government loan payable, lease liabilities, convertible debentures, loans payable to related parties and advances from director.
Initial Recognition
The classification of a financial asset or liability is made at the time the instrument is initially recognized, namely when the Company becomes a party to the contractual provisions of the instrument. All financial instruments are initially measured at fair value, adjusted for transaction costs relating to those instruments not at fair value through profit or loss.
Subsequent Measurement
Subsequent to initial measurement at fair value, all financial instruments are measured either at amortized cost or fair value. All of the Company’s financial instruments were subsequently measured at amortized cost using the effective interest method.
The effective interest method is a method of calculating the amortized cost of a financial liability and of allocating interest expense over the relevant period. The effective interest rate is the rate that exactly discounts estimated future cash payments through the expected life of the financial liability, or, where appropriate, a shorter period. |
F-16
THE BULLET ID CORPORATION |
Notes to Financial Statements |
December 31, 2021 and 2020 |
(Stated In Canadian Dollars) |
4. | SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (cont’d) |
(o) | Financial Instruments (cont’d) |
Convertible instruments including debentures are separated into liability and equity components based on the terms of the contract. On issuance of the convertible instruments, the fair value of the liability component is determined using a market rate for an equivalent non-convertible instrument. This amount is classified as a financial liability measured at amortized cost net of transaction costs until it is extinguished on conversion or redemption. The remainder of the proceeds is allocated to the conversion option that is recognized and included in equity. Transaction costs are deducted from equity. The carrying amount of the conversion option is not remeasured in subsequent years.
An exchange between an existing borrower and lender of debt instruments with substantially different terms shall be accounted for as an extinguishment of the original financial liability and the recognition of a new financial liability. The difference between the carrying amount of a financial liability extinguished or transferred to another party and the consideration paid, including any non-cash assets transferred or liabilities assumed, shall be recognised in the statements of operations and comprehensive loss.
Impairment of Financial Assets
The Company’s financial assets are assessed for impairment based on the “expected credit loss” model using the simplified approach. No provision was required as at December 31, 2021 – refer Note 21 on credit risk.
(p) | Segmented Information |
Operating segments are components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker in deciding how to allocate resources and in assessing performance. The Company has no revenue; all the Company’s assets are located, and the Company’s research, development and strategical planning operations are carried out, in Canada.
(q) | Foreign Currency Transactions and Balances |
Foreign currency transactions are translated into the functional currency using the exchange rates prevailing at the dates of the transactions or valuation where items are re-measured. Foreign exchange gains and losses resulting from the settlement of such transactions and from the translation at period-end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognized in the statements of operations and comprehensive loss. |
F-17
THE BULLET ID CORPORATION |
Notes to Financial Statements |
December 31, 2021 and 2020 |
(Stated In Canadian Dollars) |
4. | SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (cont’d) |
(r) | Recent Accounting Pronouncements Not Yet Adopted |
The following is an overview of new or amended IFRS that are relevant to the Company in preparing its financial statements in future periods. Unless noted below, the Company is in the process of assessing the impact that the new and amended standards will have on its financial statements or determining whether to adopt in advance any of the new requirements. Other accounting standards or amendments to existing accounting standards that have been issued but have future effective dates are either not applicable or are not expected to have a significant impact on the Company’s financial statements.
Amendments to IAS 1: Classification of Liabilities as Current or Non-Current
The amendment clarifies that the classification of liabilities as current or non-current on the statement of financial position should be based on rights that are in existence at the end of the reporting period.
The effective date of the amendment is for years beginning on or after January 1, 2023. The amendment will align the wording in all affected paragraphs to refer to the “right” to defer settlement by at least twelve months and make explicit that only rights in place “at the end of the reporting period” should affect the classification of a liability.
Classification will be unaffected by expectations about whether an entity will exercise its right to defer settlement of a liability and will make clear that settlement refers to the transfer to the counterparty of cash, equity instruments, other assets or services. The impact of this amendment is currently being assessed but the Company does not anticipate that it will have a material impact on the annual financial statements.
Disclosure of accounting policies: Amendments to IAS 1
IAS 1 was amended to require that only material accounting policy information shall be disclosed in the annual financial statements. The amendment will not result in changes to measurement or recognition of financial statement items, but management will undergo a review of accounting policies to ensure that only material accounting policy information is disclosed.
The effective date of the amendment is for years beginning on or after January 1, 2023. The impact of this amendment is currently being assessed. |
Definition of accounting estimates: Amendments to IAS 8
The definition of accounting estimates was amended so that accounting estimates are now defined as “monetary amounts in the financial statements that are subject to measurement uncertainty.”
The effective date of the amendment is for years beginning on or after January 1, 2023. The impact of this amendment is currently being assessed. |
F-18
THE BULLET ID CORPORATION |
Notes to Financial Statements |
December 31, 2021 and 2020 |
(Stated In Canadian Dollars) |
5. | INVESTMENT TAX CREDITS RECEIVABLE |
Investment tax credits receivable represent the amounts claimable based on the Company’s estimate of qualifying research and development expenditures incurred. These amounts are subject to review and approval by the Canada Revenue Agency prior to receipt of the funds.
The Company is entitled to apply for investment tax credits for fiscal year ended December 31, 2021 and 2020. Company’s outside consultants are in the process of completing this return. As of the date of the audit report, 2021 investment tax credits are not available and have not been recorded in these financial statements. The Company has until June 30, 2023 to file and claim these credits.
2021 | 2020 | |||||||
Opening balance | $ | 113,511 | $ | 75,700 | ||||
Proceeds from investment tax credits receivable | (113,511 | ) | (75,700 | ) | ||||
Additions | - | 113,511 | ||||||
Closing balance | $ | - | $ | 113,511 |
6. | INVENTORY |
Inventory at the year-end consisted of one ammunition packaging machine. During the year ended December 31, 2021, the Company identified circumstances which would call for evaluation of the net realizable value. A new and improved technology became available that management expect to use instead of the technology encompassed in the existing inventory. Thus, the Company recognized an inventory write-down expense of $186,125 ($291,811 in 2020) during the year ended December 31, 2021.
F-19
THE BULLET ID CORPORATION |
Notes to Financial Statements |
December 31, 2021 and 2020 |
(Stated In Canadian Dollars) |
7. | FURNITURE AND EQUIPMENT |
Furniture | Computer equipment | Total | ||||||||||
Cost | ||||||||||||
Balance as at December 31, 2020 and January 1, 2020 | $ | 1,042 | $ | 8,119 | $ | 9,161 | ||||||
Additions | - | 2,165 | 2,165 | |||||||||
Balance as at December 31, 2021 | $ | 1,042 | $ | 10,284 | $ | 11,326 |
Furniture | Computer equipment | Total | ||||||||||
Accumulated Depreciation | ||||||||||||
Balance as at January 1, 2020 | $ | 375 | $ | 4,141 | $ | 4,516 | ||||||
Depreciation for the year | 133 | 1,193 | 1,326 | |||||||||
Balance as at December 31, 2020 | 508 | 5,334 | 5,842 | |||||||||
Depreciation for the year | 107 | 1,485 | 1,592 | |||||||||
Balance as at December 31, 2021 | $ | 615 | $ | 6,819 | $ | 7,434 |
Furniture | Computer equipment | Total | ||||||||||
Net book values: | ||||||||||||
At December 31, 2021 | $ | 427 | $ | 3,465 | $ | 3,892 | ||||||
At December 31, 2020 | 534 | 2,785 | 3,319 |
F-20
THE BULLET ID CORPORATION |
Notes to Financial Statements |
December 31, 2021 and 2020 |
(Stated In Canadian Dollars) |
8. | RIGHT-OF-USE ASSET |
Premises | ||||
Cost | ||||
Balance as at December 31, 2020 and January 1, 2020 | $ | 110,352 | ||
Addition due to modification of lease | 53,571 | |||
Balance as at December 31, 2021 | $ | 163,923 |
Premises | ||||
Accumulated Depreciation | ||||
Opening balance as at January 1, 2020 | $ | 34,848 | ||
Amortization | 34,848 | |||
Balance as at December 31, 2020 | 69,696 | |||
Amortization | 31,409 | |||
Balance as at December 31, 2021 | $ | 101,105 |
Premises | ||||
Carrying value | ||||
At December 31, 2021 | $ | 62,818 | ||
At December 31, 2020 | 40,656 |
The average remaining lease term is 2 years (1.16 years in 2020). The maturity analysis of the lease liability is presented in note 13.
The lease for the premises was extended to December 2023 and the carrying amount of lease liability was remeasured due to the change in lease term resulting in the $53,571 increase in right-of-use asset.
F-21
THE BULLET ID CORPORATION |
Notes to Financial Statements |
December 31, 2021 and 2020 |
(Stated In Canadian Dollars) |
9. | INTANGIBLE ASSET |
Intangible asset represents ammunition tracking system software acquired from a third party.
Cost | ||||
Opening balance as at January 1, 2020 | $ | 959,723 | ||
Impairment | (959,723 | ) | ||
Balance as at December 31, 2020 | - | |||
Addition | - | |||
Impairment | - | |||
Balance as at December 31, 2021 | $ | - |
The Company test the intangible asset for impairment annually and more often if an event occurs or circumstances change that indicate the fair value of a cash generating unit is below its carrying amount. The qualitative factors considered include, general macroeconomic conditions, industry and market conditions, cost factors, and other relevant entity-specific events.
During the year the Company identified circumstances which would call for evaluation of intangible asset impairment. A new and improved software technology became available that management expect to use instead of the technology encompassed in the existing intangible asset. Thus, the Company determined that the existing software is impaired.
10. | LOANS PAYABLE TO (RECEIVABLE FROM) RELATED PARTIES |
Loan payable to a previous officer of the Company in the amount of $1,982 ($1,982 in 2020) is non-interest bearing, unsecured and due on demand. Loan payable to an officer of the Company in the amount of $3,063 ($3,000 in 2020) is non-interest bearing, unsecured and due on demand.
Loan payable to a director of the Company in the amount of $43,537 is non-interest bearing, unsecured and due on demand.
Advances to a director of the Company in the amount of $nil (2020 - $20,525) is non-interest bearing, unsecured and due on demand.
F-22
THE BULLET ID CORPORATION |
Notes to Financial Statements |
December 31, 2021 and 2020 |
(Stated In Canadian Dollars) |
11. | SHARE CAPITAL |
Authorized
an unlimited number of:
Common shares, no par value
Class A preferred shares, voting, redeemable, with non-cumulative dividends
Class B preferred shares, non-voting, redeemable, with non-cumulative dividends
2021 | 2020 | |||||||
Issued: | ||||||||
65,779,995 Common shares (63,124,005 in 2020) | $ | 3,269,099 | $ | 3,002,074 |
Year ended December 31, 2021:
The Company issued 200,000 common shares at $0.10/share as settlement of the loan payable (note 15).
The Company received $200,000 in connection with units issued to subscribers subsequent to the year- end.
The Company issued 2,455,990 units, of which 2,218,020 units were issued for cash at $0.25 per unit and 237,970 were issued for services valued at $0.25 per unit. Each unit consists of one common share and one common share purchase warrant, with each warrant exercisable into one common share for a period of 24 months at an exercise price of $0.40, except for 71,190 units consisted of one common share and one half of a common share purchase warrant. The proceeds from issuance of units were allocated between common shares and warrants. $366,973 was allocated to warrants and $247,025 was allocated to share capital (note 16).
Year ended December 31, 2020:
The Company raised $230,000 by issuing 2,300,000 common shares in a private placement at $0.10 per share.
1,379,439 common shares were issued for proceeds received of $128,620 from the year ended December 31, 2018 and $1,500 from the year ended December 31, 2019.
$647,542 of accounts payable was settled from the issuance of 6,474,570 common shares at $0.10 per share value based on the latest private placements.
$10,000 was received during the year in connection with 10,000 common shares to be issued to subscribers.
F-23
THE BULLET ID CORPORATION |
Notes to Financial Statements |
December 31, 2021 and 2020 |
(Stated In Canadian Dollars) |
12. | INCOME TAXES |
The reconciliation of income taxes at Canadian statutory rate with the reported loss is as follows:
2021 | 2020 | |||||||
Income tax recovery at statutory rate of 26.5% (26.5% in 2020) | $ | (268,789 | ) | $ | (496,749 | ) | ||
Change resulting from the tax effect of: | ||||||||
Share-based compensation | 2,008 | 7,319 | ||||||
Share issue costs | (4,217 | ) | (4,217 | ) | ||||
Other permanent differences | 56,462 | 259,003 | ||||||
Effect of unused tax losses not recognized as deferred tax asset | 202,288 | 244,278 | ||||||
Income tax provision - deferred | $ | (12,248 | ) | $ | 9,634 |
Deferred income taxes reflect the net tax effects of differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of the Company’s deferred tax assets and liabilities are as follows:
2021 | 2020 | |||||||
Unrecognized deferred tax asset: | ||||||||
Non-capital losses carry forward | $ | 1,097,096 | $ | 894,808 | ||||
Deferred tax liability | ||||||||
Investment tax credits | - | (30,081 | ) | |||||
Convertible debentures | (28,693 | ) | (10,860 | ) |
As of December 31, 2021, management has assessed that it is not probable that there will be sufficient future taxable profit to recognize a deferred tax asset in relation to total losses available for carry forward. The Company has non-capital loss carryforwards of $4,139,985 available for which no deferred tax asset has been recognized in these financial statements. These non-capital losses expire as follows:
2036 | $ | 39,345 | ||
2037 | 401,511 | |||
2038 | 1,000,409 | |||
2039 | 1,013,566 | |||
2040 | 921,802 | |||
2041 | 763,352 | |||
$ | 4,139,985 |
F-24
THE BULLET ID CORPORATION |
Notes to Financial Statements |
December 31, 2021 and 2020 |
(Stated In Canadian Dollars) |
13. | LEASE LIABILITIES |
2021 | 2020 | |||||||
$ | $ | |||||||
Lease liability for a premises lease (carrying value of $62,818) with interest at a rate of 10% per annum, maturing in December 2023, repayable in monthly instalments of $3,400 | 73,681 | 44,753 | ||||||
Less: current portion | (35,008 | ) | (38,037 | ) | ||||
Balance, end of year | 38,673 | 6,716 |
Interest expense related to lease liability for the year amounted to $8,723 ($6,369 in 2020).
Lease liabilities mature as follows:
$ | ||||
2022 | 40,800 | |||
2023 | 40,800 | |||
Balance, end of year | 81,600 | |||
Less: amount representing interest at 10% | (7,919 | ) | ||
73,681 |
The following are the amounts recognized in the statement of operations and comprehensive loss:
2021 | 2020 | |||||||
$ | $ | |||||||
Amortization expense of right-of-use assets | 31,409 | 34,848 | ||||||
Interest expense on lease liabilities | 8,723 | 6,369 | ||||||
Expenses relating to short-term leases | 13,425 | 4,400 | ||||||
Total cash outflow for leases | 33,366 | 40,800 |
The Company has elected not to recognize right-of-use assets and lease liabilities for short- term leases that have a lease term of 12 months or less and leases of low-value assets. The Company recognizes the lease payments associated with these leases as an expense on a straight-line basis over the lease term.
F-25
THE BULLET ID CORPORATION |
Notes to Financial Statements |
December 31, 2021 and 2020 |
(Stated In Canadian Dollars) |
14. | CONVERTIBLE DEBENTURES |
During the year ended December 31, 2019, the Company issued Convertible Unsecured Subordinated Debentures in three tranches of $150,000 originally maturing on December 1, 2019, $50,000 and $100,000 maturing on August 1, 2020, with an aggregate principal of $300,000 bearing interest at 10% per annum. During the year ended December 31, 2021, the debenture holders did not exercise their option to convert or demand for repayment and have agreed to extend the maturity date until December 31, 2025. On the date when the maturity dates were extended, the original financial liability was extinguished and the new financial liability of $64,537 has been recognized with the difference between the carrying amounts of the financial liabilities of $15,879 recognized in the statements of operations and comprehensive loss.
During the year ended December 31, 2020, the Company issued additional Convertible Unsecured Subordinated Debentures in two separate tranches of $16,950 and $110,000 maturing on July 27, 2025 and October 29, 2025, respectively. These convertible debentures bear interest at a rate of 8% per annum. The debenture holders have an option to convert each debenture into one unit for the purpose of conversion at a conversion price of $0.10 per unit. Each unit entitles the holder to one common share and one half of a warrant to acquire a common share of the Company at $0.15. The share purchase warrant expires from July 27, 2025 to October 29, 2025.
During the year ended December 31, 2021, the Company issued two additional unsecured convertible debentures of $100,000 each both maturing on May 19, 2022. These convertible debentures bear interest at a rate of 8% per annum. The debenture holders have an option to convert each debenture into one unit for the purpose of conversion at a conversion price equal to a 20% discount to their subscription price subject to a maximum of $0.25 per unit. Each unit entitles the holder to one common share and one half of a warrant to acquire a common share of the Company at $0.40.
2021 | 2020 | |||||||
Opening balance | $ | 385,967 | $ | 293,227 | ||||
New additions during the year | 181,418 | 84,510 | ||||||
Add: accretion expense | 31,703 | 8,230 | ||||||
Convertible debenture extinguishment | (80,416 | ) | - | |||||
$ | 518,672 | $ | 385,967 | |||||
Less: current | (192,705 | ) | - | |||||
325,967 | 385,967 |
The new convertible debentures were analyzed in accordance with the guidance provided under IFRS relating to the compound financial instruments. Debt element of those compound financial instruments was fair valued using a borrowing rate of 18%, based on management’s assessment of the borrowing rate on a similar instrument without equity feature. The residual amount of $18,582 ($31,193 in 2020) was allocated to equity.
Accordingly, during the year ended December 31, 2021, the Company recorded accretion expense and interest expense of $31,703 and $50,016 respectively ($8,230 and $32,085 in 2020).
15. | LOAN PAYABLE |
Loan payable to a consultant of $20,000 was unsecured, non-interest bearing and due on demand. This amount was settled through the issuance of 200,000 common shares (note 11).
F-26
THE BULLET ID CORPORATION |
Notes to Financial Statements |
December 31, 2021 and 2020 |
(Stated In Canadian Dollars) |
16. | SHARE-BASED COMPENSATION |
a) Options
The Company has adopted a stock option plan pursuant to which options may be granted to directors, officers, employees, and consultants of the Company to a maximum of 20% of the issued and outstanding common shares. The stock options cannot be assigned or transferred.
A summary of outstanding and exercisable stock options is as follows:
Exercise price | 2021 | 2020 | ||||||||||
Expiry date | ||||||||||||
January 2, 2023 | $ | 0.13 | 180,000 | 180,000 | ||||||||
January 2, 2023 | $ | 0.01 | 200,000 | 200,000 | ||||||||
January 26, 2023 | $ | 0.13 | 100,000 | 100,000 | ||||||||
May 14, 2023 | $ | 0.13 | 25,000 | 25,000 | ||||||||
July 1, 2023 | $ | 0.13 | 1,500,000 | 1,500,000 | ||||||||
October 22, 2023 | $ | 0.13 | 100,000 | 100,000 | ||||||||
October 25, 2023 | $ | 0.13 | 500,000 | 500,000 | ||||||||
Balance, end of year | 2,605,000 | 2,605,000 |
These options vest 33% per year over three years. The number of exercisable options is 2,605,000 (1,736,666 in 2020). The remaining contractual life of the outstanding options as at December 31, 2021 is 1.48 years (2.48 years in 2020).
Stock option transactions are summarized as follows:
2021 | 2020 | |||||||||||||||
Weighted Average Exercise Price | Number of options | Weighted Average Exercise Price | Number of options | |||||||||||||
Balance, beginning of year | $ | 0.12 | 2,605,000 | $ | 0.12 | 2,605,000 | ||||||||||
Expired | - | - | ||||||||||||||
Balance, end of year | $ | 0.12 | 2,605,000 | $ | 0.12 | 2,605,000 |
The fair value of stock options granted and vested during the year ended December 31, 2021 were estimated using the Black-Scholes option pricing model that resulted in a stock based compensation of $7,579 ($27,617 in 2020) using the following weighted average assumptions:
F-27
THE BULLET ID CORPORATION |
Notes to Financial Statements |
December 31, 2021 and 2020 |
(Stated In Canadian Dollars) |
16. | SHARE-BASED COMPENSATION (cont’d) |
2021 | 2020 | |||||||
Weighted average risk-free rate | 2.00 | % | 2.00 | % | ||||
Weighted average expected life of options (years) | 5.00 | 5.00 | ||||||
Weighted average volatility | 100.00 | % | 100.00 | % | ||||
Dividend | Nil | % | Nil | % | ||||
Estimated forfeiture rate | Nil | % | Nil | % |
b) Warrants
During the year ended December 31, 2021, the Company issued 2,455,990 units in a private placement of $0.25 per unit. Each unit consisted of one common share and one common share purchase warrant, with each warrant exercisable into one common share for a period of 24 months at an exercise price of $0.40, except for 71,190 of the units consisted of one common share and one half of a common share purchase warrant. The fair value of these warrants were calculated using the Black-Scholes pricing model with the assumptions of a share price of $0.25, risk-free interest rate ranging from 0.33% to 1%, 0% expected dividend yield, 2 years expected life and 100% volatility.
Common share purchase warrant transactions are summarized as follows:
2021 | 2020 | |||||||||||||||
Weighted Average Exercise Price | Number of warrants | Weighted Average Exercise Price | Number of warrants | |||||||||||||
Balance, beginning of year | $ | 0.10 | 4,323,817 | $ | 0.10 | 4,323,817 | ||||||||||
Issued | $ | 0.40 | 2,420,395 | - | ||||||||||||
Exercised | - | - | ||||||||||||||
Expired | $ | 0.15 | (3,815,500 | ) | - | |||||||||||
Balance, end of year | $ | 0.34 | 2,928,712 | $ | 0.10 | 4,323,817 |
The remaining contractual life for the outstanding warrants as at December 31, 2021 is 1.55 years (0.37 years in 2020).
No additional warrants were issued during the year ended December 31, 2020.
F-28
THE BULLET ID CORPORATION |
Notes to Financial Statements |
December 31, 2021 and 2020 |
(Stated In Canadian Dollars) |
17. | GOVERNMENT LOAN PAYABLE |
The Company has applied for, and received, governmental assistance related to the COVID 19 pandemic. The Canada Emergency Business Account (CEBA) bears interest at 0% per annum, with no principal repayments required until January 1, 2024. The Company was advanced $60,000 in 2020. If 67% of the loan $40,000 is repaid by December 31, 2023, the remaining balance of the loan $20,000 will be forgiven. Balances thereafter bear interest at the rate of 5% per annum, payable monthly. The present value of the loan of $46,817 was discounted using a rate of 5% and has been classified under non current liabilities as there is no reasonable assurance that the Company will meet the repayment conditions. During the year ended December 31, 2020, the discount on the government loan payable has been accounted for under other income as government assistance amounting to $13,183 (see note 18). Interest expense on government loan payable amounted to $2,467 for the year ended December 31, 2021 ($2,539 in 2020). The balance is due in full on December 31, 2025.
18. | GOVERNMENT ASSISTANCE |
The Government of Canada announced the Canada Emergency Rent Subsidy (“CERS”) and Canada Emergency Wage Subsidy (“CEWS”) for Canadian employers whose businesses were affected by the COVID-19 pandemic. The CERS provides a subsidy towards eligible rent expense, subject to certain criteria. The CEWS provides a subsidy towards eligible payroll expense, subject to certain criteria. Accordingly, the Company applied for CEWS and CERS to the extent it met the requirements to receive the subsidies during the year ended December 31, 2021 and $20,720 ($7,774 in 2020) was the total rent and payroll subsidy recognized in the statement of operations and comprehensive loss as government assistance at the time they are incurred.
During the year ended December 31, 2020, the discount on the government loan payable has been accounted for under other income as government assistance amounting to $13,183 (see note 17).
19. | FINANCE COSTS |
2021 | 2020 | |||||||
Interest on lease liabilities | $ | 8,723 | $ | 6,369 | ||||
Interest on convertible debentures | 50,016 | 32,085 | ||||||
Accretion on convertible debentures | 31,703 | 8,230 | ||||||
Interest on government loan | 2,467 | 2,539 | ||||||
$ | 92,909 | $ | 49,223 |
F-29
THE BULLET ID CORPORATION |
Notes to Financial Statements |
December 31, 2021 and 2020 |
(Stated In Canadian Dollars) |
20. | OTHER INCOME |
In 2020, the Company has elected to utilize the practical expedient for all rent concessions that meet the criteria as a direct consequence of the COVID-19 pandemic. The practical expedient has been applied retrospectively, meaning it has been applied to all rent concessions that satisfy the following criteria:
a) The change in lease payments results in revised consideration for the lease that is substantially the same as, or less than, the consideration for the lease immediately preceding the change;
b) The reduction in lease payments affects only payments originally due on or before June 30, 2021;
c) There is no substantive change to other terms and conditions of the lease.
By applying the practical expedient, the Company is not required to determine a revised discount rate and the effect of the change in the lease liability is reflected in the statement of loss and comprehensive loss in the period in which the event or condition that triggers the rent concession occurs. The amount recognized in the statement of operations and comprehensive loss is a gain of $13,600 for the year ended December 31, 2020 (2021 - $NIL).
21. | CAPITAL MANAGEMENT, FINANCIAL INSTRUMENTS AND RISK MANAGEMENT |
The Company is exposed to various financial instrument risks and continuously assesses the impact and likelihood of this exposure. These risks include capital management, fair value, credit risk, liquidity risk, interest rate risk and foreign currency risk. Where material, these risks are reviewed and monitored by the Board of Directors.
(a) | Capital Management
The Company manages its capital to ensure that it will be able to continue to operate on a going concern basis. The capital structure of the Company consists primarily of loans payable to related parties and share capital. The Company manages its capital by regularly monitoring its current and expected liquidity requirements. The Company is not subject to any external imposed capital requirements. | |
(b) | Fair value | |
Cash is measured using level 1 on the fair value hierarchy. All other financial instruments are measured at level 3 of the fair value hierarchy. | ||
(c) | Credit risk
Financial instruments that potentially subject the Company to a concentration of credit risk consist primarily of cash. The Company limits its exposure to credit loss by placing its cash with high credit quality financial institutions. The carrying amount of financial assets represents the maximum credit exposure. |
F-30
THE BULLET ID CORPORATION |
Notes to Financial Statements |
December 31, 2021 and 2020 |
(Stated In Canadian Dollars) |
21. | CAPITAL MANAGEMENT, FINANCIAL INSTRUMENTS AND RISK MANAGEMENT (cont’d) |
(d) | Liquidity risk | |
Liquidity risk is the risk that the Company will not be able to meet its financial obligations as they become due. The Company manages this risk by forecasting its financing needs and raising capital accordingly. Cash flow forecasts are prepared and adequate utilized borrowing facilities are monitored.
The table below analyzes the Company’s financial liabilities into relevant maturity groupings based on the remaining period at the reporting date to the contractual maturity date. The amounts disclosed in the table are the contractual undiscounted cash flows. Accounts payable and accrued liabilities balances due within 12 months equal their carrying balances as the impact of discounting is not significant. |
Less than 1 year | Between 2 and 5 years | Total | ||||||||||
As at December 31, 2021: | ||||||||||||
Accounts payable and accrued liabilities | $ | 970,278 | $ | - | $ | 970,278 | ||||||
Lease liability | 40,800 | 40,800 | 81,600 | |||||||||
Loans payable to related parties | 5,045 | - | 5,045 | |||||||||
Advances from directors | 43,537 | - | 43,537 | |||||||||
Convertible debentures | 200,000 | 426,950 | 626,950 | |||||||||
Government loan payable | - | 60,000 | 60,000 |
Less than 1 year | Between 2 and 5 years | Total | ||||||||||
As at December 31, 2020: | ||||||||||||
Accounts payable and accrued liabilities | $ | 1,016,604 | $ | - | $ | 1,016,604 | ||||||
Lease liability | 40,800 | 6,800 | 47,600 | |||||||||
Loans payable to related parties | 4,982 | - | 4,982 | |||||||||
Convertible debentures | - | 426,950 | 426,950 | |||||||||
Loan payable | 20,000 | - | 20,000 | |||||||||
Government loan payable | - | 60,000 | 60,000 |
F-31
THE BULLET ID CORPORATION |
Notes to Financial Statements |
December 31, 2021 and 2020 |
(Stated In Canadian Dollars) |
21. | CAPITAL MANAGEMENT, FINANCIAL INSTRUMENTS AND RISK MANAGEMENT (cont’d) |
(e) | Interest rate risk | |
Interest rate risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market interest rates. The Company financial debt have fixed rates of interest and therefore expose the Company to a limited interest rate fair value risk. |
(f) | Foreign currency risk | |
Currency risk is the risk that the future cash flows or fair value of the Company’s financial instruments that are denominated in a currency that is not the Company’s functional currency will fluctuate due to the change in foreign exchange rate. The functional currency of the Company is the Canadian dollar. The Company is exposed to the currency exchange rate risk on its cash and accounts payable and accrued liabilities held in US dollar. As at the period ended, the Company had $141 (2020 - $1,248) of cash and $171,670 (2020 - $178,961) of accounts payable and accrued liabilities held in US dollar. The Company does not use derivative financial instruments to mitigate its exposure to currency risk. Management, however, mitigates currency risk by regular monitoring and transacting in stable currencies. A 10% change in the value of the US dollar will result in approximately $17,200 increase/decrease in the Company’s net loss. |
22. | RELATED PARTY TRANSACTIONS |
Year ended December 31, 2021:
$14,000 in consulting fees was paid to a company owned by a director of the Company and $60,000 in consulting fees was paid to a director of the Company.
72,000 units, valued at $0.25/unit, were issued to a company owned by a director of the Company as compensation for consulting services provided and 71,190 units, valued at $0.25/unit, were issued to a director of the Company as settlement for services provided.
A total of $47,256 in salaries were paid to a director of the Company.
Amounts due to director amounted to $43,537 as at December 31, 2021.
Year ended December 31, 2020:
Amounts due from director amounted to $20,525 as at December 31, 2020.
To settle $229,031 in accrued salaries and $40,035 in amounts due to the Director and Chief Executive Officer of the Company, 2,690,066 common shares were issued at $0.10 per share. To settle $110,000 in accrued salaries owed to the previous Chief Executive Officer of the Company, 1,100,000 common shares were issued at $0.10 per share.
The Company issued $126,950 in convertible debentures to the Chief Executive Officer of the Company (see note 14).
1,000,000 common shares at $0.10 per share were issued to a Director of the Company in a private placement. 1,364,439 common shares at $0.09 per share were issued to the Chief Executive Officer of the Company in connection with $128,620 in funds received by the Company transferred from the Chief Executive Officer. During the 2020 year, the Company paid salaries and benefits to its Chief Executive Officer and co-Chief Executive Officer in the amount of $39,210 each, included in salaries and benefits. $128,883 was included in accounts payable and accrued liabilities representing the amounts owed to management.
F-32
THE BULLET ID CORPORATION |
Notes to Financial Statements |
December 31, 2021 and 2020 |
(Stated In Canadian Dollars) |
23. | CONTINGENT LIABILITY |
An action was brought against the Company from a previous consultant of the Company claiming for damages in the amount of $120,180. As at the date of these financial statements, management intends to defend the action, the outcome of this claim is uncertain and the potential loss is not measurable. As such, no amounts have been reflected in the financial statements. The Company will record a provision if it believes that the outcome of this contingency becomes probable and can be reasonably estimated.
24. | SUBSEQUENT EVENTS |
The Company’s management has evaluated subsequent events up to June 23, 2022, the date the financial statements were issued, and has determined the following material subsequent events:
The Company issued 1,600,000 common shares for $180,000 and 1,854,000 units, at a price of $0.25 per unit. Each unit comprised of one common share and one half of one common share purchase warrant, with each warrant entitling the holder thereof to acquire one common share at an exercise price of $0.40 per share for a period of two years.
The Company settled $186,250 of debt through the issuance of 221,000 common shares and 524,000 units, at a price of $0.25 per unit. 144,000 units were issued to the chief technical officer of the Company. Each unit comprised of one common share and one common share purchase warrant, with each warrant entitling the holder thereof to acquire one common share at an exercise price of $0.40 per share for a period of two years.
$200,000 in convertible debentures issued during the year ended December 31, 2021 were converted into 1,191,616 units. Each unit comprised of one common share and one common share purchase warrant, with each warrant entitling the holder thereof to acquire one common share at an exercise price of $0.40 per share for a period of two years.
F-33
PART III
INDEX TO EXHIBITS
* previously filed.
37
SIGNATURES
Pursuant to the requirements of Regulation A, the issuer certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form 1-A and has duly caused this Offering Statement to be signed on its behalf by the undersigned, thereunto duly authorized in Ontario, Canada, on, August 15, 2022.
THE BULLET ID CORPORATION | ||
By | /s/ Bruce Lewis | |
Bruce Lewis, Chief Executive Officer |
The following persons in the capacities and on the dates indicated have signed this Offering Statement.
/s/ Bruce Lewis | ||
Bruce Lewis, Chief Executive Officer, Director | ||
Date: August 15, 2022 | ||
/s/ Bruce Lewis | ||
Bruce, Lewis Chief Financial Officer, | ||
Principal Accounting Officer, Director | ||
Date: August 15, 2022 | ||
/s/ Seth Raman | ||
Seth Raman, Director |
| |
Date: August 15, 2022 | ||
/s/ Peter Breuer | ||
Peter Breuer, Director |
| |
Date: August 15, 2022 | ||
/s/ Michael Capombassis | ||
Michael Capombassis, Director |
| |
Date: August 15, 2022 | ||
/s/ Richard Senechal | ||
Richard Senechal, Director |
| |
Date: August 15, 2022 | ||
38
Exhibit 1.1
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
Exhibit 4.1
SUBSCRIPTION AGREEMENT
THIS INVESTMENT INVOLVES A HIGH DEGREE OF RISK. THIS INVESTMENT IS SUITABLE ONLY FOR PERSONS WHO CAN BEAR THE ECONOMIC RISK FOR AN INDEFINITE PERIOD OF TIME AND WHO CAN AFFORD TO LOSE THEIR ENTIRE INVESTMENT. FURTHERMORE, INVESTORS MUST UNDERSTAND THAT SUCH INVESTMENT IS ILLIQUID AND IS EXPECTED TO CONTINUE TO BE ILLIQUID FOR AN INDEFINITE PERIOD OF TIME. NO PUBLIC MARKET EXISTS FOR THE SECURITIES, AND NO PUBLIC MARKET IS EXPECTED TO DEVELOP FOLLOWING THIS OFFERING.
THE SECURITIES OFFERED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR ANY STATE SECURITIES OR BLUE SKY LAWS AND ARE BEING OFFERED AND SOLD IN RELIANCE ON EXEMPTIONS FROM THE REGISTRATION REQUIREMENTS OF THE ACT AND STATE SECURITIES OR BLUE SKY LAWS. ALTHOUGH AN OFFERING STATEMENT HAS BEEN FILED WITH THE SECURITIES AND EXCHANGE COMMISSION (THE “SEC”), THAT OFFERING STATEMENT DOES NOT INCLUDE THE SAME INFORMATION THAT WOULD BE INCLUDED IN A REGISTRATION STATEMENT UNDER THE ACT. THE SECURITIES HAVE NOT BEEN APPROVED OR DISAPPROVED BY THE SEC, ANY STATE SECURITIES COMMISSION OR OTHER REGULATORY AUTHORITY, NOR HAVE ANY OF THE FOREGOING AUTHORITIES PASSED UPON THE MERITS OF THIS OFFERING OR THE ADEQUACY OR ACCURACY OF THE SUBSCRIPTION AGREEMENT OR ANY OTHER MATERIALS OR INFORMATION MADE AVAILABLE TO INVESTOR IN CONNECTION WITH THIS OFFERING OVER THE WEB-BASED PLATFORM MAINTAINED BY THE COMPANY (THE “PLATFORM”) OR THROUGH RIALTO MARKETS LLC (THE “BROKER”). ANY REPRESENTATION TO THE CONTRARY IS UNLAWFUL.
INVESTORS WHO ARE NOT “ACCREDITED INVESTORS” (AS THAT TERM IS DEFINED IN SECTION 501 OF REGULATION D PROMULGATED UNDER THE SECURITIES ACT) ARE SUBJECT TO LIMITATIONS ON THE AMOUNT THEY MAY INVEST, AS SET OUT IN SECTION 4. THE COMPANY IS RELYING ON THE REPRESENTATIONS AND WARRANTIES SET FORTH BY EACH INVESTOR IN THIS SUBSCRIPTION AGREEMENT AND THE OTHER INFORMATION PROVIDED BY INVESTOR IN CONNECTION WITH THIS OFFERING TO DETERMINE THE APPLICABILITY TO THIS OFFERING OF EXEMPTIONS FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT.
THE OFFERING MATERIALS MAY CONTAIN FORWARD-LOOKING STATEMENTS AND INFORMATION RELATING TO, AMONG OTHER THINGS, THE COMPANY, ITS BUSINESS PLAN AND STRATEGY, AND ITS INDUSTRY. THESE FORWARD-LOOKING STATEMENTS ARE BASED ON THE BELIEFS OF, ASSUMPTIONS MADE BY, AND INFORMATION CURRENTLY AVAILABLE TO THE COMPANY’S MANAGEMENT. WHEN USED IN THE OFFERING MATERIALS, THE WORDS “ESTIMATE,” “PROJECT,” “BELIEVE,” “ANTICIPATE,” “INTEND,” “EXPECT” AND SIMILAR EXPRESSIONS ARE INTENDED TO IDENTIFY FORWARD-LOOKING STATEMENTS, WHICH CONSTITUTE FORWARD LOOKING STATEMENTS. THESE STATEMENTS REFLECT MANAGEMENT’S CURRENT VIEWS WITH RESPECT TO FUTURE EVENTS AND ARE SUBJECT TO RISKS AND UNCERTAINTIES THAT COULD CAUSE THE COMPANY’S ACTUAL RESULTS TO DIFFER MATERIALLY FROM THOSE CONTAINED IN THE FORWARD-LOOKING STATEMENTS. INVESTORS ARE CAUTIONED NOT TO PLACE UNDUE RELIANCE ON THESE FORWARD-LOOKING STATEMENTS, WHICH SPEAK ONLY AS OF THE DATE ON WHICH THEY ARE MADE. THE COMPANY DOES NOT UNDERTAKE ANY OBLIGATION TO REVISE OR UPDATE THESE FORWARD-LOOKING STATEMENTS TO REFLECT EVENTS OR CIRCUMSTANCES AFTER SUCH DATE OR TO REFLECT THE OCCURRENCE OF UNANTICIPATED EVENTS.
THE COMPANY MAY NOT BE OFFERING THE SECURITIES IN EVERY STATE. THE OFFERING MATERIALS DO NOT CONSTITUTE AN OFFER OR SOLICITATION IN ANY STATE OR JURISDICTION IN WHICH THE SECURITIES ARE NOT BEING OFFERED.
THE COMPANY RESERVES THE RIGHT IN ITS SOLE DISCRETION AND FOR ANY REASON WHATSOEVER TO MODIFY, AMEND AND/OR WITHDRAW ALL OR A PORTION OF THE OFFERING AND/OR ACCEPT OR REJECT IN WHOLE OR IN PART ANY PROSPECTIVE INVESTMENT IN THE SECURITIES OR TO ALLOT TO ANY PROSPECTIVE INVESTOR LESS THAN THE AMOUNT OF SECURITIES SUCH INVESTOR DESIRES TO PURCHASE. EXCEPT AS OTHERWISE INDICATED, THE OFFERING MATERIALS SPEAK AS OF THEIR DATE. NEITHER THE DELIVERY NOR THE PURCHASE OF THE SECURITIES SHALL, UNDER ANY CIRCUMSTANCES, CREATE ANY IMPLICATION THAT THERE HAS BEEN NO CHANGE IN THE AFFAIRS OF THE COMPANY SINCE THAT DATE.
To: | THE BULLET ID CORPORATION |
1018 Finch Avenue West, Suite 404 Toronto, Ontario, M3J 3L5 |
Ladies and Gentlemen:
1. Subscription.
(a) | The undersigned (“Subscriber”) hereby irrevocably subscribes for and agrees to purchase Common Stock (the “Securities”), of The Bullet ID Corporation, a Canadian Corporation (the “Company”), at a purchase price of $1.00 per share of Common Stock (the “Per Security Price”), upon the terms and conditions set forth herein. The minimum subscription is $750, or 750 shares of Common Stock. The rights of the Common Stock are as set forth in the Certificate of Incorporation, as amended and filed as Exhibits to the Offering Statement of the Company filed with the SEC (the “Offering Statement”). |
(b) | Subscriber understands that the Securities are being offered pursuant to an offering circular dated ______________, 2022 (the “Offering Circular”) filed with the SEC as part of the Offering Statement. By executing this Subscription Agreement, Subscriber acknowledges that Subscriber has received this Subscription Agreement, copies of the Offering Circular and Offering Statement including exhibits thereto and any other information required by the Subscriber to make an investment decision. |
(c) | The Subscriber’s subscription may be accepted or rejected in whole or in part, at any time prior to a Closing Date (as hereinafter defined), by the Company at its sole discretion. Upon the expiration of the period specified in Subscriber’s state for notice filings before sales may be made in such state, if any, the subscription may no longer be revoked at the option of the Subscriber. In addition, the Company, at its sole discretion, may allocate to Subscriber only a portion of the number of Securities Subscriber has subscribed for. The Company will notify Subscriber whether this subscription is accepted (whether in whole or in part) or rejected. If Subscriber’s subscription is rejected, Subscriber’s payment (or portion thereof if partially rejected) will be returned to Subscriber without interest and all of Subscriber’s obligations hereunder shall terminate. |
(d) | The aggregate number of Securities sold shall not exceed 52,000,000 shares of Common Stock (the “Maximum Offering”), the Company is offering up to 40,000,000 shares of Common Stock. Certain of the Company’s existing shareholders (collectively, the “Selling Shareholders”) are offering up to 12,000,000 shares of Common Stock. There is no minimum required offering amount and the Company may accept subscriptions until the termination of the Offering in accordance with its terms (the “Termination Date”). The Company may elect at any time to close all or any portion of this offering, on various dates at or prior to the Termination Date (each a “Closing Date”). |
(e) | In the event of rejection of this subscription in its entirety, or in the event the sale of the Securities (or any portion thereof) to Investor is not consummated for any reason, this Subscription Agreement shall have no force or effect with respect to the rejected subscription (or portion thereof), except for Section 5 hereof, which shall remain in force and effect. |
2
2. Purchase Procedure.
(a) | Payment. Subscriber shall deliver a signed copy of this Subscription Agreement along with payment for the aggregate purchase price of the Securities by ACH electronic transfer, wire transfer, or check to an account designated by the Company, or by any combination of such methods. |
(b) | Escrow Arrangements. Payment for the Securities shall be received by Thread Bank (the “Escrow Agent”) from the undersigned by check, wire transfer, credit or debit card, or ACH electronic transfer or other means approved by the Company at least two days prior to the applicable Closing Date, in the amount as set forth on the signature page hereto. Upon such Closing Date, the Escrow Agent shall release such funds to the Company and the Selling Shareholders. The undersigned shall receive notice and evidence of the digital entry of the number of the Securities owned by undersigned reflected on the books and records of the Company and verified by KoreConX (the “Transfer Agent”), which books and records shall bear a notation that the Securities were sold in reliance upon Regulation A. |
Upon Closing, the Escrow Agent shall release Investor’s funds to the Company and the Selling Shareholders, as applicable. The Investor shall receive notice and evidence of the digital entry of the number of the Securities owned by Investor reflected on the books and records of the Company, which books and records shall bear a notation that the Securities were sold in reliance upon Regulation A of the Securities Act.
3. Representations and Warranties of the Company. The Company represents and warrants to Investor that the following representations and warranties are true and complete in all material respects as of the date of each Closing, except as otherwise indicated. For purposes of this Agreement, an individual shall be deemed to have “knowledge” of a particular fact or other matter if such individual is actually aware of such fact. The Company will be deemed to have “knowledge” of a particular fact or other matter if one of the current officers of the Manager of the Company has, or at any time had, actual knowledge of such fact or other matter.
(a) Organization and Standing. The Company is a Canadian corporation duly formed, validly existing and in good standing under the laws of Canada. The Company has all requisite power and authority to own and operate its properties and assets, to execute and deliver this Subscription Agreement and any other agreements or instruments required hereunder. The Company is duly qualified and is authorized to do business and is in good standing as a foreign corporation in all jurisdictions in which the nature of its activities and of its properties (both owned and leased) makes such qualification necessary, except for those jurisdictions in which failure to do so would not have a material adverse effect on the Company or its business.
(b) Issuance of the Securities. The issuance, sale and delivery of the Securities by the Company in accordance with this Subscription Agreement has been duly authorized by all necessary corporate action on the part of the Company. The Securities, when so issued, sold and delivered against payment therefor in accordance with the provisions of this Subscription Agreement, will be duly and validly issued, fully paid and non-assessable.
(c) Authority for Agreement. The acceptance and delivery by the Company of this Subscription Agreement and the consummation of the transactions contemplated hereby (including the issuance, sale and delivery of the Securities) are within the Company’s powers and have been duly authorized by all necessary corporate action on the part of the Company. Upon full execution of this Subscription Agreement, this Subscription Agreement shall constitute a valid and binding agreement of the Company, enforceable against the Company in accordance with its terms, except (i) as limited by applicable bankruptcy, insolvency, reorganization, moratorium, and other laws of general application affecting enforcement of creditors’ rights generally, (ii) as limited by laws relating to the availability of specific performance, injunctive relief, or other equitable remedies and (iii) with respect to provisions relating to indemnification and contribution, as limited by considerations of public policy and by federal or state securities laws.
(d) No Filings. Assuming the accuracy of Investor’s representations and warranties set forth in Section 4 hereof, no order, license, consent, authorization or approval of, or exemption by, or action by or in respect of, or notice to, or filing or registration with, any governmental body, agency or official is required by or with respect to the Company in connection with the acceptance, delivery and performance by the Company of this Subscription Agreement except (i) for such filings as may be required under Regulation A or under any applicable state securities laws, (ii) for such other filings and approvals as have been made or obtained, or (iii) where the failure to obtain any such order, license, consent, authorization, approval or exemption or give any such notice or make any filing or registration would not have a material adverse effect on the ability of the Company to perform its obligations hereunder.
3
(e) Capitalization. The authorized and outstanding common stock of the Company immediately prior to the initial investment in the Securities is as set forth “Securities Being Offered” in the Offering Circular. Except as set forth in the Offering Circular, there are no outstanding options, warrants, rights (including conversion or preemptive rights and rights of first refusal), or agreements of any kind (oral or written) for the purchase or acquisition from the Company of any of its securities.
(f) Financial Statements. Complete copies of the Company’s financial statements, consisting of the balance sheets of the Company as of December 31, 2020 and December 31, 2021, the related statement of operations, Shareholders’ equity (deficit), and cash flows for the period ended December 31, 2020 and December 31, 2021(collectively, the “Financial Statements”), have been made available to Investor and appear in the Offering Circular. The Financial Statements are based on the books and records of the Company and fairly present the financial condition of the Company as of the respective dates they were prepared and the results of the operations and cash flows of the Company for the respective years indicated therein. SRCO Professional Corporation, which has audited the Financial Statements, is an independent accounting firm within the rules and regulations adopted by the SEC.
(g) Proceeds. The Company shall use the proceeds from the issuance and sale of the Securities sold in the offering as set forth in “Use of Proceeds” in the Offering Circular.
(h) Litigation. Except as disclosed in the Offering Circular, there is no pending action, suit, proceeding, arbitration, mediation, complaint, claim, charge or investigation before any court, arbitrator, mediator or governmental body, or to the Company’s knowledge, currently threatened in writing (a) against the Company or (b) to the Company’s knowledge, against any consultant, officer, manager, director or key employee of the Company arising out of his or her consulting, employment or board relationship with the Company or that could otherwise materially impact the Company.
(i) With respect to the Selling Shareholders and the Securities being sold by them to the Subscriber, to the Company’s knowledge:
(i) Title to the Securities. Each Selling Shareholder is the lawful owner of the Securities being offered for sale in the Offering by such Selling Shareholder, with good and marketable title thereto, and the Selling Shareholder has the absolute right to sell, assign, convey, transfer and deliver such Securities and any and all rights and benefits incident to the ownership thereof, all of which rights and benefits are transferable by the Selling Shareholder to the Subscriber, free and clear of all the following (collectively called “Claims”) of any nature whatsoever: security interests, liens, pledges, claims (pending or threatened), charges, escrows, encumbrances, lock-up arrangements, options, rights of first offer or refusal, community property rights, mortgages, indentures, security agreements or other agreements, arrangements, contracts, commitments, understandings or obligations, whether written or oral and whether or not relating in any way to credit or the borrowing of money. Delivery to the Subscriber of such Securities, upon payment therefor, will (i) pass good and marketable title to such Securities to the relevant Subscriber(s), free and clear of all Claims, and (ii) convey, free and clear of all Claims, any and all rights and benefits incident to the ownership of such Securities.
(ii) No Filings. No order, license, consent, authorization or approval of, or exemption by, or action by or in respect of, or notice to, or filing or registration with, any governmental body, agency or official is required by or with respect to each Selling Shareholder in connection with the sale and delivery of the Securities of such Selling Shareholder being sold hereunder, except (a) for such filings as may be required under Regulation A of the Securities Act, or under any applicable state securities laws, (b) for such other filings and approvals as have been made or obtained, or (c) where the failure to obtain any such order, license, consent, authorization, approval or exemption or give any such notice or make any filing or registration would not have a material adverse effect on the ability of the Selling Shareholder to perform its obligations under the transactions contemplated by this Subscription Agreement.
4
(iii) No Litigation. With respect to each Selling Shareholder, there is no action, suit, proceeding, judgment, claim or investigation pending, or to the knowledge of the Selling Shareholder, threatened against the Selling Shareholder which could reasonably be expected in any manner to challenge or seek to prevent, enjoin, alter or materially delay any of the transactions contemplated by this Subscription Agreement.
(iv) Non-Public Information. Each Selling Shareholder is not selling its Securities “on the basis of” (as defined in Rule 10b5-1 of the Exchange Act (as defined below)) any material, non-public information about the Securities or the Company.
4. Representations and Warranties of Subscriber. By executing this Subscription Agreement, Subscriber (and, if Subscriber is purchasing the Securities subscribed for hereby in a fiduciary capacity, the person or persons for whom Subscriber is so purchasing) represents and warrants, which representations and warranties are true and complete in all material respects as of such Subscriber’s respective Closing Date(s):
(a) Requisite Power and Authority. Investor has all necessary power and authority under all applicable provisions of law to subscribe to the Offering, to execute and deliver this Subscription Agreement and to carry out the provisions thereof. All action on Investor’s part required for the lawful subscription to the offering have been or will be effectively taken prior to the Closing. Upon subscribing to the Offering, this Subscription Agreement will be valid and binding obligations of Investor, enforceable in accordance with its terms, except (i) as limited by applicable bankruptcy, insolvency, reorganization, moratorium or other laws of general application affecting enforcement of creditors’ rights and (ii) as limited by general principles of equity that restrict the availability of equitable remedies.
(b) Company Information. Investor understands that the Company is subject to all the risks that apply to early-stage companies, whether or not those risks are explicitly set out in the Offering Circular. Investor has had such opportunity as it deems necessary (which opportunity may have presented through online chat or commentary functions, telephonically, or otherwise) to discuss the Company’s business, management and financial affairs with directors, officers, management, or agents of the Company and has had the opportunity to review the Company’s operations and facilities. Investor has also had the opportunity to ask questions of and receive answers from the Company and its management regarding the terms and conditions of this investment. Investor acknowledges that except as set forth herein, no representations or warranties have been made to Investor, or to Investor’s advisors or representative, by the Company or others with respect to the business or prospects of the Company or its financial condition.
(c) Investment Representations. Investor understands that the Securities have not been registered under the Securities Act of 1933, as amended (the “Securities Act”). Investor also understands that the Securities are being offered and sold pursuant to an exemption from registration contained in the Securities Act based in part upon Investor’s representations contained in this Subscription Agreement.
(d) Illiquidity and Continued Economic Risk. Investor acknowledges and agrees that there is no ready public market for the Securities and that there is no guarantee that a market for their resale will ever exist. The Company has no obligation to list any of the Securities on any market or take any steps (including registration under the Securities Act or the Securities Exchange Act of 1934, as amended (the “Exchange Act”) with respect to facilitating trading or resale of the Securities. Investor must bear the economic risk of this investment indefinitely and Investor acknowledges that Investor is able to bear the economic risk of losing Investor’s entire investment in the Securities. Investor also understands that an investment in the Company involves significant risks and has taken full cognizance of and understands all of the risk factors relating to the purchase of Securities.
(e) Accredited Investor Status or Investment Limits. Investor represents that either:
(i) Investor is an “accredited investor” within the meaning of Rule 501 of Regulation D under the Securities Act; or
5
(ii) The purchase price, together with any other amounts previously used to purchase Securities in this offering, does not exceed 10% of the greater of Investor’s annual income or net worth (or in the case where Investor is a non-natural person, their revenue or net assets for such Investor’s most recently completed fiscal year end).
Investor represents that to the extent it has any questions with respect to its status as an accredited investor, or the application of the investment limits, it has sought professional advice.
(f) Shareholder Information. Within five days after receipt of a request from the Company, Investor hereby agrees to provide such information with respect to its status as a shareholder (or potential shareholder) and to execute and deliver such documents as may reasonably be necessary to comply with any and all laws and regulations to which the Company is or may become subject, including, without limitation, the need to determine the accredited status of the Company’s Shareholders. Investor further agrees that in the event it transfers any Securities, it will require the transferee of such Securities to agree to provide such information to the Company as a condition of such transfer.
(g) Valuation. Investor acknowledges that the price of the Securities to be sold in this offering was set by the Company on the basis of the Company’s internal valuation and no warranties are made as to value. Investor further acknowledges that future offerings of securities of the Company may be made at lower valuations, with the result that Investor’s investment will bear a lower valuation.
(h) Domicile. Investor maintains Investor’s domicile (and is not a transient or temporary resident) at the address provided with Investor’s subscription.
(i) Foreign Investors. If Investor is not a United States person (as defined by Section 7701(a)(30) of the Internal Revenue Code of 1986, as amended), Investor hereby represents that it has satisfied itself as to the full observance of the laws of its jurisdiction in connection with any invitation to subscribe for the Securities or any use of this Subscription Agreement, including (i) the legal requirements within its jurisdiction for the purchase of the Securities, (ii) any foreign exchange restrictions applicable to such purchase, (iii) any governmental or other consents that may need to be obtained, and (iv) the income tax and other tax consequences, if any, that may be relevant to the purchase, holding, redemption, sale, or transfer of the Securities. Investor’s subscription and payment for and continued beneficial ownership of the Securities will not violate any applicable securities or other laws of Investor’s jurisdiction.
5. Survival of Representations and Indemnity. The representations, warranties and covenants made by the Subscriber shall survive the Termination Date. The Subscriber agrees to indemnify and hold harmless the Company, the Selling Shareholders and their respective officers, directors and affiliates, and each other person, if any, who controls the Company or any Selling Shareholder within the meaning of Section 15 of the Securities Act against any and all loss, liability, claim, damage and expense whatsoever (including, but not limited to, any and all reasonable attorneys’ fees, including attorneys’ fees on appeal) and expenses reasonably incurred in investigating, preparing or defending against any false representation or warranty or breach of failure by the Subscriber to comply with any covenant or agreement made by the Subscriber herein or in any other document furnished by the Subscriber to any of the foregoing in connection with this transaction.
6. Governing Law; Jurisdiction. This Subscription Agreement shall be governed and construed in accordance with the laws of the State of Delaware.
EACH OF THE SUBSCRIBER AND THE COMPANY CONSENTS TO THE JURISDICTION OF ANY STATE OR FEDERAL COURT OF COMPETENT JURISDICTION LOCATED WITHIN THE STATE OF DELAWARE AND NO OTHER PLACE AND IRREVOCABLY AGREES THAT ALL ACTIONS OR PROCEEDINGS RELATING TO THIS SUBSCRIPTION AGREEMENT NOT ARISING UNDER THE FEDERAL SECURITIES LAWS MAY BE LITIGATED IN SUCH COURTS. EACH OF SUBSCRIBER AND THE COMPANY ACCEPTS FOR ITSELF AND HIMSELF AND IN CONNECTION WITH ITS AND HIS RESPECTIVE PROPERTIES, GENERALLY AND UNCONDITIONALLY, THE EXCLUSIVE JURISDICTION OF THE AFORESAID COURTS AND WAIVES ANY DEFENSE OF FORUM NON CONVENIENS, AND IRREVOCABLY AGREES TO BE BOUND BY ANY JUDGMENT RENDERED THEREBY IN CONNECTION WITH THIS SUBSCRIPTION AGREEMENT NOT ARISING UNDER THE FEDERAL SECURITIES LAWS. EACH OF SUBSCRIBER AND THE COMPANY FURTHER IRREVOCABLY CONSENTS TO THE SERVICE OF PROCESS OUT OF ANY OF THE AFOREMENTIONED COURTS IN THE MANNER AND IN THE ADDRESS SPECIFIED IN SECTION 7 AND THE SIGNATURE PAGE OF THIS SUBSCRIPTION AGREEMENT.
6
EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY WAIVES ALL RIGHT TO TRIAL BY JURY IN ANY ACTION, PROCEEDING OR COUNTERCLAIM (WHETHER BASED IN CONTRACT, TORT OR OTHERWISE) ARISING OUT OF OR RELATING TO THIS SUBSCRIPTION AGREEMENT OR THE ACTIONS OF EITHER PARTY IN THE NEGOTIATION, ADMINISTRATION, PERFORMANCE AND ENFORCEMENT THEREOF, OTHER THAN CLAIMS UNDER FEDERAL SECURITIES LAWS. EACH OF THE PARTIES HERETO ALSO WAIVES ANY BOND OR SURETY OR SECURITY UPON SUCH BOND WHICH MIGHT, BUT FOR THIS WAIVER, BE REQUIRED OF SUCH PARTY. EACH OF THE PARTIES HERETO FURTHER WARRANTS AND REPRESENTS THAT IT HAS REVIEWED THIS WAIVER WITH ITS LEGAL COUNSEL, AND THAT IT KNOWINGLY AND VOLUNTARILY WAIVES ITS JURY TRIAL RIGHTS FOLLOWING CONSULTATION WITH LEGAL COUNSEL. THIS WAIVER IS IRREVOCABLE, MEANING THAT IT MAY NOT BE MODIFIED EITHER ORALLY OR IN WRITING, AND THIS WAIVER SHALL APPLY TO ANY SUBSEQUENT AMENDMENTS, RENEWALS, SUPPLEMENTS OR MODIFICATIONS TO THIS SUBSCRIPTION AGREEMENT. IN THE EVENT OF LITIGATION, THIS SUBSCRIPTION AGREEMENT MAY BE FILED AS A WRITTEN CONSENT TO A TRIAL BY THE COURT.
7. Notices. Notice, requests, demands and other communications relating to this Subscription Agreement and the transactions contemplated herein shall be in writing and shall be deemed to have been duly given if and when (a) delivered personally, on the date of such delivery; or (b) mailed by registered or certified mail, postage prepaid, return receipt requested, in the third day after the posting thereof; or (c) emailed on the date of such delivery to the address of the respective parties as follows:
If to the Company, to: | With a required copy to: | |
THE BULLET ID CORPORATION |
CrowdCheck Law LLP | |
Attn: Bruce Lewis 1018 Finch Avenue West Suite 404 Toronto, Ontario, M3J 3L5
|
Attn: | |
700 12 Street, Suite 700 | ||
Washington, DC 20005 | ||
bruce@bulletid.net |
If to Investor, at Investor’s address set forth on the signature page below, or to such other address as may be specified by written notice from time to time by the party entitled to receive such notice. Any notices, requests, demands or other communications by email shall be confirmed by letter given in accordance with this Section.
8. Miscellaneous.
(a) All pronouns and any variations thereof shall be deemed to refer to the masculine, feminine, neuter, singular or plural, as the identity of the person or persons or entity or entities may require.
(b) This Subscription Agreement is not transferable or assignable by Investor.
(c) The representations, warranties and agreements contained herein shall be deemed to be made by and be binding upon Investor and its heirs, executors, administrators and successors and shall inure to the benefit of the Company and its successors and assigns.
(d) None of the provisions of this Subscription Agreement may be waived, changed or terminated orally or otherwise, except as specifically set forth herein or except by a writing signed by the Company and Investor.
7
(e) In the event any part of this Subscription Agreement is found to be void or unenforceable, the remaining provisions are intended to be separable and binding with the same effect as if the void or unenforceable part were never the subject of agreement.
(f) The invalidity, illegality or unenforceability of one or more of the provisions of this Subscription Agreement in any jurisdiction shall not affect the validity, legality or enforceability of the remainder of this Subscription Agreement in such jurisdiction or the validity, legality or enforceability of this Subscription Agreement, including any such provision, in any other jurisdiction, it being intended that all rights and obligations of the parties hereunder shall be enforceable to the fullest extent permitted by law.
(g) This Subscription Agreement supersedes all prior discussions and agreements between the parties with respect to the subject matter hereof and contains the sole and entire agreement between the parties hereto with respect to the subject matter hereof.
(h) The terms and provisions of this Subscription Agreement are intended solely for the benefit of each party hereto and their respective successors and assigns, and it is not the intention of the parties to confer, and no provision hereof shall confer, third-party beneficiary rights upon any other person.
(i) The headings used in this Subscription Agreement have been inserted for convenience of reference only and do not define or limit the provisions hereof.
(j) This Subscription Agreement may be executed in any number of counterparts by original or electronic signature, each of which will be deemed an original, but all of which together will constitute one and the same instrument.
(k) If any recapitalization or other transaction affecting the Securities of the Company is effected, then any new, substituted or additional securities or other property which is distributed with respect to the Securities shall be immediately subject to this Subscription Agreement, to the same extent that the Securities, immediately prior thereto, shall have been covered by this Subscription Agreement.
(l) No failure or delay by any party in exercising any right, power or privilege under this Subscription Agreement shall operate as a waiver thereof nor shall any single or partial exercise thereof preclude any other or further exercise thereof or the exercise of any other right, power or privilege. The rights and remedies herein provided shall be cumulative and not exclusive of any rights or remedies provided by law.
[SIGNATURE PAGE FOLLOWS]
8
THE BULLET ID CORPORATION SUBSCRIPTION AGREEMENT SIGNATURE PAGE
The undersigned, desiring to purchase ________________ shares of Common Stock of The Bullet ID Corporation for $_________________ by executing this signature page, hereby executes, adopts and agrees to all terms, conditions and representations of the Subscription Agreement.
The Securities being subscribed for will be owned by, and should be recorded on the Company’s books as held in the name of:
(print name of owner or joint owners) |
Subscriber:
(signature) |
Name: | ||
Tax ID Number: | ||
Street Address: | ||
City: | ||
State: | ||
Postal Code: | ||
Country: | ||
Phone Number: | ||
Email Address: |
Subscription Agreement Signature Page
9
Joint Owner Subscriber (if applicable):
(signature) |
Name: | ||
Tax ID Number: | ||
Street Address: | ||
City: | ||
State: | ||
Postal Code: | ||
Country: | ||
Phone Number: | ||
Email Address: |
* * * * *
This Subscription is accepted on
Date: |
THE BULLET ID CORPORAITON | ||
By: | ||
Name: | Bruce Lewis | |
Title: | Chief Executive Officer |
Subscription Agreement Signature Page
10
APPENDIX A
An accredited investor, as defined in Rule 501(a) of the Securities Act of 1933, as amended, includes the following categories of investor:
(1) Any bank as defined in section 3(a)(2) of the Act, or any savings and loan association or other institution as defined in section 3(a)(5)(A) of the Act whether acting in its individual or fiduciary capacity; any broker or dealer registered pursuant to section 15 of the Securities Exchange Act of 1934; any investment adviser registered pursuant to section 203 of the Investment Advisers Act of 1940 or registered pursuant to the laws of a state; any investment adviser relying on the exemption from registering with the Commission under section 203(l) or (m) of the Investment Advisers Act of 1940; any insurance company as defined in section 2(a)(13) of the Act; any investment company registered under the Investment Company Act of 1940 or a business development company as defined in section 2(a)(48) of that Act; any Small Business Investment Company licensed by the U.S. Small Business Administration under section 301(c) or (d) of the Small Business Investment Act of 1958; any Rural Business Investment Company as defined in section 384A of the Consolidated Farm and Rural Development Act; any plan established and maintained by a state, its political subdivisions, or any agency or instrumentality of a state or its political subdivisions, for the benefit of its employees, if such plan has total assets in excess of $5,000,000; any employee benefit plan within the meaning of the Employee Retirement Income Security Act of 1974 if the investment decision is made by a plan fiduciary, as defined in section 3(21) of such act, which is either a bank, savings and loan association, insurance company, or registered investment adviser, or if the employee benefit plan has total assets in excess of $5,000,000 or, if a self-directed plan, with investment decisions made solely by persons that are accredited investors;
(2) Any private business development company as defined in section 202(a)(22) of the Investment Advisers Act of 1940;
(3) Any organization described in section 501(c)(3) of the Internal Revenue Code, corporation, Massachusetts or similar business trust, or partnership, or limited liability company, not formed for the specific purpose of acquiring the securities offered, with total assets in excess of $5,000,000;
(4) Any director, executive officer, or general partner of the issuer of the securities being offered or sold, or any director, executive officer, or general partner of a general partner of that issuer;
(5) Any natural person whose individual net worth, or joint net worth with that person’s spouse or spousal equivalent, exceeds $1,000,000.
(i) Except as provided in paragraph (5)(ii) of this section, for purposes of calculating net worth under this paragraph (5):
(A) The person’s primary residence shall not be included as an asset;
(B) Indebtedness that is secured by the person’s primary residence, up to the estimated fair market value of the primary residence at the time of the sale of securities, shall not be included as a liability (except that if the amount of such indebtedness outstanding at the time of sale of securities exceeds the amount outstanding 60 days before such time, other than as a result of the acquisition of the primary residence, the amount of such excess shall be included as a liability); and
(C) Indebtedness that is secured by the person’s primary residence in excess of the estimated fair market value of the primary residence at the time of the sale of securities shall be included as a liability;
(ii) Paragraph (5)(i) of this section will not apply to any calculation of a person’s net worth made in connection with a purchase of securities in accordance with a right to purchase such securities, provided that:
(A) Such right was held by the person on July 20, 2010;
11
(B) The person qualified as an accredited investor on the basis of net worth at the time the person acquired such right; and
(C) The person held securities of the same issuer, other than such right, on July 20, 2010.
(6) Any natural person who had an individual income in excess of $200,000 in each of the two most recent years or joint income with that person’s spouse or spousal equivalent in excess of $300,000 in each of those years and has a reasonable expectation of reaching the same income level in the current year;
(7) Any trust, with total assets in excess of $5,000,000, not formed for the specific purpose of acquiring the securities offered, whose purchase is directed by a sophisticated person as described in §230.506(b)(2)(ii);
(8) Any entity in which all of the equity owners are accredited investors;
(9) Any entity, of a type of not listed in paragraphs (1), (2), (3), (7), or (8), not formed for the specific purpose of acquiring the securities offered, owning investments in excess of $5,000,000;
(10) Any natural person holding in good standing one or more professional certifications or designations or credentials from an accredited educational institution that the Commission has designated as qualifying an individual for accredited investor status;
(11) Any natural person who is a “knowledgeable employee,” as defined in rule 3c-5(a)(4) under the Investment Company Act of 1940 (17 CFR 270.3c-5(a)(4)), of the issuer of the securities being offered or sold where the issuer would be an investment company, as defined in section 3 of such act, but for the exclusion provided by either section 3(c)(1) or section 3(c)(7) of such act;
(12) Any “family office,” as defined in rule 202(a)(11)(G)-1 under the Investment Advisers Act of 1940 (17 CFR 275.202(a)(11)(G)-1):
(i) With assets under management in excess of $5,000,000,
(ii) That is not formed for the specific purpose of acquiring the securities offered, and
(iii) Whose prospective investment is directed by a person who has such knowledge and experience in financial and business matters that such family office is capable of evaluating the merits and risks of the prospective investment; and
(13) Any “family client,” as defined in rule 202(a)(11)(G)-1 under the Investment Advisers Act of 1940 (17 CFR 275.202(a)(11)(G)-1)), of a family office meeting the requirements in paragraph (12) of this section and whose prospective investment in the issuer is directed by such family office pursuant to paragraph (12)(iii).
12
Exhibit 6.1
Exhibit 6.2
IRREVOCABLE POWER OF ATTORNEY
by and among
[NAME OF STOCKHOLDER]
and
Bruce Lewis
as Attorney-in-Fact,
and
The Bullet ID Corporation. (a Canadian corporation)
IRREVOCABLE POWER OF ATTORNEY
WHEREAS:
The undersigned shareholder (the “Selling Shareholder”) of Bullet ID Corporation, a Canadian corporation (the “Company”) wishes to offer shares of Common Stock of the Company (“Shares”) for sale pursuant to the Offering Statement (defined below) pursuant to which the Selling Shareholder will seek to sell the respective number of shares of Common Stock, no par value per share, of the Company (the “Common Stock”), as set forth in Exhibit A attached hereto (the “Offered Shares”);
The Selling Shareholder (defined below) understands that the Company has filed with the Securities and Exchange Commission (the “Commission”) an Offering Statement on Form 1-A (File No. 024-11933) (the “Offering Statement”) under Regulation A of the Securities Act of 1933, as amended (the “Securities Act”) in connection with the offering (the “Offering”) of shares of its Common Stock by the Company and the Selling Shareholders. The Selling Shareholder has elected to sell the Offered Shares in the Offering if the Offering is completed. Accordingly, the Offering will be qualified under the Securities Act, covering the Offered Shares to be sold by the Selling Shareholder.
The Company may undertake one or more closings (“Closings”) in respect of the Offering on an ongoing basis. Selling shareholders will participate in this Offering at the same time as the Company, selling no more than thirty percent (30%) of the shares issued to investors at each closing. That means at each closing, 30 shares will be sold by the selling shareholders for every 70 shares sold by the Company, until all 12,000,000 shares have been sold by the selling shareholders.
After each Closing, funds tendered by Investors will be available to the Company and the selling shareholders, including the Selling Shareholder, in their pro rata amount.
For avoidance of doubt, “pro rata” means that at each closing in which selling shareholders are participating, a shareholder will be able to sell its Pro Rata Portion of the shares that the shareholder is offering (as set forth in the table below) of the number of securities being issued to investors
The Selling Shareholder, by executing and delivering this Irrevocable Power of Attorney (this “Agreement”), confirms the Selling Shareholder’s willingness and intent to sell the Offered Shares in the Offering if it is completed.
It is understood that if the Selling Shareholder holds warrants, that all references herein to the Offered Shares shall mean such number of shares of Common Stock after giving effect to a cashless exercise of warrants into shares of Common Stock (“Exercise”) immediately prior to a Closing.
The Selling Shareholder hereby acknowledges receipt in electronic format of (i) a form of the subscription agreement to be executed by Investors and the Company, and (ii) the Offering Statement as originally filed and all amendments thereto, including a copy of the Preliminary Offering Circular, to be used in connection with the Offering. The Selling Shareholder understands that the subscription agreement is subject to revision before execution, with such changes as the Attorney-in-Fact deems appropriate (including with respect to the Securities Act and is subject to amendment.
NOW THEREFORE to induce the Company to enter into the subscription agreement and to secure its performance, the Selling Shareholder agrees as follows:
1. | Appointment of Attorney-in-Fact; Grant of Authority. For purposes of effecting the sale of the Offered Shares pursuant to the Offering, the Selling Shareholder irrevocably makes, constitutes and appoints Bruce Lewis the true and lawful agent and attorney-in-act of the Selling Shareholder (the “Attorney-in-Fact”), with full power and authority, subject to the terms and provisions hereof, to act hereunder, or through a duly appointed successor attorney-in-fact (it being understood that the Attorney-in-Fact shall have full power to make and substitute any executive officer or director of the Company in the place and stead of such Attorney-in-Fact (or, in the event of the death, disability or incapacity of the Attorney-in-Fact, the Company may appoint a substitute therefor), and the Selling Shareholder hereby ratifies and confirms all that the Attorney-in-Fact or successor attorney-in-fact shall do pursuant to this Agreement), in his or their sole discretion, all as hereinafter provided, in the name of and for and on behalf of the Selling Shareholder, as fully as could the Selling Shareholder if present and acting in person, with respect to the following matters in connection with and necessary and incident to the qualification and sale of the Selling Shareholder’s Shares in the Offering: |
a) | to authorize and direct the Company, Thread Bank, the Company’s Escrow Agent (“Escrow Agent”), and KoreConX, the Company’s transfer agent (“Transfer Agent”), Rialto Markets LLC, and any other person or entity to take any and all actions as may be necessary or deemed to be advisable by the Attorney-in-Fact to effect the sale, transfer and disposition of any or all of the Selling Shareholder’s Offered Shares in the Offering as the Attorney-in-Fact or any of them may, in their sole discretion, determine, including |
(i) | to direct the Company: | |
(A) | if the Selling Shareholder owns warrants, to effect an Exercise, and | |
(ii) | to direct the Escrow Agent or Transfer Agent with respect to: | |
(A) | the transfer on the stock record books of the Company of the Offered Shares in order to effect such sale (including the names in which the Offered Shares are to be issued and the denominations thereof); | |
(B) | the delivery of the Offered Shares to Investors with, if necessary, appropriate stock powers or other instruments of transfer duly endorsed or in blank against receipt by the Company of the purchase price to be paid therefor; | |
(C) | the payment by the Company (which payment may be made out of the proceeds of any sale of the Offered Shares) of the expenses, if any, to be borne by the Selling Shareholder pursuant to the Offering and such other costs and expenses as are agreed upon by such Attorney-in-Fact to be borne by the Selling Shareholder (any expenses incurred on behalf of the Company and the selling shareholders shall be apportioned among all shareholders and the Company on the basis of the respective number of shares of Common Stock to be sold by them pursuant to the Offering); and | |
(D) | the remittance to the Selling Shareholder of the balance of the proceeds from any sale of the Offered Shares. |
to prepare, execute and deliver any and all documents (the “Offering Documents”) on behalf of the Selling Shareholder with respect to the Offering, with such insertions, changes, additions or deletions therein as the Attorney-in-Fact, in his or her sole discretion, may determine to be necessary or appropriate (which may include a decrease, but not an increase, in the number of Offered Shares to be sold by the Selling Shareholder), and containing such terms as such Attorney-in-Fact, shall determine, including the price per share, the purchase price per share to be paid by Investors, and provisions concerning the Offering, the execution and delivery of such documents by the Attorney-in-Fact to be conclusive evidence with respect to his or her approval thereof, including the making of all representations and agreements to be made by, and the exercise of all authority thereunder vested in, the Selling Shareholder, and to carry out and comply with each and all of the provisions of the Offering Documents;
2
to take any and all actions that may be necessary or deemed to be advisable by the Attorney-in-Fact with respect to the Offering, including, without limitation, approval of amendments to the Offering Statement or any preliminary offering circular, the execution, acknowledgment and delivery of any certificates, documents, undertakings, representations, agreements and consents, which may be required by the Commission, appropriate authorities of states or other jurisdictions or legal counsel or such certificates, documents, undertakings, representations, agreements and consents as may otherwise be necessary or appropriate in connection with the qualification of the Shares of the Company under the Securities Act or the securities or blue sky laws of the various states or necessary to facilitate sales of the Offered Shares;
to take or cause to be taken any and all further actions, and to execute and deliver, or cause to be executed and delivered, any and all such certificates, instruments, reports, contracts, orders, receipts, notices, requests, applications, consents, undertakings, powers of attorney, instructions, certificates, letters and other writings, including communications to the Commission, documents, stock certificates and share powers and other instruments of transfer and closing as may be required to complete the Offering or as may otherwise be necessary or deemed to be advisable or desirable by the Attorney-in-Fact in connection therewith, with such changes or amendments thereto as the Attorney-in-Fact may, in his or her sole discretion, approve (such approval to be evidenced by their signature thereof), as may be necessary or deemed to be advisable or desirable by the Attorney-in-Fact to effectuate, implement and otherwise carry out the transactions contemplated by Offering and this Agreement, or as may be necessary or deemed to be advisable or desirable by the Attorney-in-Fact in connection with the qualification of the Shares of the Company, pursuant to the Securities Act or the securities or blue sky laws of the various states, the sale of the Shares to the Investors or the public offering thereof; and if necessary, to endorse (in blank or otherwise) on behalf of the Selling Shareholder any certificate or certificates representing the Offered Shares that may be issued, whether in connection with Exercise the or otherwise, or a stock power or powers attached to such certificate or certificates.
The execution of this Agreement shall not in any manner revoke, in whole or in part, any power of attorney that the Selling Shareholder has previously executed.
2. | Sole Authority of Attorney-in-Fact and the Company. The Selling Shareholder agrees that the Attorney-in-Fact has the sole authority to agree with the Company (including any pricing or similar committee established by the Board of Directors of the Company) upon the price, provided that such price is not less than $1.00 per share or such lower price per share as mandated by the Commission, at which the Shares will be sold to the public under the Offering Statement. The Selling Shareholder further agrees that the Company may withdraw the Offering Statement and terminate the Offering in its sole discretion for any reason whatsoever or for no reason, without any liability to the Selling Shareholder. |
3. | Irrevocability. The Selling Shareholder has conferred and granted the power of attorney and all other authority contained herein for the purpose of completing the Offering and in consideration of the actions of the Company in connection therewith. Therefore, the Selling Shareholder hereby agrees that all power and authority hereby conferred is coupled with an interest and is irrevocable and, to the fullest extent not prohibited by law, shall not be terminated by any act of the Selling Shareholder or by operation of law or by the occurrence of any event whatsoever, including, without limitation, the death, disability, incapacity, revocation, termination, liquidation, dissolution, bankruptcy, dissolution of marital relationship or insolvency of the Selling Shareholder (or if more than one, either or any of them) or any similar event (including, without limiting the foregoing, the termination of any trust or estate for which the Selling Shareholder is acting as a fiduciary or fiduciaries, the death or incapacity of one or more trustees, guardians, executors or administrators under such trust or estate, or the dissolution or liquidation of any corporation, partnership or other entity). If, after the execution of this Agreement, any such event shall occur before the completion of the transactions contemplated by the subscription agreement and/or this Agreement, the Attorney-in-Fact and the Transfer Agent and Escrow Agent are nevertheless authorized and directed to complete all of such transactions, including the delivery of the Selling Shareholder’s Shares to be sold to Investors, as if such event had not occurred and regardless of notice thereof. |
3
4. | Representations, Warranties and Agreements. The Selling Shareholder represents and warrants to the Company that the following representations and warranties are true and complete in all material respects as of the date hereof, as of the date of qualification of the Offering Statement by the Commission, and as of each Closing in which the Selling Shareholder participates, except as otherwise indicated. For purposes of this Agreement, an individual shall be deemed to have “knowledge” of a particular fact or other matter if such individual is actually aware of such fact. An entity will be deemed to have “knowledge” of a particular fact or other matter if one of such entity’s current officers, directors, managing member or any officer or director thereof, general partner or any officer or director thereof, or similar person of authority with respect to such Selling Shareholder has, or at any time had, actual knowledge of such fact or other matter: |
a. | Authorization of Agreement. Selling Shareholder has all necessary power and authority, including corporate under all applicable provisions of law to execute and deliver this Agreement and to perform its obligations hereunder. This Agreement is a valid and binding obligation of Selling Shareholder, enforceable in accordance with its terms, except (i) as limited by applicable bankruptcy, insolvency, reorganization, moratorium or other laws of general application affecting enforcement of creditors’ rights, (ii) as limited by general principles of equity that restrict the availability of equitable remedies, and (iii) to the extent the indemnification provisions contained herein may be limited by federal or state securities laws. |
b. | Title to the Shares. Upon taking all actions necessary, if any, as contemplated in this Agreement, Selling Shareholder is the lawful owner of the Offered Shares, with good and marketable title thereto, and the Selling Shareholder has the absolute right to sell, assign, convey, transfer and deliver such Offered Shares and any and all rights and benefits incident to the ownership thereof, all of which rights and benefits are transferable by the Selling Shareholder to Investors, free and clear of all the following (collectively called “Claims”) of any nature whatsoever: security interests, liens, pledges, claims (pending or threatened), charges, escrows, encumbrances, lock-up arrangements, options, rights of first offer or refusal, community property rights, mortgages, indentures, security agreements or other agreements, arrangements, contracts, commitments, understandings or obligations, whether written or oral and whether or not relating in any way to credit or the borrowing of money. Delivery to Investors of such Offered Shares, upon payment therefor, will (i) pass good and marketable title to such Offered Shares to the relevant Investor(s), free and clear of all Claims, and (ii) convey, free and clear of all Claims, any and all rights and benefits incident to the ownership of such Offered Shares. |
c. | No Filings. No order, license, consent, authorization or approval of, or exemption by, or action by or in respect of, or notice to, or filing or registration with, any governmental body, agency or official is required by or with respect to the Selling Shareholder in connection with the acceptance, delivery and performance by the Selling Shareholder of this Agreement or the sale and delivery of the Offered Shares of such Selling Shareholder being sold in the Offering, except (i) for such filings as may be required under Regulation A of the Securities Act, or under any applicable state securities laws, (ii) for such other filings and approvals as have been made or obtained, or (iii) where the failure to obtain any such order, license, consent, authorization, approval or exemption or give any such notice or make any filing or registration would not have a material adverse effect on the ability of the Selling Shareholder to perform its obligations hereunder and the transactions contemplated hereby. |
d. | No Litigation. There is no action, suit, proceeding, judgment, claim or investigation pending, or to the knowledge of the Selling Shareholder, threatened against the Selling Shareholder which could reasonably be expected in any manner to challenge or seek to prevent, enjoin, alter or materially delay any of the transactions contemplated by this Agreement. |
e. | Non-Public Information. Selling Shareholder is not selling its Shares “on the basis of” (as defined in Rule 10b5-1 of the Exchange Act) any material, non-public information about the Offered Shares or the Company. |
4
f. | Spousal Consent. The Selling Shareholder (if a natural person) has caused his or her spouse to join in and consent to the terms of this Agreement by executing the Consent of Spouse in the form attached hereto as Exhibit B and the Consent of Spouse is incorporated by reference herein or, if such Consent of Spouse is unsigned, the Selling Shareholder (if a natural person) has no spouse or does not reside in a state in which such Consent of Spouse is required by law to be executed. |
g. | Subsequent POA. Any subsequent power of attorney executed by the Selling Shareholder will expressly provide that the execution of such power of attorney will not revoke this Agreement. |
The foregoing representations, warranties and agreements are for the benefit of and may be relied upon by the Attorney-in-Fact, the Company, the Transfer Agent, the Escrow Agent and their respective legal counsel.
5. | Release. Subject to the provisions of Section 7 hereof, the Selling Shareholder hereby agrees to release and does release the Attorney-in-Fact and the Escrow Agent and Transfer Agent from any and all liabilities, joint or several, to which they may become subject insofar as such liabilities (or action in respect thereof) arise out of or are based upon any action taken or omitted to be taken, including but not limited to not proceeding with the Offering for any reason whatsoever, by the Attorney-in- Fact, the Escrow Agent or the Transfer Agent pursuant hereto, except for their gross negligence, willful misconduct or bad faith. |
6. | Waiver. Subject to the provision of Section 7 hereof, the Selling Shareholder acknowledges and agrees that, by accepting payment for the Offered Shares purchased by Investors the Selling Shareholder forever releases and discharges the Company and its heirs, successors and assigns from any and all claims whatsoever that the Selling Shareholder now has, or may have in the future, arising out of, or related to the Offered Shares. |
7. | Indemnification. |
a) | The Selling Shareholder agrees to indemnify and hold harmless the Attorney-in-Fact, the Escrow Agent, and the Transfer Agent and their respective officers, agents, successors, assigns and personal representatives with respect to any act or omission of or by any of them in good faith in connection with any and all matters contemplated by this Agreement. |
b) | Each indemnified party shall give notice as promptly as reasonably practicable to each indemnifying party of any action commenced against it in respect of which indemnity may be sought hereunder, but failure to so notify an indemnifying party shall not relieve such indemnifying party from any liability hereunder to the extent it is not materially prejudiced as a result thereof and in any event shall not relieve it from any liability that it may have otherwise than on account of this indemnity agreement. An indemnifying party may participate at its own expense in the defense of any such action; provided, however, that counsel to the indemnifying party shall not (except with the consent of the indemnified party) also be counsel to the indemnified party. In no event shall the indemnifying parties be liable for fees and expenses of more than one counsel (in addition to any local counsel) separate from their own counsel for all indemnified parties in connection with any one action or separate but similar or related actions in the same jurisdiction arising out of the same general allegations or circumstances. No indemnifying party shall, without the prior written consent of the indemnified parties (which consent shall not be unreasonably withheld), settle or compromise or consent to the entry of any judgment with respect to any litigation, or any investigation or proceeding by any governmental agency or body, commenced or threatened, or any claim whatsoever in respect of which indemnification could be sought under this Section 7 (whether or not the indemnified parties are actual or potential parties thereto), unless such settlement, compromise or consent (i) includes an unconditional release of each indemnified party from all liability arising out of such litigation, investigation, proceeding or claim and (ii) does not include a statement as to or an admission of fault, culpability or a failure to act by or on behalf of any indemnified party. |
8. | Termination. This Agreement shall terminate upon the earliest to occur of: |
a) | the date, if any, on which the Offering Statement is withdrawn from the Commission; and |
5
b) | the date on which the final Closing (to be determined in sole discretion of the Company) in respect of the Offering in which Offered Shares are to be sold is consummated and the proceeds have been distributed to the Selling Shareholder, whether or not all the Offered Shares owned by the Selling Shareholder are sold in the Offering, subject, however, to all lawful action done or performed by the Attorney-in-Fact or the Escrow Agent or Transfer Agent pursuant hereto prior to the termination of this Agreement. |
Notwithstanding any such termination, the representations, warranties and covenants of the Selling Shareholder contained herein and the provisions of Sections 5, 6 and 7 hereof shall survive the sale and delivery of the Offered Shares and the termination of this Agreement and remain in full force and effect. Following any termination of this Agreement, the Attorney-in-Fact, the Escrow Agent and the Transfer Agent shall have no further responsibilities or liabilities to the Selling Shareholder hereunder except to redeliver to the Selling Shareholder its Offered Shares not sold in the Offering and to distribute to the Selling Shareholder its portion of the net proceeds of the Offering, if any.
9. | Notices. Any notice required to be given pursuant to this Agreement shall be deemed given if in writing and delivered in person, or if given by telephone or telegraph if subsequently confirmed by letter: |
a) | to Bruce Lewis as Attorney-in-Fact, 1018 Finch Avenue West, Suite 404, Toronto, Ontario, M3J 3L5. |
b) | to the Company, 1018 Finch Avenue West, Suite 404, Toronto, Ontario, M3J 3L5. |
c) | to the Selling Shareholder at the addresses set forth in the stock records of the Company. |
10. | Applicable Law. The validity, enforceability, interpretation and construction of this Agreement shall be determined in accordance with the substantive laws of the State of Delaware. |
11. | Binding Effect. All authority herein conferred or agreed to be conferred shall survive the death, disability or incapacity of the Selling Shareholder, and this Agreement shall inure to the benefit of, and shall be binding upon, the Attorney-in-Fact, the Selling Shareholder and the Selling Shareholder’s heirs, executors, administrators, successors and assigns. The Escrow Agent, the Transfer Agent, the Company and all other persons dealing with the Attorney-in-Fact as such may rely and act upon any writing believed in good faith to be signed by the Attorney-in-Fact. |
12. | Recitals. The recitals to this Agreement are incorporated herein by reference and shall be deemed to be a part of this Agreement. |
13. | Counterparts. This Agreement may be signed in any number of counterparts, each of which constituting an original but all of which together constituting one instrument. |
14. | Electronic Signature. This Agreement and any other certificates, documents, undertakings, representations, agreements or consents contemplated hereby or delivered in connection herewith, including, without limitation, the subscription agreement, may be executed by an electronic signature or electronic transmission as permitted under applicable law or regulation, and shall be deemed to be written, signed and dated for purposes of execution. |
15. | Partial Unenforceability. In case any provision in this Agreement shall be invalid, illegal or unenforceable, the validity, legality and enforceability of the remaining provisions shall not in any way be affected or impaired thereby. |
[SIGNATURE PAGE FOLLOWS]
6
This Irrevocable Power of Attorney has been entered into as of ________________.
SELLING SHAREHOLDER
Very truly yours, | |
By: | |
Name: | |
Title: |
ATTORNEY-IN-FACT
Bruce Lewis hereby accepts the appointment as Attorney-in-Fact pursuant to the foregoing Irrevocable Power of Attorney and agrees to abide by and act in accordance with the terms of said Agreement.
Dated as of _________________
Name: Bruce Lewis |
THE BULLED ID CORPORATION.
This Irrevocable Power of Attorney has been entered into as of _______________.
THE BULLET ID CORPORATION | ||
By: | ||
Name: | Bruce Lewis | |
Title: | Chief Executive Officer |
7
EXHIBIT A
OFFERED SHARES
Selling Shareholder |
Amount
Owned Prior to the Offering |
Amount
Offered by Selling Shareholder |
Amount
Owned after the Offering | |||
[NAME] | XXX shares | XXX shares | XXX shares |
For Non Individual Holders:
Please list the names of all beneficial holders2 of the entity below:
2 “beneficial owners” is anyone who has sole or shared voting or investment power in respect of the entity. see Rule 13d-3 under the securities exchange act for guidance. https://www.law.cornell.edu/cfr/text/17/240.13d-3
8
EXHIBIT B
CONSENT OF SPOUSE3
I confirm that I am the spouse or another person who has a community property or similar interest in the Offered Shares of the Selling Shareholder, I confirm that I have read and understood the terms of the Irrevocable Power of Attorney and I consent to the terms thereof, including the sale of the shares of Common Stock.
Dated as of _________________
(Signature of Spouse) | |
Name: |
3 A spouse’s consent is recommended only if the Selling Shareholder’s state of residence is one of the following community property states: Arizona, California, Idaho, Louisiana, Nevada, New Mexico, Texas, Washington and Wisconsin.
9
Exhibit 8.1
ESCROW DEPOSIT AGREEMENT
This ESCROW DEPOSIT AGREEMENT (this “Agreement”) dated as of this [13th] day of [July] 2022 by and among [Bullet ID] (“Party A”), a [Canada] [Corporation], having an address at [1018 Finch Ave. West, 4th Floor North York Ontario M3J3L5 Canada], [Rialto Markets] (“Party B”), a [New York] [Corporation], having an office at [42 BROADWAY SUITE 12-129, NEW YORK, NY 10004] and THREAD BANK (“Escrow Agent”), an FDIC-insured, a Tennessee state-chartered bank and having an office at 210 East Main Street, Rogersville, TN (each a “Party” and collectively the “Parties”).
W I T N E S S E T H:
WHEREAS, Party A and Party B have agreed that a certain sum of money shall be held in escrow upon certain terms and conditions; and
WHEREAS, Party A and Party B appoint the Escrow Agent as escrow agent of such escrow subject to the terms and conditions set forth in this Agreement; and
WHEREAS, the Escrow Agent accepts such appointment as escrow agent subject to the terms and conditions set forth in this Agreement.
NOW, THEREFORE, FOR GOOD AND VALUABLE CONSIDERATION, the receipt and sufficiency of which are hereby acknowledged, the Parties hereto agree as follows:
1. Delivery of Escrow Funds.
(a) The Party A and Party B will deliver, or shall cause to be delivered, to the Escrow Agent check(s), ACH transfer(s), credit and/or debit card payment(s), or wire transfer(s) made payable to “Thread Bank as Escrow Agent for [Bullet ID]” to be held in an account at Thread Bank entitled “[Thread Bank FBO BULLET ID, Thread Bank, as Escrow Agent” having ABA No. 064202967, Account No. [1003854] ( “Escrow Account”).
(b) The collected funds deposited into the Escrow Account are referred to as the “Escrow Funds”.
(c) The Escrow Agent shall have no duty or responsibility to enforce the collection or demand payment of these check(s) or any other funds delivered to the Escrow Agent for deposit into the Escrow Account. If, for any reason, these check(s) or any other funds deposited into the Escrow Account shall be returned unpaid to the Escrow Agent, the sole duty of the Escrow Agent shall be to advise Party A and Party B promptly thereof and return check(s) in the manner directed in writing by Party A and Party B at such address prescribed in Section 9 herein.
2. Release of Escrow Funds. The Escrow Funds shall be paid by the Escrow Agent in accordance with the instructions, in form and substance satisfactory to the Escrow Agent, received from Party A and Party B or, in absence of such instructions, in accordance with the order of a court of competent jurisdiction or in such manner the Escrow Agent, in its sole discretion, deemed reasonable under the circumstance. The Escrow Agent shall not be required to pay any uncollected funds or any funds that are not available for withdrawal. The Escrow Agent may act in reliance upon any instructions, court orders, notices, certifications, demands, consents, authorizations, receipts, powers of attorney or other writings delivered to it without being required to determine the authenticity or validity thereof or the correctness of any fact stated therein, the propriety or validity of the service thereof, or the jurisdiction of the court issuing any judgment or order
1 |
3. Acceptance by Escrow Agent. The Escrow Agent hereby accepts and agrees to perform its obligations hereunder, provided that:
(a) Upon execution of this Agreement, Party A shall execute and deliver to the Escrow Agent, Exhibit A hereto and Party B shall execute and deliver to the Escrow Agent Exhibit A-1 (together with Exhibit A, each a “Certificate”) hereto, for the purpose of (i) establishing the identity of each respective authorized representative(s) of Party A and Party B entitled to singly initiate and/or confirm disbursement instructions to the Escrow Agent on behalf of each such party and (ii) providing standing wire instructions for each of Party A and Party B to be used for disbursements to said Party. The Escrow Agent may act in reliance upon any request on each Certificate reasonably believed by it to be genuine and may assume that any person who has been designated by Party A or Party B to give any written instructions, notice or receipt, or make any statements in connection with the provisions hereof has been duly authorized to do so. The Escrow Agent shall have no duty to make inquiry as to the genuineness, accuracy or validity of any statements or, including but not limited to, those contained, or contemporaneous therewith, in each Certificate. Party A and Party B may update its respective Certificate by executing and delivering to the Escrow Agent an updated Certificate in the form attached hereto as Exhibit A and/or Exhibit A-1. Until such time as the Escrow Agent shall receive an updated Certificate, the Escrow Agent shall be fully protected in relying without inquiry on the current Certificate on file with Escrow Agent.
(b) The Escrow Agent may seek confirmation of disbursement instructions by telephone call back or email to one of the authorized representatives set forth on each Certificate, and the Escrow Agent may rely upon the confirmations of anyone purporting to be the person(s) so designated. To ensure the accuracy of the instruction it receives, the Escrow Agent may record such call back. If the Escrow Agent is unable to verify the instruction or is not satisfied in its sole discretion with the verification it receives, it will not execute the instruction until all issues have been resolved to its satisfaction. Party A and Party B agree that the foregoing procedures constitute commercially reasonable security procedures. Escrow Agent further agrees not to comply with any direction or instruction (other than those contained herein or delivered in accordance with this Agreement) from Party A or Party B inconsistent with the foregoing.
(c) The Escrow Agent may act relative hereto in reliance upon advice of counsel in reference to any matter connected herewith. The Escrow Agent shall not be liable for any mistake of fact or error of judgment or law, or for any acts or omissions of any kind, unless caused by its willful misconduct or negligence.
(d) Party A and Party B, jointly and severally, agree to indemnify, release, and hold the Escrow Agent harmless from and against any and all claims, losses, costs, liabilities, damages, suits, demands, judgments or expenses, including, but not limited to, attorney’s fees, costs and disbursements, (collectively “Claims”) claimed against or incurred by the Escrow Agent arising out of or related, directly or indirectly, to this Agreement and the Escrow Agent’s performance hereunder or in connection herewith, except to the extent such Claims arise from Escrow Agent’s willful misconduct or negligence as adjudicated by a court of competent jurisdiction, as prescribed in Section 11 herein.
2 |
(e) Notwithstanding anything to the contrary herein, in the event of any disagreement between or among Party A and Party B, or between any of them and any other person, resulting in adverse claims or demands being made to the Escrow Agent in connection with the Escrow Account, or in the event that the Escrow Agent, in good faith, be in doubt as to what action it should take hereunder, the Escrow Agent may, at its sole discretion, refuse to comply with any claims or demands on it, or refuse to take any other action hereunder, so long as such disagreement continues or such doubt exists, and in any such event, the Escrow Agent shall not become liable in any way or to any person for its failure or refusal to act, and the Escrow Agent shall be entitled to continue so to refrain from acting until (i) the rights of all Parties shall have been fully and finally adjudicated by a court of competent jurisdiction, or (ii) all differences shall have been adjusted and all doubt resolved by agreement among all of the interested persons, and the Escrow Agent shall have been notified thereof in writing signed by all such persons. The Escrow Agent shall have the option, after thirty (30) days’ notice to Party A and Party B of its intention to do so, to file an action in interpleader requiring Parties to answer and litigate any claims and rights among themselves. The rights of the Escrow Agent under this section are cumulative of all other rights which it may have by law or otherwise.
(f) In the event that the Escrow Agent shall be uncertain as to its duties or rights hereunder, the Escrow Agent, with all due respect, shall be entitled to (i) refrain from taking any action other than to keep safely the Escrow Funds until it shall be directed otherwise by a court of competent jurisdiction, or (ii) deliver the Escrow Funds to a court of competent jurisdiction.
(g) The Escrow Agent shall have no duty, responsibility or obligation to interpret or enforce the terms of any agreement other than Escrow Agent’s obligations hereunder, and the Escrow Agent shall not be required to make a request that any monies be delivered to the Escrow Account, it being agreed that the sole duties and responsibilities of the Escrow Agent shall be to the extent not prohibited by applicable law (i) to accept check(s) or other instruments for the payment of money delivered to the Escrow Agent for the Escrow Account and deposit said check(s) or instruments into the Escrow Account, and (ii) disburse or refrain from disbursing the Escrow Funds as stated herein, provided that the check(s) or instruments received by the Escrow Agent have been collected and are available for withdrawal.
4. Escrow Account Statements and Information. The Escrow Agent agrees to send to Party A and/or Party B a copy of the Escrow Account periodic statement, upon request in accordance with the Escrow Agent’s regular practices for providing account statements to its non-escrow clients and to also provide Party A and/or Party B, or its designee, upon request other deposit account information, including Account balances, by telephone or by computer communication, to the extent commercially practicable. Party A and Party B agree to complete and sign all forms or agreements required by Escrow Agent for such purpose. Party A and Party B each consent to Escrow Agent’s release of such account information to any of the individuals designated by Party A or Party B, which designation has been signed in accordance with Section 3(a) by any of the persons in Schedule A. Further, Party A and Party B have an option to receive e-mail notification of incoming and outgoing wire transfers. If this e-mail notification service is requested and subsequently approved by the Escrow Agent, Party A and Party B agrees to provide a valid e-mail address and other information necessary to set-up this service and sign all forms and agreements required for such service. Party A and Party B each consent to the Escrow Agent’s release of wire transfer information to the designated e-mail address(es). The Escrow Agent’s liability for failure to comply with this section shall not exceed the cost of providing such information.
3 |
5. Resignation and Termination of the Escrow Agent. The Escrow Agent may, at its sole discretion, resign at any time by giving thirty (30) days’ prior written notice of such resignation to Party A and Party B. Upon providing such notice, the Escrow Agent shall have no further obligation hereunder except to hold the Escrow Funds that it has received as of the date on which it provided the notice of resignation as depository. In such event, the Escrow Agent shall not take any action until Party A and Party B jointly designates a banking corporation, trust company, attorney or other person as successor escrow agent. Upon receipt of such written instructions signed by Party A and Party B, the Escrow Agent shall promptly deliver the Escrow Funds, net of any outstanding charges, to such successor escrow agent and shall thereafter have no further obligations hereunder. If such instructions are not received within thirty (30) days following the effective date of such resignation, then the Escrow Agent may deposit the Escrow Funds and any other amounts held by it pursuant to this Agreement with a clerk of a court of competent jurisdiction pending the appointment of a successor escrow agent. In either case provided for in this section, the Escrow Agent shall be relieved of all further obligations and released from all liability thereafter arising with respect to the Escrow Funds.
6. Termination. Party A and Party B may terminate the appointment of the Escrow Agent hereunder upon a joint written notice to Escrow Agent specifying the date upon which such termination shall take effect. In the event of such termination, Party A and Party B shall, within thirty (30) days of such notice, jointly appoint a successor escrow agent and the Escrow Agent shall, upon receipt of written instructions signed by both Party A and Party B, turn over to such successor escrow agent all of the Escrow Funds; provided, however, that if Party A and Party B fail to appoint a successor escrow agent within such thirty (30)-day period, such termination notice shall be null and void and the Escrow Agent shall continue to be bound by all of the provisions hereof. Upon receipt of the Escrow Funds, the successor escrow agent shall become the Escrow Agent hereunder and shall be bound by all of the provisions hereof and the Escrow Agent shall be relieved of all further obligations and released from all liability thereafter arising with respect to the Escrow Funds.
7. Investment. All Escrow Funds received by the Escrow Agent shall be held only in non-interest-bearing bank accounts at Escrow Agent.
4 |
8. Compensation. The Escrow Agent shall be entitled, for the duties to be performed by it hereunder, to a fee of $6,000.00, which shall be billed to Party A and Party B on the last day of the month for which the Escrow Account had been funded (“Invoice Date”). Further, if the term of this Agreement exceeds one (1) year from the original Invoice Date, a fee of $1,500.00 will billed to Party A and Party B on each such anniversary of the Invoice Date. In addition, Escrow Agent shall be entitled, for the duties to be performed in relation to Reg CFs, to an adjusted fee of $4,500, which fee shall be billed to Party A and Party B on the Invoice Date. Further, if the term of this Agreement exceeds one (1) year from the original Invoice Date, a fee of $750 will be billed to Party A and Party B on each such anniversary of the Invoice Date. Party A and Party B shall be obligated to reimburse the Escrow Agent for all fees, costs and expenses incurred or that becomes due in connection with this Agreement or the Escrow Account, including reasonable attorney’s fees. Neither the modification, cancellation, termination or rescission of this Agreement nor the resignation or termination of the Escrow Agent shall affect the right of the Escrow Agent to retain the amount of any fee which has been paid, or to be reimbursed or paid any amount which has been incurred or becomes due, prior to the effective date of any such modification, cancellation, termination, resignation or rescission. To the extent the Escrow Agent has incurred any such expenses, or any such fee becomes due, prior to any closing, the Escrow Agent shall advise Party A and Party B, and Party A and Party B shall direct all such amounts to be paid directly at any such closing.
9. Notices. All notices, requests, demands and other communications required or permitted to be given hereunder shall be in writing and shall be deemed to have been duly given if sent by hand-delivery, by facsimile followed by first-class mail, by nationally recognized overnight courier service or by prepaid registered or certified mail, return receipt requested, to the addresses set forth below.
If to Party A:
Attention: | Tatiana Trofimova | |||
Fax No: | 1647-957-6561 |
If to Party B:
. | ||||
Attention: | Yerine Lee | |||
Fax No.: | 917-999-0091 |
If to Escrow Agent:
Thread Bank | ||||
210 East Main Street | ||||
Rogersville TN 37857 | ||||
Attention: | , Group Director and Senior Vice President | |||
Fax No.: |
5 |
10. Regulatory Compliance.
a. Party A and Party B agree to observe and comply, to the extent applicable, with all anti-money laundering laws, rules and regulations including, without limitation, regulations issued by the Office of Foreign Assets Control of the United States Department of Treasury and the Financial Crimes Enforcement Network of the U.S. Department of Treasury.
b. Party A and Party B shall provide to the Escrow Agent such information as the Escrow Agent may require to enable the Escrow Agent to comply with its obligations under the Bank Secrecy Act of 1970, as amended (“BSA”), or any regulations enacted pursuant to the BSA or any regulations, guidance, supervisory directive or order of the Tennessee Department of Financial Institutions or Federal Deposit Insurance Corporation. The Escrow Agent shall not make any payment of all or any portion of the Escrow Funds to any person unless and until such person has provided to the Escrow Agent such documents as the Escrow Agent may require to enable the Escrow Agent to comply with its obligations under BSA.
c. To help the United States government fight funding of terrorism and money laundering activities, Federal law requires all financial institutions to obtain, verify, and record information that identifies each person who opens an account. When an account is opened, and from time to time as may be required by the Escrow Agent’s internal policies and procedures, the Escrow Agent shall be entitled to ask for information that will allow the Escrow Agent to identify relevant Parties. For a non-individual person such as a business entity, a charity, a trust, or other legal entity, the Escrow Agent may request for documentation, including but not limited to, its formation and existence as a legal entity. The Escrow Agent may also request such documentation as, including but not limited to, financial statements, licenses, identification, and authorization documents from individuals claiming authority to represent the entity or other relevant documentation. Parties acknowledge and agree that a portion of the identifying information set forth herein is being requested by the Escrow Agent in connection with Title III of the USA Patriot Act, Pub.L. 107-56 (“Act”), and Party A and Party B each agrees to provide any additional information requested by the Escrow Agent, in its sole discretion, in connection with the Act or any other legislation, regulation, regulatory order or published guidance to which the Escrow Agent is subject, in a timely manner.
11. General.
a. IN THE MATTERS NOT PREEMPTED BY FEDERAL LAW, THIS AGREEMENT SHALL BE CONSTRUED AND ENFORCED IN ACCORDANCE WITH AND GOVERNED BY THE LAWS OF THE STATE OF TENNESSEE, BUT WITHOUT REGARD TO THE CONFLICT OF LAWS PRINCIPLES THEREOF.
Each Party hereby irrevocably submits to the jurisdiction of any Tennessee State or federal court sitting in or encompassing Nashville, Tennessee in any action or proceeding arising out of or relating to this Agreement, and each Party hereby irrevocably agrees that all claims in respect of such action or proceeding may be heard and determined in such state courts or, to the extent permitted by law, in such federal courts. The Parties hereby irrevocably waive, to the fullest extent they may effectively do so, the defense of an inconvenient forum to the maintenance of such action or proceeding. The Parties agree that a final judgment not subject to further appeal, in any such action or proceeding shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by law. EACH OF THE PARTIES HERETO HEREBY WAIVES ALL RIGHT TO TRIAL BY JURY IN ANY ACTION, PROCEEDING OR COUNTERCLAIM ARISING OUT OF THE TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT.
6 |
b. This Agreement sets forth the entire agreement and understanding of Parties in respect to the matters contained herein and supersedes all prior agreements, arrangements and understandings relating thereto.
c. All of the terms and conditions of this Agreement shall be binding upon, and inure to the benefit of and be enforceable by, Parties hereto, as well as its respective successors and assigns.
d. This Agreement may be amended, modified, superseded or canceled, and any of the terms or conditions hereof may be waived, only by a written instrument executed by each party hereto or, in the case of a waiver, by the Party waiving compliance. The failure of any of the Parties at any time or times to require performance of any provision hereof shall in no manner affect its right at a later time to enforce the same. No waiver of any Party of any condition, or of the breach of any term contained in this Agreement, whether by conduct or otherwise, in any one or more instances shall be deemed to be or construed as a further or continuing waiver of any such condition or breach or a waiver of any other condition or of the breach of any other term of this Agreement. Neither of the Parties may assign any rights, duties or obligations hereunder unless all other Parties have given its prior written consent.
e. If any provision included in this Agreement proves to be invalid or unenforceable, it shall not affect the validity of the remaining provisions.
f. The Parties acknowledge that each Party and its counsel have reviewed and revised this Agreement and that the normal rule of construction to the effect that any ambiguities are to be resolved against the drafting Party shall not be employed in the interpretation of this Agreement or any amendments thereto, and the same shall be construed neither for nor against either Party, but shall be given a reasonable interpretation in accordance with the plain meaning of its terms and the intent of the Parties.
g. Captions and headings in this Agreement are for convenience only and are not deemed part of this Agreement.
12. Limitation of Liability. NEITHER PARTY SHALL BE LIABLE TO THE OTHER PARTY FOR INDIRECT, SPECIAL, INCIDENTAL, PUNITIVE, CONSEQUENTIAL, OR EXEMPLARY DAMAGES OR LOST PROFITS (EVEN IF SUCH PARTY HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES) ARISING OUT OF OR IN CONNECTION WITH THE PROGRAM DOCUMENTS; PROVIDED, HOWEVER, THAT DATA BREACH, CONFIDENTIALITY BREACH AND NOTIFICATION RELATED COSTS SHALL NOT BE DEEMED INDIRECT, SPECIAL, INCIDENTAL, PUNITIVE, CONSEQUENTIAL, OR EXEMPLARY DAMAGES.
7 |
13. Condition of Effectiveness. This Agreement shall become effective when signed by the Parties herein
14. Counterparts and Facsimile Transmission. This Agreement and any modification or amendment of this Agreement may be executed in several counterparts or by separate instruments and all of such counterparts and instruments shall constitute one agreement, binding on all of the Parties hereto. The signature of a representative of Party A and Party B, to any counterpart, shall be deemed a signature to, and may be appended to, any other counterpart. Party A or Party B may deliver its signed counterpart of this Agreement to the other party by facsimile transmission, and such delivery shall be deemed made and completed upon receipt of such facsimile transmission by the other Party. Party A or Party B delivering a signed counterpart by facsimile transmission agrees to promptly send the counterpart bearing its original signature to the other Party; provided that a delay or failure to do so shall not negate the effectiveness of the delivery made by the facsimile transmission.
15. No Third-Party Beneficiaries. This Agreement is solely for the benefit of Parties and its respective successors and permitted assigns, and no other person has any right, benefit, priority or interest under or because of the existence of this Agreement.
IN WITNESS WHEREOF, Parties have duly executed this Agreement as of the date first set forth above.
[Bullet ID]
By: | ![]() |
|
Name: Bruce Lewis | ||
Title: President & CEO | ||
By: | ![]() |
|
Name: Tatiana Trofimova | ||
Title: Chief Administrative Officer | ||
By: | ![]() |
|
Name: Yana Pchelkin | ||
Title: Controller | ||
[Rialto] | ||
By: | ![]() |
|
Name: Yerine Lee | ||
Title: Operations Analyst |
8 |
By: | ![]() |
|
Name: Ryan Simmons | ||
Title: Operations Director |
THREAD BANK
By: | ![]() |
|
Name: Alex Johnston | ||
Title: Director of Operations |
By: | ![]() |
|
Name: Tyler Fruland | ||
Title: Treasury Management Operations Manager |
EXHIBIT A
CERTIFICATE OF AUTHORIZED REPRESENTATIVES – Bullet ID
Name | Thread | Initiate (Y/N) | Callback (Y/N) | Phone No. | Alt. Phone No. | |||||
Bruce Lewis | 416-271-5667 | |||||||||
Tatiana Trofimova | 647-298-1162 | |||||||||
Yana Pchelkin | 416-823-1769 | |||||||||
9 |
STANDING DOMESTIC WIRE INSTRUCTIONS FOR PARTY A
In accordance with Section 3(a) of the Agreement disbursements to Party A by wire transfer must be sent in accordance with the following wire instructions:
Bank Name: | [ ] | |
Bank Address: | [ ] | |
ABA Number: | [ ] | |
Account Number: | [ ] | |
Account Name: | [ ] |
10 |
STANDING INTERNATIONAL WIRE INSTRUCTIONS FOR PARTY A
To receive US Dollar International wire transfers in your South State Bank, N.A. account, please use the following instructions: Funds should be sent to:
Intermediary Bank Information:
South State Bank, NA
Atlanta, GA
Swift: CSBKUS33
ABA: 063116737
Account: 80014911
Beneficiary Bank:
(Your Bank Name) | |
(Your Bank Acct #) |
Beneficiary: | (Your Customer’s Name) | |
(Your Customer’s Acct#) |
South State Bank, N.A. receives wires in currencies other
than US Dollars.
If you have any questions, please contact us at:
Swift: CSBKUS33
Phone: (770) 850-3424
11 |
EXHIBIT A-1
CERTIFICATE OF AUTHORIZED REPRESENTATIVES – Rialto
Name | Thread | Initiate (Y/N) | Callback (Y/N) | Phone No. | Alt. Phone No. | |||||
Yerine Lee | 917-279-7453 | |||||||||
Ryan Simmons | 917-999-0091 | |||||||||
STANDING DOMESTIC WIRE INSTRUCTIONS FOR PARTY B
In accordance with Section 3(a) of the Agreement disbursements to Party B by wire transfer must be sent in accordance with the following wire instructions:
Bank Name: | [Piermont Bank] | |
Bank Address: | [4 Bryant Park Third Floor New York NY 10018] | |
ABA Number: | [026015053] | |
Account Number: | [1100000783] | |
Account Name: | Rialto Markets |
12 |
STANDING INTERNATIONAL WIRE INSTRUCTIONS FOR PARTY B
To receive US Dollar International wire transfers in your SouthState Bank, N.A. account, please use the following instructions: Funds should be sent to:
Intermediary Bank Information:
South State Bank, NA
Atlanta, GA
Swift: CSBKUS33
ABA: 063116737
Account: 80014911
Beneficiary Bank:
(Your Bank Name) | |
(Your Bank Acct #) |
Beneficiary: | (Your Customer’s Name) | |
(Your Customer’s Acct#) |
South State Bank, N.A. receives wires in currencies other
than US Dollars.
If you have any questions, please contact us at:
Swift: CSBKUS33
Phone: (770) 850-3424
13 |
Exhibit 11.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the use in this Registration Statement on Form 1-A/A of our audit report dated June 23, 2022 relating to the financial statements of The Bullet ID Corporation for the years ended December 31, 2021 and 2020.
/s/ SRCO Professional Corporation | |
CHARTERED PROFESSIONAL ACCOUNTANTS | |
Richmond Hill, Ontario, Canada | Authorized to practice public accounting by the |
August 15, 2022 | Chartered Professional Accountants of Ontario |
Exhibit 12.1
August 12, 2022
The Board of Directors of
The Bullet ID Corp.
To the Board of Directors:
We are acting as Canadian counsel to The Bullet ID Corp. (the “Company”) with respect to the preparation and filing of an offering statement on Form 1-A under the Securities Act of 1933 (the “Offering Statement”). The Offering Statement covers the contemplated sale of up to 40,000,000 shares of the Company’s common shares (the “Company Shares”) by the Company and up to 12,000,000 shares of the Company’s common Shares by certain selling shareholders of the Company (the “Selling Shareholders”, and such common shares being the “Selling Shareholder Shares”).
We have made such investigations and examined originals, facsimiles or copies, certified or otherwise identified to our satisfaction, of such certificates of public officials and of such other certificates, documents and records as we have considered necessary or relevant for the purposes of the opinions expressed below, including:
(a) | executed copy of the Offering Statement; |
(b) | the articles and by-laws of the Company; |
(c) | resolutions of the board of directors of the Company authorizing, among other things, the Offering Statement, the transactions contemplated therein, and the creation, issuance and sale of the Company Shares; and |
(d) | a certificate dated of even date herewith signed by the Chief Executive Officer of the Company delivered to the undersigned in support of this opinion (the “Officer’s Certificate”). |
For the purposes of this opinion, we have assumed, with respect to all documents examined by us, the genuineness of all signatures, the authenticity of all documents submitted to us as originals and the conformity to authentic original documents of all documents submitted to us as certified or conformed copies or as reproductions (including documents received by facsimile machine).
In rendering the opinions expressed herein we have also assumed:
(a) | the legal capacity of all individuals signing documents we have examined; |
(b) | the accuracy and completeness of the minute books and all other corporate records of the Company reviewed by us; |
(c) | the accuracy and completeness of all representations and statements of fact contained in all documents, instruments and certificates (including but not limited to the Officer’s Certificate); and |
(d) | the legal capacity of all individuals who are signatories to all documents, the genuineness of all signatures and the authenticity of all documents submitted to us as originals and the conformity to authentic or original documents of all documents submitted to us as certified, conformed or photostatic copies. |
CP LLP
77 King Street West, TD North Tower, Suite 700
P.O. Box 118, Toronto ON M5K 1G8 | 416.368.6200 | CPLLP.com
We have not undertaken any independent investigation to verify the accuracy of any of the foregoing assumptions.
Whenever our opinion refers to common shares whether issued or to be issued, as being “fully paid and non-assessable”, such opinion indicates that the holder of such common shares cannot be required to contribute any further amounts to the Company by virtue of his, her or its status as holder of such common shares, either in order to complete payment for the shares, to satisfy claims of creditors or otherwise. No opinion is expressed as to the adequacy of any consideration received for such common shares.
Based upon the foregoing, we are of the opinion that (i) the Company Shares are duly and validly allotted and reserved for issuance and, upon being subscribed and paid for in the manner described in the Offering Statement, will be duly and validly issued and outstanding as fully paid and non-assessable common shares in the capital of the Company; and (ii) the Selling Shareholder Shares to be sold by the Selling Shareholders in the manner described in the Offering Statement are validly issued, fully paid and nonassessable common shares in the capital of the Company
No opinion is being rendered hereby with respect to the truth and accuracy, or completeness of the Offering Statement or any portion thereof. We are solicitors qualified to carry on the practice of law in the Province of Ontario. We have not made any independent examination of the laws of any jurisdiction other than the Province of Ontario and the federal laws of Canada applicable therein. The opinions expressed herein are limited to the laws of the Province of Ontario and the federal laws of Canada applicable therein, as in force and effect on the date hereof.
This opinion is solely for the use of the addressees for the transactions contemplated herein and may not be used or relied upon by any other person or for any other purpose without our prior written consent. This opinion is limited to the matters stated herein, and no opinion or belief is implied or should be inferred beyond the matters expressly stated herein.
We further consent to the use of this opinion as an exhibit to the Offering Statement.
Yours truly, | |
![]() |
|
Chitiz Pathak LLP |
CP LLP
77 King Street West, TD North Tower, Suite 700
P.O. Box 118, Toronto ON M5K 1G8 | 416.368.6200 | CPLLP.com
Exhibit 14.1
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM F-X
APPOINTMENT OF AGENT FOR SERVICE OF PROCESS
AND UNDERTAKING
A. | Name of issuer or person filing (“Filer”): The Bullet ID Corporation. |
B. | (1) This is [check one]: |
☒ | an original filing for the Filer. |
☐ | an amended filing for the Filer. |
(2) | Check the following box if you are filing the Form F-X in paper in accordance with Regulation S-T Rule 101(b)(9) ☐ |
C. | Identify the filing in conjunction with which this Form is being filed: |
Name of registrant: | The Bullet ID Corporation | |
Form type: | Form 1-A | |
File Number (if known): | [*] | |
Filed by: | [*] | |
Date Filed (if filed concurrently, so indicate): | Concurrent |
D. | The Filer is incorporated or organized under the laws of Ontario, Canada and has its principal place of business at: |
1018 Finch Avenue West, Suite 404, Toronto, Ontario, M3J 3L5
E. | The Filer designates and appoints: |
CrowdCheck Law, LLP
700 12th Street NW
Suite 700
Washington DC 20005
as the agent (the “Agent”) of the Filer upon whom may be served any process, pleadings, subpoenas, or other papers in:
(a) | any investigation or administrative proceeding conducted by the Commission; and |
(b) | any civil suit or action brought against the Filer or to which the Filer has been joined as defendant or respondent, in any appropriate court in any place subject to the jurisdiction of any State or of the United States or of any of its territories or possessions or of the District of Columbia, where the investigation, proceeding or cause of action arises out of or relates to or concerns (i) any offering made or purported to be made in connection with the securities registered or qualified by the Filer on Form 1-A on the date hereof or any purchases or sales of any security in connection therewith; (ii) the securities in relation to which the obligation to file an annual report on Form 40-F arises, or any purchases or sales of such securities; (iii) any tender offer for the securities of a Canadian issuer with respect to which filings are made by the Filer with the Commission on Schedule 13E-4F, 14D-1F or 14D-9F; or (iv) the securities in relation to which the Filer acts as a Trustee pursuant to an exemption under Rule 10a-5 under the Trust Indenture Act of 1939. The Filer stipulates and agrees that any such civil suit or action or administrative proceeding may be commenced by the service of process upon, and that the service of an administrative subpoena shall be effected by service upon such Agent for service of process, and that service as aforesaid shall be taken and held in all courts and administrative tribunals to be valid and binding as if personal service thereof had been made. |
F. | The Filer stipulates and agrees to appoint a successor agent for service of process and file an amended Form F-X if the Filer discharges the Agent or the Agent is unwilling or unable to accept service on behalf of the Filer at any time until six years have elapsed from the date of the last sale of securities in reliance upon the Regulation A exemption. |
The Filer further undertakes to advise the Commission promptly of any change to the Agent’s name or address during the applicable period by amendment of this Form, referencing the file number of the relevant form in conjunction with which the amendment is being filed.
G. | The Filer undertakes to make available, in person or by telephone, representatives to respond to inquiries made by the Commission staff, and to furnish promptly, when requested to do so by the Commission staff, information relating to: the Form 1-A; the securities to which the Form 1-A relates; and the transactions in such securities. |
The Filer certifies that it has duly caused this power of attorney, consent, stipulation and agreement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Toronto, Province of Ontario, Country of Canada this 15th day of August 2022.
By: | /s/ Bruce Lewis | |
Name: Bruce Lewis | ||
Title: Chief Executive Officer |
This statement has been signed by the following persons in the capacities and on the date indicated.
CrowdCheck Law, LLP |
||
By: | /s/ Sara Hanks | |
Name: Sara Hanks | ||
Title: CEO | ||
Date: August 15, 2022 |
&6**22*6$%K_ "D]S'#T+?QRT_"]/Z<:N)O+XI^2_N($I:/1O:..
M."WCXX01M_2]#Q18;]DP>=[O'WS!@)8WGAGX 8..!\*ZX&MB*6*@&+D$E:3F
M5D@?W]_D]>XN^4&\J?N5+2#9KV]@M0P2M@ Q?2M[&1L[T$GUR_VFZ-_A7_^N5AZQ#,L
MZN:HZ"]! 3'!]%+*.61O\IY+T%GVSISU1V7$BIF=KPYJLF\_(8^-0/7^E-0U
M/2:3GM>(.(GD=W! BV+.:_B]
M;GR&2HF QL9*&,?'*P/<][W#AG"UJ75++7H[M"MJ%M^?J6.RQC1(!'&WW#S8
M([$%OU3 /L6?>J=C^ -&R\,4KSB9<=9D8Q@D/B[ 'G@
MH(K?M_PVU4L%!@H[5N"+/47V;0@D9%#]_ !+PK/L;)1UNTR3P\L.*M#O+"0.
M.]!2 18B[R'(+NBM##Y1".XC
MY<5$GJ-F<7 ;.R:9?QU5@'EL121VV1DGY[$'1JMNK;JPV:TS)896!\;V'EKF
MGU!!"^H"(*SJ.P7LO]"^0P6[,$L1+#][&P-:T@$$EH+2YCF@D/"M&F[1BL17N-O6)VFQ98Z(&
M!Y]7M]1PT$C\GXY/H@Z/B-KP>8MRU*5ESYHX1*YCHWQ_83V\CO YX(X*DD$%
MD=NUW%RRPV+S'3QE@=!&"^0.D!+ 0/;GA1=?J/B;%ID+*-\AQX#Q&UP]"6GD
M!W/HX%J"?Q>UZ]DY&PU
L6,5<9,"[UBD
MC74NJNUT]8QNF,LZYCLGY8' >=G B:QC&N$:"\=2]_GTG'X.W%5BEBLW6Q3!
M_)+(^.26KG^;ZW9^A#^JT=0D?@3,QD5ZCP#\='^F,# *P)#?Y;@\+:Q> P^&Q(QE*HR*FT2<0^KF@
M2N+G#[O@DH([7M/UK66SC#XZ.J)@P2=I)+_'[8DJY8.>?7.J6SXZQ,?H^O+J;'V;
T@9S"[[F]9M9VUDZ<>,AMPNL\&1CGO[5H8:ML
MF]W,_D1LV0Q5*M>EI4J],AG^H/J^1!L=&H